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ABSTRACT 
 
Low trauma hip fractures, due to bone fragility, are a major healthcare burden with 
serious consequences for individuals in terms of long-term morbidity and mortality; and 
also for society due to the high medical and care costs associated with these injuries. 
Because of the association with low bone mass, these fractures are particularly prevalent 
in elderly populations and are likely to become more common as longevity increases 
globally. Avoidance of these fractures is therefore an extremely important goal. 
 
Low bone mass, manifested in the conditions of osteopenia and osteoporosis, is the 
primary cause of bone fragility, and reductions in bone mass are the inevitable corollary 
of aging and menopause. Bone loss may be exacerbated by immobilisation and reduced 
weight-bearing activity, giving rise to the condition of disuse osteopenia. 
Immobilisation may itself be the result of low trauma leg fragility fractures that 
potentially causes further bone density loss. If this loss occurs at the hip, there is an 
increased risk for hip fracture as a sequela to the original injury. Osteoarthritis is also a 
condition strongly associated with aging that may necessitate knee arthroplasty as a last 
stage treatment, potentially causing a period of reduced mobility and weight-bearing 
activity following surgery. Leg fracture and knee replacement both present additional 
risk factors for hip fracture due to changes in muscle mass, gait and postural stability 
that may increase the risk of falls. 
 
This study aims primarily to investigate the effects of immobilisation on leg fracture 
and knee replacement patients, immediately following injury or surgery, in order to 
quantify bone and muscle loss and to monitor recovery over a one year period. A 
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postmenopausal population were studied as they are already losing bone density 
systemically and may be at greater risk of further bone loss following immobilisation. 
Factors of activity, function, weight-bearing, pain, treatments, therapies, health 
perceptions and mental wellbeing, that potentially contribute to bone loss and recovery, 
were also investigated.  Results from the study may provide information relating to 
increased future hip fracture risk and lead to treatment options to alleviate bone loss in 
these groups. 
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CHAPTER 1. INTRODUCTION 
 
1.1 MOTIVATION FOR STUDY 
Disuse osteopenia is a condition characterized by loss of bone mineral density (BMD) 
and micro-architectural changes that arise as a consequence of reduced mechanical 
loading on the skeleton. This can be due to immobilization or lack of weight-bearing (1-
5). The result of such bone density loss may be a reduction in the structural integrity of 
bones predisposing them to increased fracture risk.  Prolonged immobilization and 
reduced weight bearing activity following lower limb fractures or surgical procedures 
may result in either unilateral or bilateral loss in BMD (6-14). The resulting effects of 
disuse osteopenia can give rise to an increased probability of re-fracture at the original 
injury site or secondary fracture at another site that has also been subject to a bone 
density loss due to reduced weight-bearing (15-17). This potentially includes fractures 
of the hip, which are more closely linked to BMD than other fracture types and have the 
most serious social and economic consequences due to high rates of subsequent 
morbidity and mortality (18). Hip fractures inevitably require hospitalization and 20% 
will result in patient death within a year following injury (19). A further 50% of patients 
will remain permanently disabled (20). Hip fracture is a serious injury of older people 
and as life expectancy increases globally, the number of hip fractures is likely to 
increase commensurately. In 2000 there were approximately nine million osteoporotic 
fractures worldwide and 20% of these were hip fractures (21). It is projected that on 
current trends in the United Kingdom (UK), there could be approximately 140,000 
hospital admissions for hip fracture per year by 2036 with costs for treatment and care 
in excess of £6 billion (22). There is a 2.6–fold increase in fracture risk at the femoral  
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neck for each standard deviation (SD) decrease in BMD (23). As the rate of hip fracture 
increases exponentially with age, estimated to be a 17% lifetime risk from the age of 50 
years in white females (18), this represents a major problem for post-menopausal 
women who are already losing bone systemically due to a reduction in their oestrogen 
levels and may be at greater risk of not recovering bone following a period of disuse. 
 
Most research on disuse-induced bone loss is focused on spinal cord injury (SCI), stroke 
patients, astronauts and bed-rest volunteers and this may not be directly comparable to 
the effects of immobilization of a single limb (3). Earlier research on long-term 
unilateral disuse osteopenia is limited and the majority of studies are retrospective in 
design using bone density in the contralateral leg as a control. This does not account for 
potential residual bone deficit on the contralateral side and the full extent of bone loss in 
the ipsilateral leg may be underestimated as a result (11). This study affords an 
opportunity to assess the factors that contribute both to loss and recovery of bone mass 
and quality in a post-menopausal population over a period of one year, thereby 
identifying participants who may be at heightened fracture risk following a period of 
disuse.  Currently there is no routine clinical pathway for BMD screening when patients 
sustain low trauma leg fractures as these are not considered to be strongly related to 
bone fragility (24). Effective and relatively inexpensive pharmacological interventions 
are available to mitigate bone loss (18) and prophylactic treatment, without prior 
screening, may be indicated for high risk groups immediately following injury or 
surgery, particularly when additional risk factors for osteoporosis are present.  
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1.2 BONE ANATOMY     
                                                   
1.2.1  SKELETAL ANATOMY AND FUNCTION 
The human skeleton is a highly complex mechanical structure normally consisting of 
206 individual bones that are grouped into two skeletal divisions: appendicular and 
axial. The appendicular skeleton includes 80 bones of the arms and legs together with 
the girdles connecting the limbs to the axial skeleton. The axial skeleton comprises the 
bones arranged around the axis of the body and consists of 126 bones, including the 
spine, ribs and skull bones (25). In combination with counter balancing forces of the 
body’s musculature, the skeleton is capable of bearing loads in compression, tension 
and torsion (26). Although it primarily provides a supportive and protective framework 
for the body’s organs and tissues, it also fulfils a number of other functions. These 
include: 
 
 Insertion sites for muscles. 
 Transmission of locomotive forces through the body by acting as levers for muscle 
contractions.  
 Mineral storage, principally for calcium and phosphorus.  
 Energy storage by lipids contained in the yellow marrow within bone.  
 Hematopoiesis; the production of blood cells (red, white and platelets) in red bone 
marrow stored within certain types of bones (25, 27). 
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The individual components of the skeleton exhibit a huge diversity in size, shape and 
form, each adapted for their specific function. The capacity of bone to store energy 
elastically, and thereby resist fracture, is greatly influenced by shape and structure as 
well as by its material properties (28). Bones are classified by shape into four main 
types: 
 
 Long bones are found in the appendicular skeleton and are tubular in shape designed 
to withstand compressive loads and bending moments without excessive 
deformation e.g., femur, tibia, fibula. 
 Short bones are approximately equal in size in all directions and tend to have thin 
cortices enclosing trabecular bone. In general they are not greatly subjected to 
bending and primarily carry compressive loads over short distances e.g. bones of the 
ankle and wrist. 
 Flat bones are much thinner in one direction that the other two and generally consist 
of two sheets of cortical bone enclosing a layer of trabecular bone. Their function is 
mainly protective e.g. the skull, or the provision of large areas for the attachment of 
muscles e.g. the scapula. 
 Irregular bones have more complex shapes that partly combine the functions of the 
previous types e.g. the vertebrae, where the centra are load-bearing and similar to 
short bones whilst the projections are shaped like, and fulfil, the function of, flat 
bones (25, 29).  
 
Bone is a specialised connective tissue with a composite structure consisting of 
trabecular bone enclosed in a layer of compact cortical bone. The typical anatomy of a 
long bone is shown in Figure 1.1.  
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Fig. 1.1. Diagram illustrating the typical structure of a long bone (30). 
 
Whist fundamentally the same at a nano-structural level, trabecular and cortical bone 
tissue have different  micro- and macro-structural properties and vary in their 
distribution within different types of bones with trabecular bone mainly occupying the 
epiphyseal ends of long bones or the core of small or flat bones (31). The combination 
of these two types of bone and their spatial distribution within individual bones is 
optimized to produce site-appropriate strength and resistance to fracture (32). In a 
healthy condition, bone is able to continually adapt its mass and shape to the mechanical 
demands placed upon it. This is achieved by a process known as remodelling (27). 
 
 
This image has been removed by the author of this thesis 
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1.2.2  STRUCTURE AND COMPOSITION OF BONE 
Bone is a specialised connective tissue having a complex hierarchical structure with the 
adaptive ability to regulate its structural stiffness in response to mechanical usage (33). 
It is a composite heterogeneous material at all hierarchical levels. The mechanical 
properties of bone are influenced by both material and geometric properties at any of 
these hierarchical levels and therefore behavioural variation is exhibited according to 
the composition at various skeletal sites and in differing states of age and health (34, 
35). At a nano-structural level, bone has organic and mineral phases consisting of a soft 
organic collagen matrix interspersed and stiffened by mineral crystals of calcium 
hydroxyapatite (36). The organic matrix is mostly composed of the structural protein 
type 1 collagen and water (29).  The collagen molecules, orientated lengthwise, pack 
together to form a collagen fibril. Within these fibrils are distinct gaps termed ‘hole 
zones’ and it is in these holes that the mineral crystals form (37). These fibrils, arranged 
in parallel, combine together to form collagen fibres which form the basis of the next 
level of tissue organisation (Fig. 1.2) (34).  
 
 
 
 
 
 
 
 
 
Fig. 1.2. Diagram showing the hierarchical structure of cortical bone (38) 
 
 
This image has been removed by the author of this thesis for 
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Human bone is divided into two types; trabecular and cortical. At the nano-structural 
level, both types of bone are fundamentally the same (39). Beyond this level, the 
organisation of the tissue varies and will be discussed separately below: 
 
Cortical (also known as compact) bone forms the outer casing of bones and defines their 
external proportions and geometry. Its distribution and thickness varies in different 
types of bones and at differing sites within bone. It has a dense compact structure with 
lower surface area and porosity than trabecular bone and it accounts for approximately 
80% of total bone mass within the body (27, 40). Cortical bone tissue at the micro-
structural level consists of collagen fibres and mineral formed into layers termed 
lamellae. Spaces called lacunae form between lamellae and contain osteocyte cells. The 
lacunae are interconnected for nutrient transfer by a system of channels known as 
canaliculi. Numerous lamellae, arranged concentrically, form a unit known as an osteon 
and many osteon units combine together, generally orientated parallel to the long axis of 
bones, to form the macro-structure of cortical bone. Gaps between osteons are filled by 
interstitial lamellae which are the remnants of older osteons. A thin layer of non-
collagenous material called the cement line separates the osteon from the interstitial 
lamellar material (27, 34). Running along the center of each osteon is a channel called a 
central or Haversian canal containing blood vessels, lymphatics and nerves. The 
longitudinally arranged Haversian canals communicate with neighbouring osteons via a 
system of transverse channels termed Volkmann’s or perforating canals (25, 34, 41).   
 
Trabecular bone (also known as spongy or cancellous bone) has an open porous 
structure in which bony elements enclose spaces filled with bone marrow (Fig. 1.3). It is 
a cellular solid in engineering terms and can be regarded as a system of interconnecting 
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beams (trabeculae) (42). Whereas in cortical bone the collagen fibres are organised 
regularly in sheets of cylindrically shaped lamellae, trabecular bone consists of 
irregularly accreted lamellae that form trabecular elements in a combination of plate- 
and rod-like shapes (38). The open, porous structure of trabecular bone provides 
optimal strength for minimal weight and volume of material (43). Cement lines separate 
groups of lamellae (trabecular packets) that originate from  different periods of growth 
and remodelling (44).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.3. Scanning electron microscope image showing normal trabecular bone from a 
lumbar vertebra (45). 
 
The arrangement of the rods and plates is anisotropic (46). This appears to be an 
adaptive response to the multi-axial strains and stresses during physiological loading 
with the plates aligned longitudinally in the direction of principal axial loading and the 
rods arranged transversely, acting as stabilising links (Fig.1.4) (31, 47-49). This 
anisotropic alignment can be clearly seen in coronal sections and radiographs of the 
proximal femur (Fig. 1.5). 
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Fig. 1.4. Diagram showing principal lines of stress in the proximal femur (40) 
 
 
 
 
 
 
 
 
 
Fig. 1.5. Coronal section (a) and X-radiograph (b) of the proximal femur (50). 
 
Trabecular bone is in general more metabolically active than cortical bone and responds 
more rapidly to changes in bone formation stimuli. Both the quantity and micro-
architecture of trabecular bone material is therefore highly adaptable and varies widely 
across anatomic sites and with different age and disease states (38). In a three 
dimensional morphometric analysis of human bone biopsies, it was found that samples 
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with a lower bone mass were characterized primarily by smaller plate-to-rod ratio and to 
a lesser degree by thinner trabecular elements (51).  
 
Bone marrow occupies the medullary cavity of bone and the inter-trabecular spaces. 
This marrow is red at birth producing both red and white blood cells. It becomes 
inactive yellow marrow in adulthood except in a limited number of bones that include 
the vertebrae and proximal femur (52). 
 
Bone tissue has two main surfaces, the periosteum and endosteum. The periosteum is a 
connective tissue membrane covering the outer surface of cortical bone and contains 
osteoprogenitor cells and osteoblasts. The endosteum lines the medullary cavity of 
bones and consists of osteoprogenitor cells and osteclasts. The endosteum is further 
subdivided into intracortical, endocortical and trabecular surfaces. Bone is limited by its 
rigid non-expandable nature to appositional growth and remodelling at these surfaces. 
These surfaces may, at any time, be in a state of bone formation, resorption or 
quiescence (27). 
 
Bone cells are categorized into four main types described briefly below: 
 
 Bone lining cells cover the surfaces of bones. They are derived from 
osteoprogenitor cells and are quiescent osteoblasts (29). 
 Osteoblasts are bone forming cells derived from bone lining cells and lay down 
the collagen matrix (osteoid) into which mineral is later deposited (29). 
 Osteocyte cells are derived from osteoblasts and are located within lacunae. The 
cell bodies  have approximately 50 - 60 long slender processes that extend into 
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the canaliculi and connect them to neighbouring osteocytes and bone lining cells 
(53).  
 Osteoclasts are specialized variants of macrophage cells and are responsible for 
resorption of the mineralized bone matrix (54, 55).    
 
1.3   BONE HEALTH AND MAINTENANCE 
 
1.3.1  REMODELLING  
Bone is a dynamic tissue that has the ability to maintain itself, and adapt to the physical 
loading placed upon it, by a continual process of bone remodelling. This process is 
regulated by a combination of biomechanical and biochemical factors and continues 
throughout life, even after peak bone mass has been achieved and skeletal growth has 
been completed. The adaptive process can work in both positive and negative directions 
such that  net bone formation will result from higher than customary strains but net bone 
loss  will follow decreased activity or ‘disuse’ (56, 57). Remodelling is a complex 
process involving the interaction of different cell phenotypes and involves the coupling 
of bone resorption by osteoclast cells and bone formation by osteoblasts (Fig. 1.6) (55).  
 
 
 
 
 
 
 
Fig. 1.6. Diagram showing the bone remodelling process (58) 
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Osteoclasts are multi-nucleated cells derived from haemopoietic progenitor cells 
recruited from bone marrow and splenic tissues. They have a ruffled border and a clear 
zone that serves in the attachment of the cell to bone surfaces. Bone material is 
dissolved by lysosomal enzymes and acids secreted by the osteoclast in the area beneath 
the ruffled border which forms a resorption cavity (Fig. 1.7) (59). Osteclasts have a 
limited lifespan and ultimately undergo apoptosis. The regulation of this programmed 
cell death is important in the remodelling process and can either promote or inhibit bone 
resorption (55).  
 
Osteoprogenitor cells proliferate and differentiate into osteoblasts (60). These 
osteoblasts congregate in the resorption cavity to reform the surface as osteoid by laying 
down new matrix that is subsequently mineralised.  As the new matrix is completed, 
some osteoblast cells gradually flatten to become quiescent bone ling cells whilst others 
differentiate into osteocytes that become embedded in the lacunae of the newly formed 
bone (55). 
 
 
 
 
 
 
 
 
Fig. 1.7.  Scanning electron microscope image of  bone resorption by an osteoclast cell 
(61) 
Chapter 1 
[36] 
 
Remodelling occurs on endosteal, trabecular and intracortical surfaces and can change 
bone geometry by thinning the cortex (62). Although cortical and trabecular bone are 
both subject to the remodelling process, trabecular bone is more rapidly responsive to 
changes in loading conditions (63). Squire et al (63) found that disuse induced losses, 
after 21 days of hind limb unloading in mice, were two times greater in trabecular bone 
than in cortical bone at the distal femur and proximal tibia. Trabecular bone has up to 
eight times greater surface area per unit bone volume than cortical bone and as 
remodelling occurs on bone surfaces, those regions with higher surface area to volume 
ratio are susceptible to more immediate and severe bone loss (63).  If remodelling is in 
stasis bone is maintained in a healthy condition, however an imbalance in favour of 
bone loss will lead to the conditions of osteopenia and osteoporosis.  
 
The remodelling process has  been  known for over a century when Wolff observed  the 
mechanical adaptation of bone tissue in response to altered functional loading and 
formulated his ‘Law of Bone Remodelling’ in 1892 (55, 64). Remodelling is controlled 
by a feedback mechanism known as the ‘mechanostat’ whereby by osteocytes sense 
strains caused by mechanical usage in specific directions determined primarily by the 
contractions of regional muscles and impact forces (62, 65). The osteocyte stimulus is 
locally determined and is created by displacement of interstitial fluid through the 
lacunar-canalicular network in which the osteocytes are located (66-68). The magnitude 
of the strain is communicated to the cellular network by the magnitude of the fluid shear 
stress (64). Mechanotransduction is the process by which osteocyte cells sense these 
physical stimuli and respond with biochemical signals (69). It is proposed that this 
operates either by direct deformation of the osteocyte cell processes projecting into the 
canaliculii (70) or by means of primary cilia which are solitary rigid projections 
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extending from the osteocyte cell body into the extracellular space. (66, 71).   In vitro 
studies have demonstrated that shear stress induced by  the flow of fluid  results in the 
release of molecules including nitric oxide and prostaglandins that signal the 
remodelling response (65).   
 
The largest forces causing strains on the skeleton arise from muscle contractions (72) 
and osteocyte signalling can be reduced or absent as a result of reduced mechanical 
loading caused by immobilization and disuse (73).  Studies of bed rest in humans and 
hind limb disuse in rats have shown that muscle atrophy is also a consequence of 
reduced loading, particularly in the lower limbs, and loss of bone and muscle mass are 
therefore considered to be linked (74-78). Grosset and Onambele-Pearson (79) studied 
the time course of changes in muscle volume and shape following immobilization of the 
lower limbs and found rapid and substantial losses in muscle volumes distally & 
proximally to the immobilization site. Muscle-bone proportionality  may have a  bearing 
on the structural adequacy of bones such that a low bone mineral content value may be 
functionally adequate if it is proportional to regional or whole body muscle mass (62, 
80, 81).  
 
1.3.2  FACTORS CONTRIBUTING TO BONE HEALTH AND QUALITY 
Although mechanical loading is the principal stimulus for the remodelling process, there 
are multiple biochemical factors that interact with the mechanical control of bone 
structure and affect bone growth, renewal and quality to some degree.  The multi-
factorial and interactive regulation of bone quality is highly complex.  Mediating factors 
are broadly categorised by Davy & Hart as genetic, hormonal and metabolic as shown 
in Figure 1.8 (27). Pathological, systemic or local alterations to any of these factors can 
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lead to imbalances in the remodelling cycle and thereby cause deleterious effects on 
bone mass and quality (18). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.8. Schematic diagram of the Davy and Hart model of the adaptive feedback 
process in bone remodelling (27). 
 
 The distinction between Davy and Hart’s three categories of mediating factors is not 
necessarily clear-cut. For example, the ageing process in individuals is largely 
genetically controlled but can also be strongly influenced by lifestyle factors such as 
nutritional intake and smoking that may affect metabolism. 
 
 Genetic factors have been widely studied in twins and families and a number 
have shown the heritability of spine and hip BMD to be in the range of 70-85% 
(2). In female populations, the ages at which menarche and  menopause occur 
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have a genetic component and these affect the attainment of peak bone mass as a 
young adult as well as the onset of postmenopausal bone loss due to reduced 
oestrogen levels (2). Aging is also associated with a decrease in osteogenic 
potential (reduced osteoblast progenitor number) and an increase in apoptosis of 
the mechanosensing osteocyte cells (60, 82). Sarcopenia, i.e. age related 
reduction in muscle mass, may also have a mechanical influence on maintenance 
of bone mass, particularly in men (83). 
 
Two key determinants of bone size and mass, both genetically controlled, are 
sex and ethnicity with average females having lower bone size and peak bone 
mass than average males (84). Age related declines in bone quality and quantity 
are different between the sexes.  Dalzell et al (85) studied age related changes in 
normal adult radii and tibiae and found that, after the age of 50 years, declines in 
cortical thickness were more rapid and trabecular bone density consistently 
lower in females. Interestingly, they found that trabecular microstructural 
parameters, measured with high resolution peripheral quantitative computed 
tomography (pQCT), were not significantly associated with age. Chen et al 
found that age-related changes in cortical porosity at the femoral neck were 
more noticeable than changes in trabecular parameters (86). Schuit et al (87) 
investigated fracture incidence in elderly men and women (The Rotterdam 
Study) and found a similar pattern in both sexes for increasing non-vertebral 
fracture incidence with increasing age; however women had a higher incidence 
of these fractures compared to men of equal age. Differences in bone 
composition are evident in different ethnic groups. Asian women, for example, 
are reported to have lower areal BMD than Caucasian women or other racial 
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groups but lower incidence of hip and forearm fractures. They are also reported 
to have higher cortical thickness and density in addition to thicker trabeculae at 
the distal radius and tibia (88). Structural differences between races may not be 
solely attributable to genetic factors as local diet and exposure to sunlight (and 
thereby synthesis of vitamin D) will also contribute (89). Some cultural aspects 
of behaviour may also contribute to bone health; Mayhew et al, for example, 
suggest that the reduced hip fracture incidence in societies where near ground-
level sitting is customary, may be attributable in part to a beneficial loading 
effect from regular standing from a squatting position (90). 
 
 Metabolic factors that can affect bone growth and health are manifold. 
Maintenance of the optimal material composition of bone relies upon an 
adequate supply of key nutrients, without which pathological changes to bone 
can occur.  The effects of inadequate nutrition have been observed in adolescent 
females suffering from Anorexia Nervosa in whom osteopenia is a frequently 
observed and often persistent complication of their condition (91). A range of 
pathological and gastrointestinal conditions such as coeliac disease, 
inflammatory bowel disease, chronic liver disease, chronic pancreatitis or other 
causes of malabsorption can inhibit the uptake of nutrients and minerals thereby 
exacerbating detrimental changes to bone mass and quality (18). Calcium is a 
major constituent of the mineral composition of bone and sufficient intake and 
efficient absorption is required. In addition, vitamins D and K are necessary to 
stabilise calcium balance and have anti-resorptive and anabolic effects (92, 93). 
Increased urinary excretion of calcium and decreased intestinal absorption, 
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leading to a negative calcium balance, are observed following immobilisation 
(94, 95). 
 
 Hormonal controls modulate the functions of osteocytes, osteoblasts and 
osteoclasts in a systemic way (55, 62). The biochemistry and mechanisms of 
hormonal control in bone health encompass a vast field of knowledge and 
research and will not be covered expansively here. The main hormones affecting 
bone health are (52, 96): 
o Parathyroid hormone; produced in the parathyroid glands and regulates 
calcium and phosphate levels in the blood. 
o Growth hormone; produced in the anterior lobe of the pituitary gland and 
influences growth and remodelling of bone. 
o Thyroid hormones (T3 and T4); produced by the thyroid gland and 
influence skeletal development and bone mass. 
o The sex hormones, testosterone and oestrogen; influencing skeletal 
development and bone mass. 
 The contribution of hormonal controls to the maintenance of bone health is not 
always readily assessable. Studies of astronauts in spaceflight are conducted on 
optimally fit individuals who maintain a regime of exercise and controlled 
nutrition, nevertheless large bone losses occur due to the extreme reduction of 
weight-bearing in microgravity that confirms the importance of mechanical 
loading on bone mass. However, microgravity also affects almost all human 
physiological systems and it is proposed that alterations in immune and 
endocrine functions also play a part in this bone loss (97). A review by Sheng-
dan et al. (98) observed that the pattern of bone loss in SCI differed from that  
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found in disuse osteoporosis. Whilst bone loss occurs in the pelvis and lower 
extremities of both paraplegics and tetraplegics, there is also bone loss in the 
upper extremities of paraplegics, who have normal innervation and weight-
bearing ability in the upper limbs, indicating that  hormonal influences play a 
part in the development of osteoporosis in these populations (98, 99). Obvious 
and well understood alterations in hormonal balances are observable in 
menopause. In addition to age-related BMD deficits, the onset of menopause 
brings a gradual reduction in the levels of oestrogen with consequent bone loss 
and changes in calcium metabolism. Average bone loss in early stage 
menopause is in the region of -1% per annum but it is not consistent at all 
skeletal sites with the rate of change at the spine showing a more accelerated, 
stepped decline compared to a more gradual linear decline at the hip (100). 
 
Whilst some diseases and conditions have direct pathological effects on bone, others 
may have secondary effects due to hormonal changes resulting from that condition or as 
side-effects of medications used to treat it. Rheumatoid arthritis is a notable example 
where glucocorticoids are used to reduce the  inflammatory symptoms of the disease but 
cause enhanced bone resorption alongside suppressed bone formation that can have a 
dramatically detrimental effect on bone mass (18). Depression is a condition that is 
significantly associated with low BMD (101-103) and is discussed in detail in section 
1.3.3.  
 
It should be noted that just as deficits or imbalances in hormonal, biochemical or 
nutritional agents can cause detrimental changes in bone health, these same agents may 
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be utilised therapeutically to counteract or mitigate bone tissue deterioration and will be 
discussed further in section 1.5.1. 
 
1.3.3  RELATIONSHIP BETWEEN DEPRESSION, PAIN AND BONE HEALTH  
 
Alongside the debilitating effects of depression on general recovery in activity and 
function following injury or surgery, depression is a condition that is significantly 
associated with low BMD (101-103). The reasons for this are complex and may be 
attributable in part to lifestyle factors, hormonal changes or to pharmacological 
treatments for depression (104). Depression may cause a number of behavioural 
responses which are risk factors for secondary osteoporosis e.g. increased smoking or 
alcohol consumption, poor diet and a more sedentary lifestyle that may limit exposure 
to sunlight with consequent reduction in vitamin D levels (105). Changes in the bone 
remodelling balance may be attributable in part to hormonal changes during depressive 
episodes including increased plasma cortisol levels resulting from stress (106).  
Pharmacological treatments for depression, i.e. selective serotonin reuptake inhibitors 
(SSRIs), have been shown to contribute to reduced BMD due to their action on the 
seratonin system, which is thought to have a regulatory effect on bone mass (104, 105). 
Depression and anxiety have been identified to have a high incidence in 1,212,413 
patients undergoing total joint arthroplasty in the United States between the years of 
2000 and 2008. More than one in fourteen patients had a diagnosis of depression, 
anxiety or both which were associated with higher healthcare costs (107). 
 
The effects of pain and post-surgical nerve damage may also have implications for bone 
loss in addition to their effect on mood, mobility and weight-bearing activity. Whiteside 
Chapter 1 
[44] 
 
et al (108) report that osteopenia has been observed in humans suffering from regional 
pain syndrome and in a rat model of neuropathic pain. In a study of neuropathy-induced 
osteopenia in rats, they demonstrated a lack of correlation between BMD reduction and 
weight-bearing. This suggested that disruption to bone cell neurotransmission involved 
in the remodelling process, may also have a role in bone loss. Pain may persist for 
protracted periods after injury or surgery.  A study of 632 TKR patients by Wylde et al 
(109) found that, 3-4 years after surgery, 44% of patients experienced persistent pain of 
a varying degree of severity, with 15% suffering severe or extreme pain. As both pain 
and depression can be significant problems for patients following injury or surgery, 
these factors merit further investigation to assess their impact on recovery and bone 
fragility. 
 
 
1.4   MECHANICAL PROPERTIES OF BONE AND FRACTURE RISK 
 
1.4.1  MECHANISMS OF FAILURE 
 
It is evident that bone, as a composite structure, is highly complex and heterogeneous 
with varied geometric and material composition at different body sites and in different 
individuals. How these variations affect the mechanical behaviour and fracture potential 
for individual bones is an area that has been much studied over recent decades. The 
factors that influence the structural integrity of bone are numerous and no single factor 
can be regarded in isolation as the sole contributor to fracture risk.  
The mechanical properties of bone include strength, stiffness and the ability to absorb 
energy elastically (33). The principal skeletal property with regard to weight bearing is 
stiffness, i.e. the relationship between load on a bone and its deformation (62).  During 
Chapter 1 
[45] 
 
normal activities bones are subjected to multi-axial loading conditions in compression, 
tension and shear.  The strength of bone in these various conditions is not the same 
being lowest in shear, then tension and highest in compression (48). The architectural 
properties of bone are necessarily a compromise and cannot be optimal for all possible 
loading conditions. The stiffness measured along the long axis of bone, in the direction 
of greatest compressive loading, is in the range of 1.6 to 2.4 times that perpendicular to 
the long axis. Whilst stiffness may be the main requirement to withstand loading in 
compression and tension, some resilience to bending afforded by elastic and plastic 
properties is also required. Stiffer materials are more brittle i.e. they exhibit little or no 
plastic deformation and fail more abruptly than ductile materials which exhibit 
observable plastic deformation before fracture occurs (29).  
 
Skeletal fracture occurs where applied load exceeds strength (110).  A typical load-
deformation curve for bone is shown in Figure1.9.  As load is applied, the material 
deforms in an elastic fashion whereby the material will revert to its original shape when 
the load is removed. If loading is sustained, the yield point will be reached where the 
material begins to behave plastically and will continue to deform without the ability to 
reform its original shape. Eventually a point is reached of ultimate stress and strain 
when the load is sufficient to cause total failure and a fracture will occur. The yield and 
failure points will clearly depend on the elastic and plastic properties of the material 
(33) .  
 
 
 
 
 
Chapter 1 
[46] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.9. Diagram showing the stress-strain curve of bone (111). 
 
 
 
 
Stiffness, as shown in Figure 1.10, is a material’s resistance to deformation  given by 
the slope in the elastic region (112). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.10. Diagram showing the relationship of stiffness to stress and strain in bone 
(111). 
 
 
 
The rate of loading is an important factor in the occurrence of fracture. High trauma 
incidents, such as car crashes, where very large forces are applied suddenly, will 
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inevitably cause catastrophic failure of bone regardless of its quality and structural 
integrity.  Isolated overloading may not however cause overt fracture initially but 
repeated overloading at the same site (cyclic loading) can result in cumulative fatigue 
i.e. microdamage, even in healthy bone, that ultimately results in fracture at a later stage 
(47).  Microdamage is observed in both cortical and trabecualar bone and may be 
present either as diffuse microscopic cracks or as complete fractures of individual 
trabeculae (113). It is recognised as a normal age-related physiological phenomenon but 
can also result from bone disorders, excessive repetitious exercise or following 
implantation of orthopaedic prostheses (48). Microdamage has an important role in the 
dissipation of energy (114) but, unrepaired, results in decreased strength and stiffness in 
the affected bone that may eventually lead to failure at lower loads than would be 
required to fracture the original healthy bone (5). It is thought that remodelling targets 
microdamage to prevent the accumulation of excessive damage and that this represents 
approximately 30% of total remodelling (115). Waldorff et.al.(5) investigated 
microdamage repair in a model of rat hind-limb unloading and found that, as with 
systemic remodelling, physiologic loading is necessary to stimulate the microdamage 
repair response. 
 
Where bone quality is compromised by low density or sub-optimal structure, even low 
trauma events, such as a fall from standing height, can result in failure.  Crack 
propagation and the mechanisms of mechanical failure are complex in heterogeneous 
materials and the mechanical properties of cortical and trabecular bone components are 
not the same. Susceptibility to fracture will depend upon a combination of material and 
geometric characteristics and, when analysing fracture behaviour, it is necessary to 
consider tissue properties at both a micro-architectural and at a whole bone level (33, 
116). 
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Many studies have been conducted to identify and quantify the fracture behaviour of 
bone and thereby aid fracture prediction. Difficulties arise in attempting comparisons 
between results from such studies as the methodologies can be very varied. Lucchinetti 
et al (44) for example, provide a summary table of results from a variety of studies that 
use different experimental protocols and show measurements of  the elastic modulus of  
trabecular material ranging between 0.76 GPa and 14.8 GPa. Mechanical testing of bone 
is the field of bioengineering and can take the form of macro-scale to micro-scale 
testing i.e. from whole bones to individual trabeculae.  Problems with mechanical 
testing are manifold, not least because no two bone samples are identical and destructive 
testing can only be performed once on any given sample (117). Loading directions and 
the distribution of tensile and compressive stresses during a fall are complex and are not 
readily replicated in an experimental situation (118, 119). Additional problems in 
mechanical testing may arise due to variations in the preparation of samples that may 
have a significant effect on the mechanical properties of those samples. Bone, in vivo, 
has a variable but high water content and the hydration of test samples significantly 
affects their mechanical characteristics, with dry bone being stiffer and more brittle than 
wet (29). Removal of marrow (a viscous fluid) frequently precedes testing and this also 
affects the hydration of the sample, although marrow is not thought itself to contribute 
significantly to the mechanical behaviour of bone (29).  Erroneous results may occur 
due to unavoidable  micro-cracking damage  when cutting samples or excising 
individual trabeculae for testing (120). By its very nature, destructive testing of bone is 
usually an in vitro procedure that cannot replicate the important in vivo muscle 
interactions that are determinants of load transmission across joints and of stress 
distribution within bones (27). Finite element analysis (FEA) affords a reproducible 
method to test and apply different loading conditions to generic samples created from 
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three dimensional computational models based on computed tomography (CT) derived 
data of real bone architectures (43).   
 
The relative contributions of cortical & trabecular bone to whole bone mechanics are 
poorly understood and studies generally focus on either bone type in isolation (121). 
Reich and Geffen (122), in an in vitro study of the avian femur, found the deformation 
response and impact resistance of whole bone was substantially altered by removal of 
more than 10% of trabecular bone that reduced structural support and internal constraint 
of the cortex. Conversely, Holzer et al (123), in a study of human cadaver samples, 
reported that complete removal of trabecular bone from the femoral neck resulted in 
only a marginal decrease in femoral neck bone strength. FEA enables comparison of the 
mechanical contributions of trabecular and cortical components in isolation as well as 
their behaviour in combination. Using this method in rat vertebral bodies, Ito et al (124) 
calculated the yield strength in models with varying amounts of trabecular or cortical 
mass. They found that the mechanical contribution of the spongiosa (trabecular 
component) ranged between 11% and 57%. The cortical shell acted as a constraint on 
the trabecular material and stress was mostly distributed in the cortical shell in vertebral 
bodies with deteriorated trabecular microstructure. Eswaran et al performed FEA 
simulations of removal of the cortical shell from human vertebral bodies and found that 
the shell was on average only 0.38 ± 0.06 mm thick, accounted for 21-30% of overall 
bone mass but contributed 38-68%  to overall vertebral stiffness (125).  
 
1.4.2  MATERIAL CHARACTERISTICS OF BONE  
Intrinsic variation in the material quality of bone occurs at the most fundamental level 
i.e. the bone matrix and the degree of mineralisation (DMB) within it (126).  
Mineralisation in the remodelling sequence is a two phase process of primary and 
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secondary deposition. Newly formed matrix starts to mineralise between 5 and 10 days 
following deposition but completion of secondary mineralisation is much slower, 
therefore older bone is more highly mineralised than newer remodelled bone (126). 
Higher mineralisation is associated with increased stiffness (127). Wu et al (126) 
investigated differences in DMB in the femoral neck cortex in women with hip fracture 
and demonstrated that DMB values were significantly greater in the osteons and 
interstitial tissue compared to controls .  This result was contradicted in a previous study 
by Loveridge et al (128) which showed significantly less mineralisation in the femoral 
neck of hip fracture patients. It has been proposed that heterogeneity and a wide 
distribution of crystal sizes is optimal for bone strength (126) and that non-uniform 
inelastic deformation in heterogeneous material may enable greater dissipation of 
energy (129). Results from studies in this area are not always consistent and it has also 
been observed that hip fracture patients show greater variability in local DMB  and that 
this variability may result in an increase in number and spread of  micro-cracks (130). 
Busse et al (131) investigated the fracture properties of individual trabeculae and found 
significantly increased calcium content, decreased Young’s modulus, yield strength and 
bending  stiffness but greater heterogeneity in calcium distribution in osteoporotic bone.  
 
Collagen itself has a major role in bone strength and toughness, and the size and 
arrangement of collagen fibrils affects the orientation and size of mineral crystals within 
it (126).  Whilst the mineral phase of the bone matrix provides stiffness, collagen 
affords tensile strength and ductility which are major determinants of the fracture 
behaviour in individual trabeculae (132, 133).  
 
Water is a significant contributor to bone mechanical properties with an inverse 
relationship between hydration and the ultimate stress and Young’s modulus (134).  
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1.4.3  GEOMETRIC  CHARACTERISTICS OF BONES 
 The mechanical efficiency of bone is not solely dependent on the quality and 
accumulation of material but also on the optimisation of its spatial distribution and is 
therefore the product of its material and geometric properties (62).  The external and 
internal architectures of bones are both important factors in the distribution and 
transmission of loads, and have a significant effect on how fractures initiate and 
propagate throughout the material (130).  
 
Cortical and trabecular bone both have anisotropic properties. This is manifested by the 
preferential orientation along the principal loading axis by the osteons of cortical bone 
and the plate shaped trabeculae in the spongiosa.  This best adapts bone to withstand the 
greatest forces to which it is habitually subjected (135).   Figure 1.11 shows the relative 
differences in ultimate stress that can be tolerated by a typical long bone in various 
loading directions.  Kreider et al (130) discuss a study of trabecular bone samples from 
osteoporotic hip fracture patients that found a substantially greater orientation of bone 
tissue in the direction of habitual loading compared to controls with equivalent bone 
density. They suggest that this increased aniostrophy in these patients could reduce their 
ability to withstand impacts due to falls in directions orthogonal to the customary 
loading direction.  They also report parallel findings in osteoporotic vertebrae and 
postulate that remodelling in osteoporotic bone may compensate for low material 
density by increasing anisotrophy to maximise strength in the direction of the most 
frequent loading. 
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Fig. 1.11. Diagram showing the anisotropic behaviour of bone (111). 
 
 
 
As force is applied to a material a fracture may be initiated, by debonding atoms of the 
material, which will propagate until the energy from that force is dissipated. The elastic 
and plastic deformation properties of bone are a major determinant in energy dissipation 
along with various geometric factors (136). Stresses in a material can be concentrated 
by small ‘defects’ or ‘stress risers’ such as small holes, spaces or cracks that are integral 
to bone tissue composition e.g. lacunae and resorption cavities (137, 138). Conversely, 
other structural components may serve to dissipate energy, for example cement lines. 
These contain minimal collagen and are less well mineralised than surrounding bone 
tissue thereby providing weak interfaces that may mitigate fatigue damage elsewhere by 
allowing cracks to occur along these lines (139, 140). The degree of porosity in both 
cortical and trabecular bone is a well studied area and it has been demonstrated that  
fracture incidence is strongly related to increased porosity (141).  
The specific geometric properties of cortical and trabecular bone will be discussed 
below:- 
 
 
 
This image has been removed by the author of this thesis for copyright 
reasons. 
Chapter 1 
[53] 
 
 Trabecular geometry. 
 Optimised for strength and weight, trabecular bone has a high surface area to 
volume ratio that is an important factor in its potential to adapt via the 
remodelling process (63).  Its open, porous texture can be described by a range 
of structural parameters that include; trabecular thickness (Tb.Th), trabecular 
separation (Tb.Sp), trabecular number (Tb.N), bone surface area (BS),  bone 
volume (BV), total tissue volume (TV), trabecular volume fraction (BV/TV),  
and trabecular surface density (BS/TV) (142).  The connectivity of trabeculae is 
an important determinant of strength as more numerous, thin but well connected 
trabeculae are more structurally competent than an equivalent quantity of bone 
distributed as fewer, thicker, more widely distributed and disconnected 
trabeculae (138). In clinical terms, heavy reliance has been placed on the density 
of bone as a surrogate for bone fragility i.e. quantity rather quality.  True BMD 
is a measure of bone mineral content (BMC) divided by volume (34). Studies 
that use bone density as an indicator of bone quality generally show a reduction 
in strength and modulus as density decreases. In a computational model, equal 
values of trabecular bone mass were shown to be associated with different 
values of biomechanical stiffness explaining how clinical bone integrity can be 
maintained despite significant reduction in bone mass (143). These results 
explain the observation that bone mass accounts for 65% of variation in bone 
strength whilst consideration of the full range of micro-architectural parameters 
may improve fracture predictability up to 94% (51).   
 
The architectural factors that determine trabecular bone strength are interrelated 
in a complex fashion but the greatest mechanical competency is afforded by high 
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connectivity, high trabecular number and higher trabecular thickness (138) Bone 
loss leading to increased fragility fractures is associated with loss of trabeculae, 
reduced connectivity and  increased inter-trabecular spacing i.e. porosity (130). 
  
 Cortical geometry. 
Whilst whole bones are recognizable by their specific shape, their mechanical 
properties will be affected by differences in overall size and the relative 
proportions of their components. Although the overall size and shape of an 
individual’s bones is largely dictated by genetics (144) these can be modified to 
some degree by remodelling. Hip geometry plays a role in fracture etiology and 
examination of geometric factors in addition to BMD may improve 
identification of people at heightened fracture risk (145-147). The geometric 
parameters (Fig. 1.12) most relevant to hip strength are:  
o HAL:  hip axis length (mm).  
o Angle of femoral neck (Ө degrees).  
o CSMI: cross sectional moment of inertia (mm4) describes geometry 
and density in the femoral neck and is a measure of the distribution 
of material around the axis of the neck.  
o CSA: cross sectional area (mm2) of the minimum CSMI section 
within the femoral neck.  
These variables can be used to calculate the femur strength index (FSI) that 
provides an estimated ratio of the femoral neck yield strength against expected 
compressive stress from a fall on the greater trochanter (148). 
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Fig. 1.12  Diagram showing geometric parameters of the proximal femur (149). 
 
Leslie et al observed that in a cohort of 30,953 women with incident hip 
fractures and osteoporotic non-hip fractures, HAL and FSI made a small but 
significant contribution to hip fracture prediction independent of BMD and age 
(150). This result is corroborated by a previous study on 2506 women aged 
above 50 years in which HAL was significantly higher and FSI significantly 
lower in women with hip fracture (149). 
 
Figure 1.13 shows the CSMI for two hollow cylinders with equal mass where 
one has a greater distribution of mass farther from the axis of bending (neutral 
axis) compared to the other. Although the walls are thinner in the right-hand 
structure, the distribution of material results in a substantially increased 
resistance to bending along its length. Larger bones have larger CSMI compared 
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to smaller ones and greater resilience to fracture for any given value of BMD 
(151). The strength and stiffness of a hollow tubular shaped bone are 
proportional to the product of the CSMI and the elastic modulus (E) (33). 
Increasing CSMI therefore increases fracture resistance if E remains unchanged. 
 
 
 
 
 
 
 
Fig. 1.13.  Distribution of equal cortical mass in bones of different diameter 
(151). 
 
In remodelling, expansion of long bones results from periostial apposition and 
endosteal resorption thereby increasing the outer cortical diameter over time. 
The femoral neck is an intracapsular structure not covered by periosteum. It is 
not therefore subject to periostial apposition and cortical thinning may 
consequently result (123). The potential effect of cortical thinning in the femoral 
neck with aging and osteoporotic conditions is an increased susceptibility to 
buckling fracture (152, 153). Mayhew et al (90) found that cortical thinning in 
this region is not uniform. Changes in physical activity with aging affect loading 
patterns in the proximal femur that can cause differential changes in the cortex, 
potentially altering its stability and exacerbating fracture risk (90). Kaptoge et al 
(154) concluded from a study of 7474 women, of whom 635 sustained incident 
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hip fractures over a period of 13 years, that the proximal femurs of elderly 
women with hip fracture had lower bending and CSA strengths, thinner and 
more asymmetric cortices, wider bone diameters and more obtuse neck-shaft 
angles than non-fractured participants . 
 
Although cortical bone is relatively non-porous compared to trabecular bone, it 
does have intrinsic qualities of porosity that increase with age. Chen et al (86) 
suggest that this relates to the enlargement of intracortical channels during 
osteonal remodelling. Increased cortical porosity is associated with reduced 
bone strength, although porosity in the endocortex has less structural impact 
than that in the outer cortex or periosteum (138).   
 
 
1.4.4  CLINICAL PREDICTION OF FRACTURE AND FACTORS RELATING TO 
FRACTURE RISK 
It is evident that knowledge of fracture mechanics in human bone, and therefore fracture 
prediction, remains incomplete.  Fracture in individual patients cannot be predicted with 
any certainty and can only be expressed as a probability extrapolated from 
epidemiological evidence of known fracture incidence in populations with known bone 
parameters.  In an attempt to clinically evaluate fracture probability for individual 
patients, a wide range of fracture prediction tools have been designed in recent years.  In 
current UK clinical practice the most commonly used are the Fracture Risk Assessment 
Tool (FRAX) & Q Fracture Scores. Based on the National Health and Nutrition 
Examination Survey (NHANES) database (a nationally representative sample of the 
United States population) (155),  FRAX can be used with or without neck of femur 
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(NOF) BMD to estimate the 10 year probability of an individual sustaining either a 
major osteoporotic fracture (vertebral, wrist or humerus) or a hip fracture (156). The 
FRAX tool uses an algorithm that incorporates factors contributory to bone fragility 
including age, personal and parental history of fracture, glucocorticoid use, smoking 
and alcohol intake, disease and medications. Fracture risk assessment by this method is 
of limited clinical value without appropriate intervention thresholds at which treatment 
should be recommended (157). A link from the online version of FRAX to The National 
Osteoporosis Guideline Group (NOGG) gives some guidance to physicians in this 
regard (158). There are acknowledged limitations with assessment tools as they cannot 
take all possible risk factors fully into consideration or account for their level of 
contribution (159). They therefore lack sensitivity and rigid adherence to results from 
these tools will inevitably mean that some patients are prescribed medications 
unnecessarily whilst others, who might benefit from treatment, will not receive it. In 
real terms, fracture risk cannot be assessed on bone mechanical parameters and risk 
factors for fragility alone and other considerations, such as propensity for falling, need 
to be taken into account. This may be particularly significant for certain patient groups 
e.g. the elderly, recovering stroke patients, alcoholics or patients recovering from leg or 
other surgery where muscular control, co-ordination and balance problems may be an 
issue (160).  
Other potential risk factors, not currently assessed in fracture risk prediction, are coming 
to the fore. Obesity has not been considered previously as a risk factor for bone fracture 
as high body mass index (BMI) has generally been associated with higher BMD. It has 
been suggested that fat tissue has a protective function in postmenopausal women by 
increasing remodelling associated with weight-bearing and possibly by cushioning 
against falls (161).  The effects of obesity on bone are potentially complex as it is 
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associated with altered hormone levels including higher serum concentrations of human 
parathyroid hormone (hPTH) and lower circulating 25-hydroxy-vitamin D both of 
which influence bone maintenance and quality (162). In terms of mechanical risk, 
applied loads during activity can create resultant forces many times greater than during 
normal stance. The resultant force on the femoral head during level walking has been 
reported as 1.6 to 3.3 times body weight (27). Excessive stresses can be placed on 
bones, particularly during high impact activities, and their adequacy to support the 
greater loads to which they are subjected in obese people is becoming an area of 
increasing interest (161, 162). Skeletal alignment in obese people may also be a factor 
in increasing fracture risk. Alignment of the lower limb bones and joints can be 
substantially altered by increased soft tissue mass between the legs that compromises 
normal stance and gait (163). The altered efficiency of load distribution throughout the 
leg may potentially contribute to fracture risk. 
 
 
1.4.5 FRACTURE REPAIR AND COMPLICATIONS 
The healthy young body has a remarkable ability to repair bone fractures by means of 
callus formation and remodelling. Complications can however arise due to mal-union or 
non-union and as osteogenic potential decreases with aging and some disease states, 
fractures may not repair adequately to restore full function to all patients in these 
categories (164).  Fracture healing is itself influenced by mechanical stresses within the 
callus material and early remobilisation may mitigate bone loss elsewhere due to the 
effects of limited weight-bearing. Nevertheless, to prevent re-fracture, an appropriate 
degree of healing and restoration of stiffness must take place before full weight-bearing 
and return to normal gait is attempted (165, 166). Some of the major and life-
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threatening consequences of fracture are not related to the repair process but result from 
postoperative medical complications such as cardiac or pulmonary problems. These 
outcomes are frequently associated with fractures of the hip and account for the  poor 
recovery and high mortality rates following hip trauma (167). 
 
1.5 BONE DISEASES AND DISORDERS 
Disruptions to the mechanisms that control skeletal growth and maintenance have 
potential to cause a wide variety of bone diseases and disorders either by directly 
affecting bone tissue or indirectly by interfering with mineral metabolism (168). 
Osteoporosis (OP), osteopenia and osteoarthritis (OA) are common degenerative 
conditions in aging populations & will be discussed in the following sections.  
 
1.5.1  OSTEOPOROSIS AND OSTEOPENIA  
Osteoporosis is defined as a systemic skeletal disorder characterised by a reduction in 
bone mineral density and micro-architectural changes that increase bone fragility and 
susceptibility to fracture (169). Osteopenia is a precursor of OP but is not regarded as a 
disease state. OP may be either ‘primary’ or ‘secondary’. Primary OP is the most 
common form and is not caused by another disorder whereas secondary OP arises as a 
consequence of other specific diseases or medications that affect the bone remodelling 
process. Primary OP is mainly age-related although idiopathic forms can occur in 
younger people.  Whilst genetics, nutrition and a range of lifestyle factors influence age 
related bone loss, oestrogen deficiency is common to men and women and is 
responsible for the gradual phase of bone loss in both. OP is however 2-3 times more 
prevalent in females mainly due to the accelerated phase of bone loss lasting between 4-
8 years around the time of menopause. It is an asymptomatic condition until physical 
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changes manifest themselves as reduced height, altered stature and low trauma fractures 
that can result in pain and disability (168). It is therefore often described as a silent 
disease and may be frequently undiagnosed and untreated even after an event causing 
low trauma fracture(170).  
In 1994 the World Health Organization (WHO) formulated a simplified stratification of 
BMD values to define OP.  The categories are based on standard deviations from the 
young adult mean BMD i.e. T scores, and are: normal (T score > -1), osteopenia (T 
score -1 to -2.5) and osteoporosis (T score < -2.5). These categories have been taken to 
represent a fracture risk of low, medium and high respectively (21). There is an 
exponential relationship between fracture risk and T score as shown in figure 1.14. In 
this figure (approximating to the relationship between hip BMD and hip fracture risk), 
fracture risk is increased by a factor of 2.5 for each unit T score reduction, therefore a 
relatively small reduction in BMD in the osteoporotic range can substantially increase 
the probability of fragility fracture (171).  
 
 
 
 
 
Fig.1.14 Graph showing relationship between T-score and fracture risk (171). 
 
Using the WHO criteria, approximately 20% of postmenopausal women in western 
countries would be diagnosed as osteoporotic (169). Although T scores provide a useful 
framework to assess potential fracture risk, it is well recognised that BMD only explains 
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part of bone fragility and a large overlap exists in low trauma fracture incidence across 
the BMD categories (172).  
 
 Disuse osteopenia 
Static weight-bearing, ground reaction forces and mechanical loading generated 
by muscles during locomotion are important physical stimuli for bone 
remodelling (173) and it is axiomatic that immobilization and an absence of 
load-bearing will result in a reduction in BMD as manifested in the condition of 
disuse osteopenia. Disuse osteopenia is a secondary form of 
osteopenia/osteoporosis that can occur at any age and has been observed in 
human studies of bed-rest (74, 174, 175), SCI (176), stroke (177-179) and 
conditions of micro-gravity (180-182). Bartl and Frisch (4) report that young 
bed-ridden patients can lose up to 30% of their bone density in only a few 
months and that on average there is a decrease in trabecular bone of 
approximately 1% per week but only a 1% per month recovery on resumption of 
physical activity. The effect of lack of weight bearing on otherwise healthy & 
physically active human subjects is most clearly demonstrated in studies of 
astronauts following time spent in microgravity during space missions. Lang 
(110) reported that up to 15% of bone strength can be lost at the proximal femur 
over a 6 month flight. Zayzafoon et al. (183) state that in the most severe forms 
of bone loss due to micro-gravity, there is a 2% decrease in BMD in a one 
month period equating to that of a post-menopausal woman over the period of  
one year. Immobilization induced bone loss has generally been found to be 
greater at the epiphyses (where trabecular bone is most abundant) than the 
diaphyses. This has led to the assumption that bone loss is greater in trabecular 
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compared to cortical bone. More recent evidence contradicts this assumption 
showing that bone loss in the distal tibial epiphysis after 35 days of bed rest was 
predominantly from the cortical compartment (72). Although both human & 
animal models of disuse osteopenia exhibit similar responses to reduced weight 
bearing, intriguing evidence has emerged from studies of hibernating brown 
bears (Ursas Americanus) that demonstrates minimal bone loss during protracted 
periods of hibernation inactivity. This suggests that some mechanism of 
hormonal or biological control may be able to mitigate the effects of disuse to a 
major degree in these mammals (97, 184-186). 
 
There is a large body of literature on the subject of disuse osteopenia and studies 
include both in vivo and in vitro human and animal models at various skeletal 
sites. Methods of measurement, including Dual Energy X-Ray Absorptiometry 
(DXA), Quantitative Computed Tomography (QCT) and high resolution 
Magnetic Resonance Imaging (MRI), and the parameters of bone quality 
measured are varied. Mechanical assessment includes histomorphometry, FEA 
and mechanical testing of tissue samples. These studies mostly focus on 
trabecular or cortical bone in isolation and few consider the combined effects of 
both. The diverse methodologies employed in these studies each have their own 
limitations and direct comparison of results is not always readily made.   
 
There are major differences in the extent of skeletal weight bearing at different 
sites within the body. Other than the patella, bones of the lower extremities are 
subject to the highest loads. Fracture or injury to the lower extremities is 
therefore likely to result in the greatest loss of bone following disuse (11). 
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Jarvinen and Kannus (11) provide a comprehensive review of studies, up to 
1997, of injuries to the lower extremities and their effect on bone density. The 
studies are grouped into knee injuries, femoral shaft, tibial shaft and ankle 
fractures. It is evident from all of these studies that varying degrees of bone loss 
are associated with lower limb injury. This also includes bone density changes in 
the contralateral limb. Several studies include measurement of BMD changes in 
the proximal femur (6-9, 12, 187). These studies, with one exception (8), 
showed  long-term bone loss in the ipsilateral proximal femur to a varying 
degree as a result of lower limb injury.  The length of follow up period and the 
sample populations, in terms of age and sex, varied greatly in these studies.  In 
each case the sample size was very small, maximum 29 participants. The 
majority of these studies were retrospective in design and compare bone density 
on the affected side against the contralateral limb i.e. effectively using this as a 
control. If this assumes that no or minimal bone loss has occurred in the 
contralateral limb post injury, calculation of the relative difference between ipsi 
and contralateral sides may considerably underestimate the absolute loss in the 
ipsilateral limb after the baseline injury.  
 
 Time course of bone loss and recovery 
Post traumatic bone loss is a high turnover condition whereby both formation 
and resorption of bone are increased but out of balance such that the later is 
greater than the former. The most important determinants in the development of 
disuse bone loss appear to be the length of immobilization and impairment of 
function.  The time span of recovery is greater than the duration of the unloading 
that caused the bone loss (9, 11). Ito et al (188) found that bone in the trabecular 
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and endosteal regions diminished faster and recovered more quickly than the 
cortical compartment in a study of tibial BMD in patients with hip surgery. A 
study by Van der Wiel (9) found that bone loss in the proximal femur following 
unstable leg fracture showed no sign of recovery in the trochanter and femoral 
neck after one year.  In a study of bone loss following unilateral tibial fracture, 
Eyres and Kanis (189) found that persistent bone loss remained in the distal 
tibia, at a mean time interval of 8 years post fracture, for patients who had 
sustained their fractures during adulthood; no significant differences in BMD 
were however apparent in the injured and control limb after fractures sustained 
in childhood. In a case study of  prolonged external fixation of a severe 
tibia/fibula fracture, Knapp et al (13) found that the patient demonstrated a T-
score 2.5 standard deviations (SD) lower on the ipsilateral hip 18 years after the 
original injury. In a computational model of disuse, restored trabecular 
architecture was found to differ from the original and the duration of the 
osteopenic stage was found to be the main determinant of these changes. Older 
individuals may have diminished osteogenic potential with fewer trabeculae 
acting as a scaffold for new bone formation and thus may be least likely to 
recover bone mass after disuse (143). These findings have clinical implications 
and strategies to reduce the period of unloading may be indicated to alleviate 
bone loss.  Factors such as type of medical treatment, levels of pain and 
depression that delay remobilization and restoration of normal activity levels 
may also contribute to the degree and time scale of recovery (11).  
 
 Treatments and therapies 
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Although bone recovery to baseline values has been reported in some studies 
following re-ambulation or return to normal gravity (98), in most instances of 
disuse osteopenia, recovery is slow and incomplete. There are however 
interventions, including lifestyle and nutritional changes, that can either reduce 
bone loss or contribute to its recovery (190). A range of therapeutic agents are 
available that have varying effects on bone turnover and the matrix properties, 
mineralisation and microdamage accumulation in bone. These may be either 
antiresorptive or anabolic and can have different effects in trabecular and 
cortical bone (169). Bisphosphonates are a range of antiresorptive drugs 
including Etidronate, Alendronate and Risedronate. These are selectively 
distributed to bone where they inhibit osteoclast activity and shorten their 
lifespan. Anabolic agents directly increase bone formation and are a less well 
developed group of drugs that includes parathyroid hormone (PTH), sodium 
fluoride and strontium ranelate (18). Bisphosphonates including tiludronate have 
been demonstrated to be an effective treatment in paraplegic patients (98, 191) 
and alendronate has been shown to be both well tolerated and effective in non-
ambulatory children (192). Trabecular bone increases in the tibiae of 
immobilized rats treated with 1,38 hPTH were reported in a study by Ma et al 
(193). Nutritional interventions have been reported to have a small influence in 
rectifying the negative calcium balance in disuse osteopenia (92).  
 
New data suggests that muscle contractions may prevent disuse osteopenia 
independent of weight-bearing and therefore, where safe and practicable, 
strategies to return patients to early resistance exercise may be useful (194). 
Grosset and Onambele-Pearson (195) postulate that for certain injuries the use of 
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a removable splint would enable patients to exercise and limit the process of 
atrophy. It has been suggested that the shivering of skeletal muscles in 
hibernating black bears may contribute to the maintenance of bone mass during 
hibernation by a mechanism involving low magnitude mechanical stimulation 
(184) and non-pharmacological therapeutic interventions such as vibrating plates 
(196) may have a role in bone recovery.  
 
1.5.2  OSTEOARTHRITIS  
OA is a disease that can involve peripheral and axial joints and is most common in the 
knees, hips and hands.  It arises from a repair response to tissue damage caused by wear 
or trauma and although aging itself is not a cause of OA the condition is nonetheless 
strongly associated with advancing age.  OA is a metabolically active process that 
repairs damaged tissue by structurally altering the joint and can be symptomless. 
However, this repair process may be compromised resulting in localised cartilage loss 
and structural alteration of the adjacent bone, ultimately causing joint pain and limiting 
function (197). As both OA and osteoporosis (OP) are age related, it might be expected 
that the two conditions would regularly co-exist in elderly populations. Research over 
recent decades has generally demonstrated a higher bone mass associated with OA and 
therefore the two conditions have been assumed to be mutually exclusive (198, 199). A 
study by van Hove et al, investigating osteocyte morphology in human tibial bone from 
different pathological states, observed significant differences in OA and OP affected 
bone suggesting that the two conditions are quite distinct (53). More recent research 
indicates that the relationship between OA and OP is more complex than originally 
proposed (200). Glowacki (199) reports that several studies using DXA assessed BMD, 
demonstrate an incidence of occult OP in 20-29% of both men and women with OA. A 
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study by Drees et al (201) found that in 82 osteoarthritic, postmenopausal females, (who 
subsequently required knee or hip replacement), 23.2% were affected by OP reflecting 
the normal distribution of OP in the general female population. Although higher BMD 
is part of the pathogenesis of OA, this potentially disguises poorer quality of sclerotic 
bone and inferior fracture resistance. Osteoarthritic bone has thicker trabeculae than 
normal or osteoporotic subchondral bone. It is also characterized by increased 
subchondral plate thickness, osteophyte formation, and the development of bone 
marrow lesions that may precede the formation of bone cysts. It has been generally 
thought that osteoarthritic subchondral bone is stiffer and therefore more brittle than 
normal bone, but more recent work suggests that remodelled bone in OA is less 
mineralised and therefore less stiff.  These characteristics have also been found in the 
inter-trochanteric region of the proximal femur, some distance from the subchondral 
region, suggesting that pathological changes in OA are not restricted to the subchondral 
bone (202). Localised osteosclerosis in hip OA sufferers may manifest itself as higher 
BMD that does not reflect bone density status elsewhere in the body.  As the femoral 
neck region of interest (ROI) is generally used for fracture prediction, errors may result 
if this ROI is considered in isolation. 
 
Arden et al report evidence from large population studies where levels of BMD are up 
to 15% higher in OA patients compared to controls (203). As increased BMD is 
generally associated with reduced fracture risk it might also be expected that OA 
patients would demonstrate reduced fracture prevalence; a number of studies indicate 
that this is not the case (203-206). The reasons for this are not clear but may be 
attributable to a variety of functional impairments associated with OA that possibly 
contribute to an increased propensity for falls and greater severity of injuries. These 
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include reduced agility, reduced muscle strength, postural instability and heightened 
pain levels (203, 207). In addition to causing a general impairment in activity levels and 
function, OA also commonly necessitates joint replacement with limited and impaired 
mobility for a variable period post surgery (208, 209). A study by Prieto-Alhambra et al 
(210) showed that patients with knee OA, from the General Practice Research Database 
(UK), have a non-significantly lower hip fracture incidence than controls in the year 
preceding total knee replacement (TKR), but a significantly increased hip fracture 
incidence in the year following surgery (RR 1.58; 95% CI) that only returns to the same 
level as the control group 3 years post-operatively. These results were supported by a 
further study using the Dutch PHARMO Record Linkage System (211). Whilst the 
authors discuss the aforementioned possible reasons for this phenomenon (propensity 
for falls etc), the extent of disuse-related bone loss at the hip following TKR and its 
potential contribution to post-surgical hip fracture risk has not been reported. Bone loss 
at the tibial and femoral diaphyses has been demonstrated following TKR and this was 
most marked in the operated leg for one year post-operatively (212). Post-surgical 
bisphosphonate use (BPU) has been found to be associated with a 50-55% hip fracture 
risk reduction in a TKR population (213). As BPU would be expected to alleviate the 
effects of disuse-related bone loss, this finding supports the suggestion that post-
surgical disuse may indeed play an important contributory role in hip fracture following 
TKR (214). 
 
1.6   IMAGING TECHNOLOGIES FOR THE QUANTITATIVE EVALUATION 
OF BONE AND SOFT TISSUE 
BMD measured by DXA  is currently the primary screening tool for clinical diagnosis 
of osteopenia and osteoporosis  but has limitations because of the large overlap in the 
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BMD of patients who do or do not sustain fractures (215). Sornay-Rendu et al (216) 
showed that 48% of women who sustained a fragility fracture had a baseline BMD in 
the osteopenic range and 8% were in the normal range.  A combination of structural and 
densotomic indices can provide a more accurate assessment of bone quality and fragility  
that may improve sensitivity and/or specificity to identify individuals at heightened 
fracture risk (51). Bone structural parameters are not however currently assessed as part 
of normal clinical routine. 
 
Much of the current knowledge of the mechanisms of  bone failure comes from 
computational and theoretical studies based on data derived from 3-dimensional 
imaging modalities (217). High resolution QCT (33) and high field 3-Tesla MRI (218) 
can provide information non-invasively regarding mass, volumetric density and 
distribution of mineralised tissue and these are valuable research modalities for in vivo 
assessment of bone architecture. In an in vitro study by Bousson et al (219), the 
combination of  QCT densitometric and geometric variables in the proximal femur 
explained 76% of femoral failure load variance compared to 69% explained by DXA 
BMD.  Whilst the last decade has seen considerable progress in bone imaging 
techniques, there are major limitations to their use in clinical situations due to low 
availability,  high cost, inconvenience for patients and, in the case of CT, higher 
radiation dose (220). Quantitative ultrasound (QUS) affords a relatively cheap option to 
provide densitometric information from either Broadband Ultrasonic Attenuation 
(BUA) or Speed of Sound (SOS). Some systems combine BUA and SOS to provide a 
single measure of bone density: the Quantitative Ultrasound Index (QUI). QUS offers a 
fast, safe and convenient option for patients in that it measures peripheral sites, usually 
the calcaneus, and does not use ionising radiation (171).   
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1.6.1  DXA 
DXA is, at present, the most widely used, non-invasive, modality for in vivo research 
and clinical assessment of BMD and the quantitative evaluation of soft tissue. DXA 
may be used to measure BMD at any skeletal site but it is typically used to measure 
posterior/anterior (PA) lumbar spine and the proximal femur as these are the most 
clinically relevant in terms of fracture incidence and severity (221). DXA is a 2-
dimensional (2D) modality that utilises the differential attenuation of X-rays with two 
different photon energy peaks, by bone and soft tissue. The attenuation of X-ray 
photons in a given material allows the areal density (mass per unit area) of that material 
to be calculated.  The attenuation coefficient of any material is dependent on its atomic 
number and the photon energy of the X-ray beam transmitted through it. Simultaneous 
scanning with two beams of different photon energy enables acquisition of high- and 
low-energy profiles of tissues in the scan line. Low-energy photons are attenuated 
slightly more than high energy photons in soft tissues. The attenuation differential 
between the two photon energies is greater in bone because it has a much larger 
attenuation coefficient at lower photon energies than soft tissue. In a two dimensional 
image of the body there is soft tissue over- and underlying bone and subtraction of the 
high-energy from the low-energy profile is used to provide information on variation in 
BMD along the scan line (221). Soft tissue regions immediately adjacent to bone are 
used as a baseline reference area for soft tissue composition when calculating the 
differential between the two energy profiles in the in the ROI. The attenuation 
coefficient of fat is different to that of lean soft tissue due to its higher hydrogen content 
and the same principle of differential attenuation between tissue types is used to derive 
information on tissue distribution in DXA total body scans (171). Data from total body 
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scans therefore allows determination of the proportionality of muscle and bone mass, 
either for specific regions or for the body as a whole (222).   DXA methodology is 
based on the differential attenuation between two tissue types and is only strictly 
accurate when that condition applies (223). Soft tissue in the ROI will invariably 
contain a combination of fat and lean tissue therefore differences in the soft tissue 
composition i.e. lean/fat ratio, in the path of the X-ray beam compared to the adjacent 
reference area, may cause errors in the accuracy of BMD measurement (171). 
 
As a 2-dimensional imaging technique, DXA can only calculate areal BMD (aBMD) 
which only provides a surrogate for true BMD (mass per unit volume) as measured by 
3-dimensional (3D) techniques. Because aBMD does not have a value for depth, 
misleading values are obtained where the projected area is either much smaller or larger 
than average for any given ROI. This anomaly may be minimised by correcting for the 
missing depth value to provide an estimate of ‘apparent’ BMD (BMAD) (224, 225).  
 
DXA has stable calibration and high precision (221) but a number of issues should be 
considered when interpreting results from repeat scans: 
 
 As biological changes in BMD are generally small relative to the error 
inherent in the test itself, interpretation of serial BMD tests depends on 
knowledge of the least significant change (LSC) in BMD that is beyond the 
range of error (226). In clinical terms, significance is based on a LSC of 
2.8% assuming precision error of 1% (227).  
 Higher BMI has been demonstrated to contribute to increased DXA 
precision error due to a reduction in signal to noise ratio in larger 
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participants (228). In addition, tissue inhomogeneities may be more evident 
in these participants. These inhomogeneities may alter over time as a 
participant’s weight and muscle mass fluctuates, changing the distribution of 
soft tissue in the ROI  and resulting in long-term precision error (229). 
 Variation in a participant’s positioning for repeat scans can cause 
measurement error and it is therefore desirable to use the same operator to 
avoid inter-operator differences in positioning technique. Participants may 
also change in their ability to assume correct scan positions over a prolonged 
period of follow-up particularly if they suffer from degenerative musculo-
skeletal conditions that affect their flexibility. This is notable in scans of the 
hip where internal rotation of the legs is required to achieve the correct 
scanning position (230). 
 
DXA also has limitations in that it does not distinguish between cortical and trabecular 
bone. It is therefore unable to provide specific information on how these two different 
bone types respond to external stimuli and treatments for osteoporosis (219). Despite 
these limitations DXA is currently the gold standard methodology for clinical diagnosis 
of osteoporosis on the basis of its relatively low cost, availability and convenience for 
patients, short scan times and minimal radiation dose (171). The effective radiation dose 
for a PA spine examination using DXA is typically in the region of 1.0 microSievert 
compared to 60 microSieverts for QCT in an average sized adult participant (231). The 
advantages of DXA, particularly for research purposes, include a number of recent 
technological developments that could be potentially incorporated into clinical routine 
to complement BMD information and enhance fracture prediction.  
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 The macro-scale geometric parameters of the hip, and their relevance to the 
mechanical properties of the proximal femur, have been discussed in section 
1.4.3. Advanced Hip Assessment (AHA)/Hip Strength Analysis (HSA) software 
is available commercially and can be used during routine hip scans to provide 
geometric measurements of the proximal femur. The structural parameters 
measured can be combined with age, height and weight to calculate the femur 
strength index (FSI) as an ancillary measure of hip structural competence (149, 
156). Whilst HAL and FSI have been demonstrated to make a small but 
statistically significant contribution to the prediction of hip fractures, the 
incremental information gained from this analysis may be too minimal to justify 
its use in routine clinical practice except in borderline cases (150).  
 
 The known limitations of standard densitometry have been a driver for the 
development of techniques to assess bone microarchitecture. Although 
methodologies, such as high resolution QCT and MRI, have the capability to 
provide this information, their use is not practical in clinical situations. Boehm 
et al (232) investigated the topological properties of bone mineral distribution 
patterns from images generated during conventional DXA hip scanning to test 
the ability of this method to discriminate between postmenopausal women with 
hip fracture and controls. In a study population of 100, of whom 50 were hip 
fracture patients, they found 71-84% of patients were correctly identified by 
regional topological analysis compared to 58-68% identified by BMD. Using a 
similar principle, based on two dimensional DXA image analysis, software has 
recently been developed to provide a Trabecular Bone Score (TBS, Med-Imaps, 
France) for assessment of the lumbar spine ROI. TBS is a grey-level texture 
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measurement that differentiates between two micro-architectures exhibiting the 
same bone density but different trabecular characteristics (233). A study by 
Boutroy et al (234) assessed 564 postmenopausal women over a mean follow-up 
period of 7.8 years during which 94 sustained a fragility fracture. They 
concluded that BMD and TBS predicted these fractures equally well but a 
combination of the two indices afforded only limited additional information on 
fracture prediction across the entire cohort.  Nevertheless, they found that a 
subset of women in the osteopenic range of BMD with lowest TBS were at 
higher risk of fracture. Further in vivo research on the efficacy of TBS to predict 
fracture would be valuable. 
 
 
1.6.2 MRI 
MRI is a non-invasive 3D modality that can produce images in various planes. It is a 
highly complex technology that utilizes magnetic fields and radio waves to construct 
images mathematically (230). MRI exploits the magnetic properties of the abundant 
hydrogen atoms in body tissues. Hydrogen atoms have one proton in the nucleus and 
effectively behave as mini magnets. In normal conditions, these protons spin on their 
axes and precess in a random fashion. In MRI, magnetic fields are employed to alter this 
random orientation and spin of the hydrogen protons. Energy, in the form of radio wave 
pulses at a particular resonant frequency, is introduced to the system and absorbed 
causing the hydrogen protons to precess in phase. As different tissues contain varying 
quantities of hydrogen, energy absorption will vary accordingly (235). When energy 
transfer ceases, the hydrogen protons ‘relax’ returning to a more random configuration 
and energy at the same frequency is reemitted. This produces signal that can be 
interpreted mathematically to produce an image. The rate of relaxation in different 
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tissues, generally referred to as T1 or T2, affects the image appearance whereby 
different brightness properties are exhibited by tissue type according to which relaxation 
mode is applied (230).  
 
MRI is regarded as a safe technique to image bone and soft tissue that does not employ 
ionising radiation. Because soft tissues have high hydrogen content due to their 
composition of approximately 85% water (H2O), MRI is an excellent imaging modality 
for soft tissue anatomy. Whilst bone itself does not produce a signal in MRI, due to the 
tightly bound hydrogen nuclei within the bone matrix (230), its structure can 
nevertheless be inferred from the negative image created by the strong signal generated 
in abundant fat and water in the surrounding soft tissue and marrow (220). 
 
The description of MRI given above is extremely simplified and the parameters that can 
be manipulated to affect image quality will not be addressed in detail. Image quality 
depends on the amount of signal produced and this is influenced by data acquisition 
time, field strength, and the pulse sequence and echo time used (220).  In common with 
any imaging technology, image quality is dependent on the resolution that can be 
achieved by the system. Smaller voxels contain fewer hydrogen atoms and produce 
lower signal than larger voxels. Higher resolution is achieved by increasing signal 
accumulation and this demands higher energy input to the system. This is associated 
with heating effects and is therefore a comfort and safety issue for the participant being 
scanned. High resolution in vivo imaging involves a compromise between minimising 
heating effects (by increasing exposure time) and producing artefacts that inevitably 
result from patient movement as the scan time increases. This is a major limitation of 
MRI to image fine structural detail in vivo. Trabeculae are typically in the range of 80-
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150 microns in diameter, below the minimum spatial resolution achievable in most 
systems (236). MRI systems, commonly 1.5 Tesla, used in clinical or research practice 
do not have the capability to produce in vivo images of bone microstructure, however 
using a higher field strength will increase signal and reduce exposure time; high 
resolution 3 Tesla MRI scanners have been used for this purpose in a research context 
(218). Super-high field strength magnets up to 7 Tesla are available and used in some 
research facilities (230).  
 
An important factor in quantitative assessment of bone in MRI is accurate segmentation 
of bone and adjacent fat components such as marrow. Partial volume effects occur in 
these transition zones that may result in inaccurate differentiation of tissue type at these 
interfaces (236). 
 
 
1.7  AIMS OF THESIS  
In summary, the short and long-term consequences of disuse osteopenia, following 
lower limb fracture or surgery, may be profound in terms of predisposing patients to 
both immediate and future increased fracture risk.  This potentially involves re-fracture 
at the original site or secondary fractures at other sites affected by bone loss, including 
the hip. Hip fractures are associated with high rates of morbidity and mortality with 
consequent social and economic impact. In 2000 there were approximately nine million 
osteoporotic fractures worldwide and 20%  of these were hip fractures (21). As life 
expectancy increases globally, the number of hip fractures is likely to increase 
commensurately. Disuse effects in postmenopausal populations may be of significant 
importance as these women are already losing bone systemically due to decreased 
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oestrogen levels and are at greater risk of not recovering bone lost due to 
immobilization. Osteoarthritis is also a common condition in the postmenopausal age 
group that frequently necessitates joint replacement. A significant increase in hip 
fracture incidence in the year following TKR has been demonstrated (210) but the 
extent of disuse-related bone loss at the hip following TKR and its potential 
contribution to post-surgical fracture risk has not been reported. Earlier research on 
long-term unilateral disuse osteopenia is limited and most research on disuse-induced 
bone loss is focused on SCI, stroke patients, astronauts and bed-rest volunteers which 
may not be directly comparable to the effects of immobilization of a single limb. 
Further knowledge in this field, specifically in a postmenopausal population, may 
improve prediction of fracture risk and inform the use of pharmacological & mechanical 
interventions to mitigate bone loss in this group.  
 
This longitudinal study will investigate the causes and effects of disuse osteopenia in 
four groups of postmenopausal participants: patients having sustained a recent leg 
fracture (< 3 weeks previously), leg fracture > 1 year ago, TKR surgery and controls. 
Baseline differences between the groups and long-term changes in physiological & 
functional parameters during recovery will be measured at intervals over a one year 
period. The following factors will be assessed: 
 
1. DXA measurements of BMD at both hips and the lumbar spine. 
2. DXA total body measurements of leg lean tissue mass (LLTM). 
3. DXA AHA measurements of macro-architectural hip parameters. 
4. DXA derived TBS measurements of trabecular micro-structure at the lumbar 
spine. 
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5.  Changes in relative Left/Right Weight-Bearing (L/R WB) through the legs over 
time and during recovery. 
6. Medical history of co-morbitities, medications and lifestyle factors, contributory 
to bone health, assessed by questionnaire. 
7. Levels of pain, physical function and activity assessed by questionnaires and 
pedometer readings. 
8. Levels of depression and anxiety assessed by questionnaires. 
 
In addition: 
 
The precision of a dual-scales method for measurement of L/R WB will be evaluated. 
 
The utility of 1.5 Tesla MRI scanning, for the measurement of cortical bone and muscle 
mass changes at the proximal femur, will be investigated in sub-groups of control 
participants and newly fractured patients treated by plaster of Paris. 
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CHAPTER 2. MATERIALS AND METHODOLGY 
This chapter describes the methods and materials used in the study. The safety and 
ethical concerns, and recruitment difficulties associated with the study design are also 
addressed. 
The study utilised a  prospective observational case-control study design to investigate 
the short- and long-term effects of disuse osteopenia at the hip resulting from 
immobilisation following lower limb fracture or total knee replacement (TKR) in a 
postmenopausal population. The long-term objective was to identify risk factors, 
resulting from immobilisation that may increase the likelihood of future fractures at the 
hip. The study focused on effects at the hip as fractures at this site have the most 
significant consequences for patients in terms of loss of function and mortality. Results 
from the study may help to identify when and to whom preventative treatments should 
be administered to reduce any bone density loss. The effects of immobilisation on 
functionality, quality of life and mental health (with regard to depression and anxiety), 
were also investigated. Changes in cortical bone and muscle mass at the proximal femur 
were investigated in sub-groups using 1.5 Tesla MRI scanning.  
 
 
2.1 PARTICIPANTS 
The study focused on postmenopausal women over the age of 45 years. This group was 
selected because they lose bone systemically (at a particularly accelerated rate in the 
two years post menopause) and may be potentially at greatest risk of not recovering 
bone lost following a period of immobilisation. Osteoarthritis is also a common 
condition in this age group, frequently requiring TKR as the end stage treatment for  
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severe disease. Although ankle fractures are not considered to be a typical osteoporotic 
fracture, this age group also frequently present with ankle fractures that often result 
from relatively minor trauma. An age-matched control population, with no history of 
lower limb fracture after the age of 21 years, was also recruited as a comparison for the 
other groups. Sub groups were selected for MRI scanning of the hip ROI to ascertain 
whether this methodology is suitable to measure changes in cortical bone geometry and 
muscle mass.  
 
2.1.1 PARTICIPANT GROUPS  
 
A sample size calculation was based on BMD loss at the ipsilateral femoral neck in a 
study by van der Poest Clement (12) in which significant loss (p=<0.01) of 5.1% was 
reported after an interval of one year following lower leg fracture in eleven participants. 
Baseline ipsilateral NOF BMD (0.78±0.15 g/cm
2
) was low compared to that expected in 
the current study. Assuming a smaller loss of 2.0% BMD and based on a mean hip 
BMD of 0.812 g/cm
2
 and a population standard deviation of 0.1 g/cm
2
, a sample size of 
25 participants per group was calculated(237) using an α value of 0.05 and β of 80%.  
.  
Given the long-term commitment to the study required from participants, and the 
possibility of ill health or other difficulties arising in this age group, a high attrition rate 
(50%) was factored in to the study design (238). Fifty participants per group were 
therefore targeted for recruitment comprising the following: 
 
50 x Control participants 
50 x Patients undergoing total knee replacement 
50 x Lower limb fracture patients treated by plaster of Paris (POP) 
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50 x Lower limb fracture patients treated by internal fixation (IF) 
 
Sub-groups of ten volunteers were selected from each of the control and fracture 
populations to have MRI scans of their hips. The participants were randomly selected 
on the basis of their willingness to have the scans, absence of contra-indications for 
MRI scanning, and scanner availability at the time of their first appointment. 
Participants, who had TKR surgery or internal fixation of their fracture, were excluded 
from this element of the study as the implantation of metal fixation or prostheses is a 
contra-indication for the MRI scans.  
 
2.1.2 INCLUSION CRITERIA    
Fracture Cases 
 Postmenopausal women > 45 years  
 Fractured lower limb within past 2 weeks  
 Immobilization > 6 weeks 
TKR cases 
 Postmenopausal women > 45 years  
 TKR booked 
Controls 
 Postmenopausal women> 45 years 
 
The fracture participants were recruited on the basis that their injuries were sufficiently 
severe to necessitate a minimum of 6 weeks without weight-bearing on the affected 
limb. Foot fractures were therefore excluded from this study, since they rarely require 6 
weeks of immobilisation.  
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2.1.3 EXCLUSION CRITERIA 
Cases 
 Premenopausal women < 45 years 
 Treatment of fracture by external fixation 
Controls 
 Premenopausal women < 45 years 
 Corticosteroid use >2.5mg for >3 months within last 5 years. 
 Lower limb fracture or TKR post age 21 years. 
 Immobilisation of a lower limb for > 4 weeks within last 10 years or in 
postmenopausal period. 
 Known knee osteoarthritis likely to result in a TKR within 1 year. 
 
 
The exclusions were made on the basis of avoidable confounding factors known to have 
major effects on bone remodelling and quality (e.g. long-term corticosteroid use), or 
that may prohibit completion of the study (i.e. further leg surgery during the course of 
the study). Participants already on treatment for low BMD were not excluded as it was 
statistically probable that a high proportion of the study population would be in the 
osteopenic or osteoporotic range at baseline and already receiving treatment. It was 
expected that some participants would be diagnosed with low BMD during the course of 
the study and would commence treatment within the study period. It was felt important 
to keep the patients in the study as close to those seen in clinical practice as possible to 
ensure that the results are generalisable to the clinical population.  Having a long list of 
exclusion criteria would mean that the population was screened to such an extent to not 
reflect the usual clinical population, which would also reduce the number of patients 
available for recruitment.   
Chapter 2 
[84] 
 
 
Previous immobilization could have residual effects on BMD in the affected limb and it 
was intended that cases with previous knee or total hip replacement (THR) would be 
excluded from all groups. In addition, the presence of a hip prosthesis would prevent 
DXA measurement at that site. However, it became apparent early in the recruitment 
process that enforcement of these exclusion criteria in the TKR group would severely 
limit the number of suitable respondents as bilateral OA in hip and knee joints (with 
consequent THR or TKR) was a common complication in these participants.  Of the 
twenty-one TKR participants who completed the entire study, 5 had a previous TKR, 2 
had a previous contralateral total hip replacement (THR) and 1 had both previous 
contralateral THR and TKR. Participants (particularly those with existing OA) 
frequently exhibited exacerbated pain in the contralateral knee or hip following surgery 
that unpredictably increased the probability of further surgery during the study period. 
One participant required a second TKR during the study period and was lost to follow-
up for this reason. A further participant required a second THR after her third visit and 
her subsequent bone density data were unavailable. 
 
2.1.4 RECRUITMENT        
Patients were recruited immediately following treatment for traumatic fracture or before 
TKR surgery. Recruitment posters and leaflets (Appendix 1 & 2) were placed in the 
Emergency Department (ED) and fracture clinic at the Princess Elizabeth Orthopaedic 
Centre (PEOC) at the Royal Devon &Exeter (RD&E) Hospital to provide preliminary 
information about the project. Participants were also approached in the following ways: 
 Suitable fracture patients were initially approached during their first appointment at 
the fracture clinic by staff involved with their treatment. They were given a patient 
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information sheet (PIS), (Appendix 3) and asked to contact the researcher if they 
were interested to participate. 
 TKR patients were either approached by the clinical team during their clinic 
appointment or identified from the hospital waiting list and invited to participate by 
written communication (Appendix 4) that included the PIS and the researcher’s 
contact details.  
 
Controls were also recruited by a poster and leaflet campaign (Appendix 5 & 6). These 
were distributed around Exeter University campuses and other public places, such as 
gyms and health clubs, targeting people who might be interested to know about their 
bone health. Talks were given to selected groups with an interest in osteoporosis and 
leaflets distributed to anyone wishing to participate in the study. Prospective volunteers 
were asked to phone or write direct to the researcher to establish that they met the 
criteria to participate.  
 
 
2.1.5 RESPONSE RATES 
The control group was recruited easily and steadily as most participants recognized the 
benefit to themselves of discovering their BMD status. Once the initial volunteers were 
recruited, word-of-mouth communication amongst their peers proved a very effective 
recruitment method.  
Recruitment of the TKR group was initially slow and recruitment via clinic staff was 
erratic. The strategy of direct mailing proved effective. All suitable participants, 
identified from the hospital surgery waiting list, were contacted and the group was 
recruited steadily.  
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The initial strategy for recruiting fracture patients via staff contact in fracture clinic was 
not successful for a number of reasons; in part due to lower than anticipated numbers of 
suitable fracture patients attending the RD&E Hospital. The study design required 
patients to attend the first data collection session within two weeks of sustaining their 
injury in order to obtain baseline data as close to injury as possible. This was not 
practical for many patients who were dependent on friends or relatives to provide 
transport following their injury. Patients frequently did not attend fracture clinic until 
many days after injury, having had initial treatment/casting in ED. Many patients 
attending fracture clinic were therefore effectively ‘timed out’ and eliminated as 
potential recruits.  An attempt was made to approach patients in ED at the time of their 
first presentation with the injury, with caution in regard to any distress or confusion that 
patients were suffering at this time. 
 
Although a number of named staff,  both in fracture clinic and ED, were requested to 
focus efforts on recruitment for the project, difficulties were encountered in engaging 
other team members in this task due to the heavy workload, large numbers and high 
turnover of staff working in these departments. Attempts were made for the researcher 
to attend both fracture clinic and ED to approach patients directly. Although this was 
often successful, the infrequency and unpredictability of suitable patients being present 
at any given time, made this a prohibitively time consuming method of recruitment. 
 
In order to complete the study within the given timeframe, some amendments to the 
original study design were implemented.  Firstly, the two fracture patient groups, POP 
and IF, were merged reducing recruitment from a total of 100 patients to 50 patients.  
Secondly, for the convenience of patients and to facilitate recruitment of this group, the 
period of 2 weeks between injury and baseline measurement was extended to 3 weeks. 
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To address the issues of low recruitment in the fracture group, a cross-sectional arm was 
added to the study design. 50 additional volunteers were targeted who had sustained a 
leg fracture (resulting in approximately 6 weeks of immobilisation) more than one year 
previously, post menopause and within the previous ten years. This enabled comparison 
of bone changes due to previous immobilization against the control group. This ‘cross-
sectional’ (Xsect) group were only required to provide baseline data and therefore only 
attended for one visit and one set of scans. These participants were recruited by the 
same methods used for the other groups i.e. direct approaches to members of the public 
by poster and leaflet campaign (Appendix 7 & 8) or written communication (Appendix 
5) direct to patients who had previously attended at the RD&E Hospital as identified by 
the clinical teams. 2 participants in this Xsect group had sustained injury to the 5
th
 
metatarsal of the foot but were included in the study as their fractures were of sufficient 
severity to require 6 weeks of immobilization. 
 
The final groups recruited to the study were: 
Group 1.  Controls  
Group 2. TKR 
Group 3. Fracture < 3 weeks before baseline data collection (#<3 wks) 
Group 4. Fracture >1 year and <10 years before baseline data collection (#>1 yr) 
 
The recruitment strategy is summarized in Figure 2.1  
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The response rate for the various recruitment methods is summarised in Table 2.1. 
Table 2.1. Participant recruitment summary 
   Group 1  Group 2  Group 3  Group 4  
 Controls TKR #< 3 wks #> 1 yr  
      
Poster/Leaflet/Word-of-mouth      
Contacted Unknown Unknown Unknown Unknown  
Volunteered 49 1 3 3  
Suitable 46 1 1 3  
Direct mailing      
Contacted 0 100 0 41  
Volunteered 0 30 0 23  
Suitable 0 30 0 23  
Staff/researcher  contact in clinic      
Contacted 0 0 Unknown 0  
Volunteered 0 0 11 0  
Suitable 0 0 9 0  
 
 
2.1.6 RETENTION RATES 
Table 2.2 shows the retention rates for the main study. 
Table 2.2. Participant retention summary - Main study 
      
 Recruited Data collection completed 
  Visit 1 Visit 2 Visit 3 Visit 4 
 n= n= n= n= n= 
Controls 46 46 - 45 43 
TKR 31 28 25 22 20 
#< 3wks 10 9 9 9 9 
#> 1yr 26 25 - - - 
Total 113 108 - - - 
 
Although the target of 50 participants was difficult to achieve for the patient groups, 
within the available time frame, retention rates for the study were much higher than 
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expected. Participants demonstrated a high level of interest and engagement with the 
project and attrition was mainly due to illness. This was particularly notable in the TKR 
group who had a higher co-morbity rate than the other groups. Three participants 
recruited to the study did not complete data collection at Visit 1. This was due to 
delayed or cancelled surgery. One participant completed questionnaires but was unable 
to have scans due to immobility that prohibited safe manual handling to position them 
on the DXA scanner. One TKR participant sustained a peri-prosthetic fracture following 
surgery and a further TKR participant required a second knee replacement during the 
course of the study. The attrition for all groups was minimal for the remainder of the 
project.  
Table 2.3 shows the retention rates for the MRI study.  
Table 2.3. Participant retention summary - MRI study 
      
 Recruited Data collection completed 
  Visit 1 Visit 2 Visit 3 Visit 4 
 n= n= n= n= n= 
Controls 11 9 - 9 6 
TKR 0 - - - - 
#< 3wks 2 2 2 2 1 
#> 1yr 0 - - - - 
Total  13 11   2  11  7 
 
Two control participants were lost to the MRI element of the study because they were 
unable to enter the scanner due to claustrophobia. Four scanning sessions could not be 
completed at Visit 4 due to postponement of appointments by participants and 
unavailability of the MRI scanner at the rescheduled dates.  
A grant application was submitted to the Society and College of Radiographers Industry 
Partnership Scheme (CORIPS). This was funded and provided travel and consumables 
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costs for the study in addition to conference attendance.  The project was reviewed and 
approved by the Devon and Torbay Research Ethics Committee REC Ref: 
09/H0202/64.  
  
 
2.2 METHOD  
 
 
2.2.1 PRELIMINARY ADMINISTRATION  
 
 Positive respondents to the recruitment campaign were sent a PIS if they had not 
already received one and their contact details were recorded.  
 Participants were recruited to the study if they met the inclusion criteria and did not 
have contra-indications for DXA scanning i.e. to minimise radiation exposure, 
participants were excluded if they had had a DXA scan within 6 months prior to the 
first appointment due on the study. 
  Participants were asked if they were willing to have MRI scans and the MRI 
contraindication checklist (Appendix 9) was used to screen participants’ suitability 
for this section of the study.  
 Appointments were sent to suitable recruits using the appropriate forms that 
included relevant information on appropriate attire (with no metal fixings) for the 
scanning procedures. Travel information and a parking permit were provided.  
Where necessary, due to mobility problems, special arrangements were made to 
reserve a parking space close to the scanner facilities and to escort the participant 
using a wheelchair. 
 To reduce the session time at Visit 1, a Bone Questionnaire (Appendix 10) was sent 
to participants to complete at their own convenience. 
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2.2.2  DATA COLLECTION SCHEDULE 
 
Data collection was conducted at the Children's Health and Exercise Research Centre 
(CHERC) and the Peninsula MR Research Centre (PMRRC) at St.Luke’s Campus of 
the University of Exeter. 
 
Participants attended data collection sessions at the intervals shown in Table 2.4. 
 
 
Table 2.4. Schedule of visits for different groups 
  
2 weeks pre-
baseline 
Baseline* 6 weeks post 
baseline 
6 months post 
baseline 
12 months post 
baseline 
Contro
ls           
TKR           
#< 
3wks           
#> 1yr           
* Baseline = Surgery date for TKR or within 3 weeks of fracture (at participant's convenience for control and #> 1 yr 
groups). 
 
 
Some difficulties arose in obtaining baseline data within a 2 week period prior to 
surgery for the TKR group as a number of participants had unexpected postponements 
to their surgery following Visit 1. The mean interval between Visit 1 and surgery was 
22.5 days for the TKR group. The mean interval between injury and Visit 1 for the #< 3 
week group was 19.7 days. 
 
2.2.3. SCREENING AND DATA COLLECTION PROCEDURES AT VISIT 1 
 
 
Preliminary consenting and checks 
 Informed consent was obtained having ensured that participants had read and fully 
understood the information provided to them. 
 Before DXA or MRI scans took place, participants were asked to confirm that they 
were post menopause and therefore could not be pregnant.  
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  The Bone Questionnaire provides participants’ GP contact details plus their medical 
and lifestyle history relating to bone health. This questionnaire was checked in the 
participant’s presence enabling them to clarify or complete any missing information. 
 
Questionnaires 
 
Permissions were obtained to use copyrighted questionnaires in the study. Validated 
questionnaires were selected on the basis of their reliability, precision and relevance to 
the age range and pathologies of the study population. To achieve comparability and 
continuity in participant responses, questionnaires were administered during the data 
collection sessions by the same researcher at each visit.  As some of the questions were 
sensitive and possibly intrusive in nature, participants were offered the opportunity to 
complete the questionnaires at home if they preferred, however no participants opted to 
do this. As questions were posed to all groups irrespective of the presence of lower-limb 
problems, answers regarding depression, anxiety, pain, perception of health state and 
quality of life were not restricted to direct association with leg injury/surgery. 
 
  A visual pain scale was used with score range from 0 (no pain) to 100 (intolerable 
pain). In order to assess the overall impact of pain on function and wellbeing, 
participants were asked to give a generlised assessment of their pain levels i.e. not 
relating only to their fracture injury or TKR surgery. This was because these 
participants frequently exhibited referred pain in their hips or contralateral limb 
during recovery. Some participants also suffered shoulder pain as a result of using 
crutches.  
 The Lower Extremity Functional Scale (LEFS) (Appendix 11) developed by 
Binkley et al (239) was used to assess functional ability and recovery. This 
questionnaire has 20 activity domains each with 5 levels of difficulty. A maximum 
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score of 80 represents full functionality in all domains. The LEFS questionnaire 
relates to lower limb functional impairment only, however many of the patient 
participants experienced secondary problems in their overall function due to 
shoulder pain resulting from use of crutches, or to referred pain in the spine or 
contralateral limb associated with alterations in their gait and distribution of weight-
bearing.  Questions regarding lower-limb functional impairment are not directly 
applicable to the control group (although they may experience functional limitations 
due to other factors), therefore, in order to achieve comparability between the 
different groups, all participants were asked to answer questions relating to 
functional difficulties due to any physical reason regardless of the association with 
lower-limb injury or surgery. 
 A quality of life questionnaire (EQ5D)* (Appendix 12) was administered to provide 
a basic assessment of difficulties with mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression. Scores range from 5 (best possible) to 15 
(worst possible). A visual scale ranging from 0 (worst imaginable) to 100 (best 
imaginable) provides a score of the participant’s state of health as they perceive it to 
be.  
 The Patient Health Questionnaire (PHQ-9)** (Appendix 13) was used to assess the 
psychological impact of injury/surgery and immobilisation.  With 9 domains and 4 
levels, scores range from 0 (best possible) to 27 (worst possible). 
 Additionally the Generalised Anxiety Disorder questionnaire (GAD-7)*** 
(Appendix 14) was used for the same purpose. With 7 domains and 4 levels, scores 
range from 0 (best possible) to 21 (worst possible). 
  Participants were asked to take home and complete the International Physical 
Activity Questionnaire (IPAQ) (Appendix 15).This questionnaire contains questions 
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about the types, intensity and duration of activity for a 7 day period immediately 
following their visit. There was high degree of subjectivity in the questions asked in 
this questionnaire as participants varied in their concept of vigorous and moderate 
activity, largely according to their own current level fitness and mobility. Although 
the form provides some guidance as to which activities are moderate or vigorous, in 
an attempt to achieve some level of consistency, all participants were asked to 
consider general housework as moderate activity and heavier housework (such as 
cleaning windows or changing duvet covers) as vigorous. It should be noted that the 
IPAQ was developed and tested for use in an age range of 15 to 69 years. Whilst some 
participants in this study were above this 69 year limit, this was the most appropriate 
validated questionnaire available for the majority of participants and as many of the older 
participants in the study demographic were very active, the questions were considered 
appropriate. 
 
 
Measurements 
 Height was measured to the nearest 0.01m using a wall mounted stadiometer (Seca, 
Germany). 
 Total weight was measured to the nearest 0.1 kg using weighing scales (Seca 877, 
Germany).   
 
 
*©1990 EuroQol Group. EQ-5D ™ is a trade of the EuroQol Groupmark (Appendix 12). 
** Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational 
grant from Pfizer Inc. Copyright © 2005 Pfizer, Inc. All rights reserved. Reproduced with permission (Appendix 13). 
***GAD-7 Copyright Pfizer Inc. all rights reserved; used with permission (Appendix 14).  
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 Left/right weight-bearing was measured using two sets of identically calibrated 
weighing scales (Seca 877, Germany). Ensuring stability of the scales, participants  
were positioned in a natural standing posture astride two sets of scales. Three 
random consecutive readings, recorded from the left hand side, were taken with the 
researcher standing slightly behind the participant to minimise any influence on 
their balance.  The average of these three readings was calculated as representative 
of the participant’s left side weight-bearing. The right measurement was calculated 
as the difference between left average weight-bearing and the participant’s total 
weight. A precision study (240) was undertaken to validate this technique and is 
described in Chapter 3.  
 All participants underwent DXA (GE Lunar Prodigy, Bedford, MA) scans of 
bilateral hips, lumbar spine and total body in accordance with the manufacturer’s 
protocols. The lumbar spine and hip scans are clinically relevant sites for scanning 
and enabled the diagnosis of low bone density or osteoporosis. The total body scan 
provided measurements of body composition in addition to total bone density. The 
bone mineral density, fat and lean mass can be divided into subsections, providing 
regional measurements of changes in bone density and lean tissue mass in the lower 
limbs.  
  
The total radiation effective dose equivalent for the entire study was estimated at 7.8 
µSv for the average control participants and 10.4 µSv for the average case. The risk 
benefit assessment (Appendix 16) shows that this represents a trivial risk compared 
to the daily background radiation (depending on location).of 6 to 20 µSv. Allowing 
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for a repeat exposure due to positioning inaccuracy or equipment failure, a dose 
constraint of 15 µSv was set for each participant in the study.  
Correct patient positioning was important to obtain accurate reproducible 
measurements and standard protocols were followed by a single researcher to avoid 
inter-operator variation. Training was undertaken by the operator at the RD&E DXA 
department to learn the correct positioning techniques.  Where necessary, due to 
plaster casting or discomfort following surgery, standard positioning was adapted 
with supports. These adaptations were reproduced at all scanning intervals to 
achieve directly comparable results between scans. 
 
Quality Assurance (QA) tests, assessing functional performance and calibration, 
were performed on the DXA scanner using a QA phantom to ensure safe and 
accurate operation before the start of each day’s scanning session. In addition 
regular QA tests were performed using a manufacturer-supplied aluminium spine 
phantom (number 15867). The QA precision results for the equipment over the 
period of the study are shown in Figures 2.2 and 2.3. 
 
Fig 2.2 BMD QA results over the total study period. 
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The precision error of DXA scanners is typically quoted as being in the region of 
1%, however a recent study (224), on the scanner used in this study, demonstrated 
higher precision errors in overweight and obese groups. The Knapp et al study 
performed lumbar spine, left hip and total body scans on female participants and 
repeated these after a short interval during which participants were removed from 
the scanner and walked around the room. The effect of BMI on precision error at the 
hip ROI was limited, meaning that this is a good site for measuring changes in BMD 
even in obese participants. Data for 91 participants (mean age 47±13 yrs) available 
from the Knapp et al. study were used to assess short term precision error (STPE), 
calculated using the root mean squared coefficient of variation (RMSCV%), for the 
range of parameters shown in table 2.5. The table summarises the STPE results for 
all 91 participants without subdivision into BMI groups.  
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Fig. 2.3 Spine Phantom QA results for period 4.1.10 to 
30.10.12 (82 measurements) RMSCV% = 0.23%
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Table 2.5. Short term precision error in DXA measurements. 
Measurement RMSCV% 
BMD spine L1-L4 1.29 
BMD at Total Hip 0.92 
BMD at NOF 1.58 
Fat-Total body 2.19 
Lean tissue-Total body 1.57 
TBS 2.07 
AHA - Hip Axis Length (HAL) 0.66 
AHA - Cross Sectional Moment of Inertia (CSMI) 3.94 
AHA – Cross Sectional Area (CSA) 2.90 
AHA –  Femur Strength Index (FSI) 9.80 
  
 
 
 
 Subgroups selected for MRI were scanned at the hip region at each of their visits 
over the one year period using a 1.5 Tesla Philips Intera scanner. Participants were 
scanned in a supine position using a SENSE 4 element body coil. The same operator 
positioned participants and performed the scans for all examinations.  Data were 
acquired for coronal and axial sections using the sequences and scanning parameters 
shown in Table 2.6. The T1 weighted turbo spin echo sequence was selected as this 
provides good contrast between bone and soft tissue. The STIR TSE and PDW 
SPAIR sequences were included as a secondary option. Whilst these sequences do 
not give the same level of tissue contrast as T1W TSE and are therefore less easy to 
interpret, they are not susceptible to chemical shift image artefacts that can occur at 
tissue interfaces and cause potential measurement error (241). 
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Table 2.6. MRI scanning protocol 
Plane Sequence Acquisition 
voxel size (mm) 
Reconstruction 
voxel size (mm) 
Minimum  slice 
gap (mm) 
Coronal T1W TSE* 1.97/2.11/5/00 0.99/0.99/5.00 5 
Coronal STIR TSE
†
 1.97/2.11/5/00 0.99/0.99/5.00 5 
Axial T1W TSE* 1.97/2.11/5/00 0.99/0.99/5.00 5 
Axial PDW SPAIR
‡
 1.97/2.11/5/00 0.99/0.99/5.00 5 
* T1 weighted Turbo spin echo 
†Short T1 Inversion Recovery Turbo spin echo 
‡Proton Density Spectral attenuated Inversion Recovery 
 
 
 Pedometer readings: Participants were asked to take home a pedometer and use it in 
accordance with the Activity Monitor Instructions provided to them (Appendix 17) for 3 
days in the week following their visit.  For comparability with the #>3 week group, 
TKR patients were asked to perform the pedometer measurements immediately 
following surgery. 
 
 
2.2.4. SCREENING AND DATA COLLECTION PROCEDURES AT VISIT 2, 3 & 4 
Questionnaires and measurement procedures, as described for Visit 1, were repeated at 
the follow-up visits. However, to avoid unnecessary radiation exposure, the Lumbar 
Spine scan was not performed at visit 2 because changes in this region were not 
expected within the 6 week immobilisation period. In order to achieve consistent patient 
positioning, allowing accurate comparison of repeat scans, previous scans were checked 
so that the original positioning could be reproduced. This was particularly necessary for 
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the patient groups where positioning at the first visit may have been affected by plaster 
casts or the use of supports. 
 
The MRI screening questionnaire was used at every visit to ensure that no 
contraindications had arisen since the previous visit. 
 
The following additional questionnaires were designed and used at the follow-up visits: 
 Immobilization record (Appendix 18) in which periods of total and partial 
immobility were recorded. 
 Treatment and falls record (Appendix 19) in which any further changes in fractures, 
drugs or diseases, and physical therapies known to affect bone metabolism were 
recorded. 
 
 
2.2.5. COMPLETION ADMINISTRATION 
 Participants were provided with their bone mineral density results during their visits, 
which may have indicated the presence of osteopenia or osteoporosis. They were 
advised that the researcher was a student and that this was not an official diagnosis. 
Their fracture history and other osteoporosis risk factors were assessed from the 
questionnaire and included in a report prepared by the researcher and approved by 
Dr. K. Knapp (project supervisor). With participants’ consent, abnormal results 
were sent to their GPs. 
 The consultant orthopaedic surgeon responsible for care of the TKR patients was 
informed if any of these participants exhibited BMD in the osteopenic or 
osteoporotic range. 
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 Some of the newly fractured patients may have been identified by the RD&E as 
requiring DXA scans as part of their clinical care. To avoid scanning duplication, a 
list of participants from this group was supplied to the relevant team at the RD&E 
hospital.  
 Follow-up appointments were sent to participants and their travel expenses 
reimbursed. 
 Newsletters were distributed at appropriate intervals to inform participants about 
progress with the project. 
 Progress reports were prepared at designated intervals for the Research Ethics 
Committee (REC), NHS Research and Development Department and for the funders 
of the study, CORIPS.  
 
 
2.2.6 SAFETY & ETHICAL CONSIDERATIONS 
The following safety and ethical issues in the study design were addressed to minimise 
any potential adverse effects, pain, discomfort, distress, intrusion, or inconvenience to 
participants: 
 
All participants were given a PIS with a copy of the consent form attached to enable 
them to thoroughly read and understand the contents before volunteering. An 
opportunity to ask further questions regarding the study was offered before signed 
consent was requested at the time of the first appointment. Participants from vulnerable 
groups were not approached. To avoid any possibility of patients sensing coercion by 
hospital staff or the researcher, patients (who were directly approached in ED and 
fracture clinic and who expressed willingness to participate) were asked to read the PIS 
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at home and contact the researcher later to make an appointment after they had fully 
considered all the information provided to them. 
 
The main potential risk in this study arose from the ionising radiation used for the DXA 
scans. Despite the number of scans involved, the dose was very low, at a total of 
approximately 10 microSieverts over the entire study, roughly equivalent to the risk 
involved with 1 day’s exposure to the sun without sunscreen. Participants were assured 
that this is a very small dose and whilst there are risks of stochastic/"chance effects" 
occurring, these are very small. DXA scans are usually stress-free, painless and 
comfortable. Participants were shown the equipment and had the procedure explained to 
them prior to the scan. 
 
The MRI scan does not use ionising radiation although heating effects have been noted 
with MRI. The protocols used for MRI ensure that any heating effects are kept to a 
minimum and that the heating falls within the safety limit of an increase no greater than 
1% to the total body temperature during the scan. All participants undergoing MRI 
underwent strict safety screening and completed the MRI contraindications checklist to 
ensure that they were suitable to enter the magnet. The MRI scanner may be 
claustrophobic for some participants. Where this was the case, participants were not 
encouraged to proceed and were able to opt out of this part of the study. MRI scanning 
is a noisy procedure and all participants were provided with headphones and music if 
desired.  
 
To minimise the time burden for participants, questionnaires were selected for their 
brevity and ease of completion. It was possible that questions regarding the depression 
and anxiety status of participants could have been sensitive and upsetting for them, 
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although the questions were not highly specific in nature. A mood disorders protocol 
was in place for risk assessment and reporting should any participant be identified from 
their responses as being at a significant risk of harm (Appendix 20). Training in the use 
of this protocol was undertaken at the University of Exeter’s Mood Disorders Centre 
before the study commenced. Participants were offered the option to complete the 
questionnaires at home and return them by post if they preferred. 
 
The total visit time averaged approximately 1 hour for most participants and about 2 
hours for those having MRI scans. Arrangements were made to reserve a parking space 
and provide a wheelchair escort for any participant who was experiencing difficulty in 
walking after injury or surgery.  No incentives or payments were made to participants 
but parking permits were provided and travel expenses reimbursed. 
. 
  
Data collection and DXA scanning was undertaken by a single researcher working 
alone. It was therefore important to be mindful of potential safety issues for both 
participants and researcher in this context. Where there were any concerns about 
transporting participants or manual handling, due to immobility, the scanning 
procedures did not proceed.  The University of Exeter indemnity arrangements applied 
to the study and personal indemnity cover for the researcher was provided through her 
membership of the Society of Radiographers. 
 
Confidentiality issues were addressed by employing the following safeguards. Data files 
for analysis were de-identified and participants provided with a unique identifier code. 
Computerised DXA data files were identified by participants' initials and unique 
identifier. Only individuals authorised to use the DXA laboratory were permitted access 
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to the password protected computer. Computerised MRI data files were stored under a 
unique identifier and access to these limited to MR staff.  Hard copies of data and 
material containing participant contact details were stored in a locked filing cabinet in a 
private office with access only available to authorised personnel. 
 
2.3 DATA ANALYSIS & STATISTICS  
 
The primary outcome measures for the study are: 
 Changes in bone mineral density and lean tissue mass. 
 Changes in  bone quality and structural parameters measured by AHA and TBS 
The secondary outcome measures are: 
 Relationships between longitudinal changes in bone mineral density and fracture 
risk at the hip. 
 Changes in mood as measured by anxiety and depression questionnaires. 
 Changes in functionality and quality of life. 
 Changes in cortical bone and muscle thickness as measured by MRI. 
 
Statistically, it was probable that a high proportion of participants would be diagnosed 
with osteopenia or osteoporosis as a result of taking part on the study and would 
consequently be put onto treatment. Table 2.7 shows a summary of all participants (who 
were included in the final analysis) receiving treatment for low bone density at baseline, 
and additional participants put onto treatment during the course of the study. Data for 
two participants, who completed the study, were ultimately excluded from the final 
analysis of results because they were prescribed strontium ranelate which is a drug for 
the treatment of osteoporosis known to artificially elevate BMD measurements due to 
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its high atomic number, (Z=38) compared to calcium (Z=20), causing greater 
attenuation of X rays (242).   
 
Table 2.7. Summary of participants receiving treatment for low bone density at baseline, and 
additional participants put onto treatment during the course of the study. 
 
Visit 1 Visit 2 Visit 3 Visit 4 Total 
Calcium supplement 3 3 3 4 11 
Bisphosphonate + Calcium 11 0 8 3 22 
 
 
 
 
2.3.1  ANALYSIS OF DXA SCANS 
Raw data from the DXA scans were analysed using the GE Lunar enCORE™ 2005 
software version 9.30.044. This software automatically detects the bone edges of the 
ROI and subdivides that region as shown in Figures 2.4 and 2.5.  
 
 
 
 
 
 
 
 
 
Fig 2.4  DXA image showing ROI subdivisions of the hip region (243) 
 
 
 
 
This image has been removed by the author of 
this thesis for copyright reasons. 
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Fig 2.5  DXA image showing ROI subdivision of the spine into individual vertebrae (L= 
Lumbar, T=thoracic) (243) 
 
 
The subdivisions demarcated in the total body scans are shown in figure 2.6. 
 
 
 
 
 
 
 
 
 
Fig 2.6 Total body scan regions of interest (244). 
 
 
This image has been removed 
by the author of this thesis for 
copyright reasons. 
 
 
This image has been removed 
by the author of this thesis for 
copyright reasons. 
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The regions demarcated by the computer were checked by the researcher for any 
anomalies and manual adjustments made where appropriate. For consistency in 
analysing the follow-up scans, the ROIs from the original scan were copied and 
transferred onto the new scan images. Where there were differences in the patient 
position between the original and follow-up scan, manual corrections were applied as 
appropriate. The scanner output provides bone densitometry and body composition 
results and calculates T & Z scores based on the National Health and Nutrition 
Examination Survey (NHANES) database. The enCORE™ 2005 software version 
9.30.044 also automatically provides AHA results of hip geometry and strength.  An 
example of the DXA output is shown in Appendix 21. A macro was used to transfer the 
DXA data to Microsoft Excel Spreadsheets. 
 
TBS (TBS iNsight
®
, v1.8. Med-Imaps, France) software was used to analyse all lumbar 
spine scans. TBS uses the same raw data, edge detection and ROIs that generate the 
bone densitometry results and provides a visual representation of TBS values in the 
lumbar spine together with regional scores for bone microarchitecture. An example of 
the TBS report is shown in Appendix 22. TBS scores are based on data for French 
Caucasian women and range from 0.9 to 1.6 where a low score represents a 
poor/deteriorated bone microstructure with low connectivity, high inter-trabecular 
spacing and a low number of trabeculae. The TBS scoring system and relationship to 
bone quality is shown in Fig 2.7. 
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Fig 2.7. TBS scoring system and relationship to bone quality (245) 
 
 
 
2.3.2  ANALYSIS OF MRI SCANS  
Data from the coronal images only, for five control participants who provided useable 
images and completed the MRI scans at the end of the one year period, were analysed 
using OsiriX v.3.9.4 software. The number of fracture participants suitable for MRI 
scanning was insufficient to provide meaningful results and these were therefore 
excluded from the final analysis. Measurements were made from the anonymised 
images at the sites shown in Figure 2.8 and described in Table 2.8.  
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Fig. 2.8. Measurement sites of cortical bone and muscle tissue thickness. The numbered 
sites represent the measurement location; actual measurements were obtained 
perpendicular to the femoral neck or shaft. 
 
Table 2.8.  MRI measurement site descriptions 
SITE  Tissue Level Position  
1 Cortical  A Lateral Perpendicular to Mid femoral neck 
2 Cortical  A Medial   Perpendicular to Mid femoral neck 
3 Cortical  B Lateral 9 cm  inferior to superior aspect of greater trochanter 
4 Cortical  B Medial 9 cm  inferior to superior aspect of greater trochanter 
5 Cortical  C Lateral 14 cm  inferior to superior aspect of greater trochanter 
6 Cortical  C Medial 14 cm  inferior to superior aspect of greater trochanter 
7 Vastus lateralis muscle  B Lateral 9 cm  inferior to superior aspect of greater trochanter 
8 Medial muscle compartment B Medial 9 cm  inferior to superior aspect of greater trochanter 
9 Vastus lateralis muscle  C Lateral 14 cm  inferior to superior aspect of greater trochanter 
10 Medial muscle compartment C Medial 14 cm  inferior to superior aspect of greater trochanter 
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A single operator performed the image analysis and was instructed to take 
measurements of cortical bone and muscle compartments perpendicular to the femoral 
neck and femoral shaft at the levels indicated in Figure 2.9. The aim was to ascertain 
long-term change in bone and muscle measurements rather than to compare specific 
sites between individuals; therefore these levels were used consistently for all cases 
irrespective of the overall body height or femur length of the individual participant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.9. Levels selected for measurement of cortical bone and muscle tissue thickness. 
 
 
2.3.3 ANALYSIS OF QUESTIONNAIRES 
Questionnaires were scored in accordance with the designers’ instructions.  
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2.3.4 STATISTICAL METHODS   
After making appropriate exclusions for confounding cases, data for 95 participants 
were ultimately analysed as shown in Table 2.9.  
 
Table 2.9.  Summary of participants included in final data analysis. 
Group 1 Group 2 Group 3 Group 4 
Controls TKR #< 3 wks #> 1 yr 
43 19 9 24 
 
 
Data from questionnaires, weight, height and left/right weight-bearing measurements 
were de-identified and entered into Microsoft Excel spreadsheets. BMI was calculated 
as weight in kg/height m
2
. No weighting was given for duration or level of treatments, 
medications or medical conditions and these were coded as dichotomous variables. Raw 
data from the DXA scanner were downloaded and converted to a macro for transfer to 
Microsoft Excel. Left and right side DXA measurements were re-designated as 
ipsilateral and contralateral sides. The left side was designated as the ipsilateral side for 
the control group. 
 
Data were cleaned of errors and inconsistencies and analysed in PASW statistics 
version 18 (IBM Armonk, NY). Distributions for all parameters were tested for 
normality and parametric or non-parametric statistics used as appropriate. Descriptive 
statistics are reported as means and standard deviations, percentage of group, and as 
medians and interquartile ranges for Gaussian and non-Gaussian data respectively. 
Longitudinal changes in parameters are presented graphically (SigmaPlot v. 12). 
Significant differences between the groups are reported, calculated by Independent 
Samples t Test (2-tailed) for parametric variables and Independent Samples Median 
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(Fisher’s Exact) Test for non-parametric variables. Significant differences in 
measurements, at intervals over the study period, compared to the baseline measurement 
are also reported, calculated from Paired Samples t Test for parametric variables and 
Related-Samples Friedman's Two-way Analysis of Variance by Ranks for non-
parametric variables. The significance of differences between ipsilateral and 
contralateral measurements was calculated by Paired Samples t Test. 
 
Stepwise multiple regression analyses (PASW statistics 18) were performed on a cases 
excluded listwise basis, and reported using unstandardised coefficients. Potential 
confounding factors, such as the presence of a previous TKR, treatment for 
osteoporosis, age and BMI, were included as explanatory variables in the models. 
 
Specific statistical methods used for the sub-studies evaluating the dual scales and MRI 
techniques (chapters 3 and 4) are described in the relevant chapters.  
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CHAPTER 3.  EVALUATION OF A DUAL-SCALES METHOD TO 
MEASURE WEIGHT-BEARING THROUGH THE LEGS, AND EFFECTS OF 
WEIGHT-BEARING INEQUALITIES ON HIP BONE MINERAL DENSITY 
AND LEG LEAN TISSUE MASS  
 
3.1 INTRODUCTION 
This chapter investigates the accuracy of measuring relative left/right weight-bearing 
(L/R WB) through the legs using two identically calibrated weighing scales.   The short-
term weight-bearing (WB) tendencies in a general population of nine participants 
(Group A) and the long-term WB tendencies in forty-two females from the control 
group of the main study (Group B) are assessed. The effect of weight-bearing 
inequalities at baseline on hip bone mineral density and Leg Lean Tissue Mass (LLTM) 
in Group B are also investigated. 
 
This study required a convenient and reliable method to monitor changes in L/R WB 
during recovery following leg fracture or TKR. A number of studies investigating re-
ambulatory function, activity and recovery following injury or surgery, use 
technologically sophisticated methods, including force plates and portable monitoring 
devices such as accelerometers, to assess changes in patients’ weight-bearing activity 
and return to ‘normal’ gait (209, 246-249).  These devices can provide comprehensive 
information for complex gait and activity analysis and although force plates were 
available at the research facility where the study was conducted, they were located 
remotely from the main data collection area and were not readily accessible to 
participants with limited mobility. The necessity for the researcher, working alone, to 
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transport some participants by wheelchair from one facility to another, prohibited the 
use of this equipment on the grounds of manual handling difficulties, safety and 
convenience for both participant and researcher. A simple, inexpensive and reliable 
alternative was required that could be used in the main research area to provide basic 
information on standing weight-bearing and balance. It is evident that a dual-scales 
method is currently used in some clinical situations to monitor L/R WB changes in 
patients recovering from conditions that are associated with postural imbalance. 
Although this is a simple option, no published studies have been found that have 
investigated the precision of this method either in the short or long-term. Prolonged 
immobilization, reduced weight bearing activity and altered L/R WB are inevitably 
associated with leg injury or surgery potentially resulting in either unilateral or bilateral 
loss in BMD  and leg muscle mass (6-13). In order to investigate the effects of altered 
L/R weight distribution in an injured study population using the dual- scales method, it 
was first necessary to assess the accuracy of the method, and the normal L/R WB 
variation of a general population in the immediate short term. L/R WB in the uninjured 
control sample, from the main study on Disuse Osteopenia in a postmenopausal female 
population, was investigated to assess whether minor/normal inequalities in L/R WB at 
their baseline visit were associated with any differences in L/R BMD and LLTM. L/R 
WB measurements for this control group, taken at three six-monthly intervals, were 
used to assess the long-term variation in their L/R WB tendencies. 
 
3.2  AIMS AND OBJECTIVES  
This study investigated: 1. (a) The accuracy of a method for measuring L/R weight 
distribution using two sets of identically calibrated scales and (b) the short-term 
variation of L/R WB tendencies in a general population sample comprising a mixed age 
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and sex group of 9 volunteers (Group A).  2.  (a) The effect of L/R WB inequalities at 
baseline on BMD at the hip and on LLTM measured by Dual Energy X-ray 
Absorptiometry (DXA) and (b) the long term L/R WB tendencies in the control group 
from the main study (Group B). 
 
3.3 METHODS & STATISTICS 
3.3.1 Participants 
1.  Group A comprised a mixed sex group of 9 volunteers (aged 19-54 years). 
Volunteers were recruited from students, staff and members of the public available at 
the Children’s Health and Exercise Research Centre, University of Exeter.  No 
exclusion criteria were applied other than absence of an adult history of leg fracture or 
surgery, 
 2. Group B consisted of 42 postmenopausal women > 45 years, with no history of leg 
or ankle fracture, from the control group of the main study.  
Participant characteristics for Groups A&B are shown in Table 3.1. 
 
Table 3.1. Participant Demographics  
  Group A Group B 
 (n=4 m, 5 f) (n=42 f) 
  Mean (SD) Mean (SD) 
Age (years) 36.2 (17.0) 64.6 (7.6) 
Height (m) 1.68 (0.08) 1.64 (0.05) 
Weight (kg) 73.8 (8.2) 68.7 (10.0) 
Body Mass Index  (kg.cm
2
) 26.1 (2.9) 25.5 (3.13) 
SD: standard deviation     
 
 
3.3.2 Methods 
1. (a) Three participants from Group A were weighed on one set of scales to establish 
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their true total weight. The scales were calibrated equally by placing identical weights 
on each. Ensuring stability of the scales, participants were then positioned in a natural 
standing posture astride two sets of scales (Seca 877, Germany) as shown in Figure 3.1. 
Participants were instructed to stand in a forward facing position that they would 
naturally adopt when standing still with no specific instruction given regarding the 
placement of their feet on the scales. They were asked to look directly ahead, (to 
prevent participants adjusting their stance when seeing their readings), and were also 
asked not to speak during the measurement to avoid unnecessary movement. As it is not 
possible to simultaneously read both left and right digital readouts (due to the inherent 
tendency of participants to sway slightly), the measurement was recorded 
photographically. This procedure was repeated ten times for each participant. The 
combined weight measured on the two scales was compared to the true total weight 
measured on one scale to calculate the error in the method. Recording the measurement 
photographically for routine use of this method was impractical due to the problem of 
glare from the camera flash that frequently obscures the weight reading in the image. 
The following technique was therefore applied for the remainder of the study.  
Participants were weighed on one set of scales to measure their total weight.  To 
account for the natural tendency for participants to sway slightly when standing still, the 
average of three random consecutive readings, recorded from the left hand side, was 
taken as representative of the participant’s left side weight-bearing. The right 
measurement was calculated as the difference between left average weight-bearing and 
the participant’s total weight.  Measurements were taken with the researcher standing 
slightly behind the participant to minimise any influence on their balance (Figure 3.2). 
To assess the possible influence of the researcher’s proximity to the participant, the 
average of three measurements was also recorded from the right side and compared to 
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the calculated result. (b) The technique described above was repeated ten times with 
repositioning after participants had walked across the room between measurements.  
 
 
 
 
 
 
 
 
Fig.3.1 Participant standing astride two identical scales in a natural standing posture.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.2. Participant measurement technique 
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2. (a) Group B measurements acquired at their baseline visit by DXA (GE Lunar 
Prodigy, Bedford, MA) from bilateral hip and total body scans were correlated with L/R 
WB measurements at baseline to assess whether any inequalities in L/R WB at this time 
point were associated with differences in L/R LLTM or BMD at the Total Hip or Neck 
of Femur (NOF).  These regions were selected as they are most clinically relevant for 
the assessment of fracture risk. (b) L/R WB measurements were recorded in Group B by 
the dual-scales method at each of three visits at baseline, 6 months and 12 months. 
 
3.3.3 Statistical analysis 
The mean percentage difference between total weight measured on one scale and the 
combined weight distributed over two scales was calculated. The Intraclass Correlation 
Coefficient (ICC) between the right calculated and right recorded results, for Group A, 
was computed (SPSS version18.0).  Short- and long-term consistency in L/R weight-
bearing was calculated using the Root Mean Square Coefficient of Variation 
(RMSCV%) using the formula described by Gluer et al (250).  Linear regression 
analysis (SPSS version18.0) was used to investigate relationships between left/right 
differences in weight-bearing and differences in BMD (at total hip & neck of femur 
sites) and LLTM from Group B results recorded at their first visit.   
 
3.4 RESULTS  
1. (a) The difference between total weight measured on one scale compared to dual-
scales was 0.34%. The Intraclass Correlation Coefficient between right calculated and 
right recorded WB was 0.77 (p<0.05). (b) The mean percentage L/R WB for Group A 
was 50:50 and the short-term CV for L/R WB was 5.41%. 
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2. (a) Measurements of hip BMD and LLTM, at baseline for Group B, are shown in 
Table 3.2. No significant correlation was found in Group B between hip BMD 
differences and L/R WB at baseline. A weak, but statistically significant correlation of 
r=0.31 (p=0.047) was however found for differences in LLTM and L/R WB differences. 
(b) The mean percentage L/R WB at baseline for Group B was 51:49. The long-term 
CV for L/R WB in Group B was 7.01%.  
 
Table 3.2.  Group B DXA results at baseline visit 
  
Left Right 
  Mean (SD) Mean (SD) 
BMD (g/cm
2
) -  NOF 0.89 (0.13) 0.90 (0.13) 
BMD (g/cm
2
)  -  Total Hip 0.94 (0.15) 0.95 (0.15) 
LLTM (kg) 6.34 (0.76) 6.31 (0.79) 
SD: standard deviation     
 
 
3.5 DISCUSSION 
To assess the accuracy of two sets of identically calibrated scales to record the L/R 
distribution of total weight, it was necessary to establish that the combined weight 
measured whist standing astride two scales equalled the total weight measured 
conventionally on one scale. A photographic method was employed because the digital 
readout of the scales was highly sensitive to minor participant movements and it was 
therefore impossible to simultaneously read both digital readouts visually. The small 
amount of measurement error (0.34%) indicates that this is an accurate method. This 
photographic method is not however practical for routine use as the digital readout from 
the scale can often be obscured in the image due to glare from the camera flash. For this 
reason, having established that the dual scales are accurately measuring the distribution 
of total weight, an alternative visual method was adopted. To allow for the natural side-
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to-side sway of participants whilst standing on the scales, three consecutive readings 
were taken from the left-hand side and the average of these calculated as representative 
of weight-bearing on that side. The right side was calculated as the difference between 
the left side average weight-bearing and the participant’s total weight (recorded on one 
set of scales). It should be stressed that the equipment used in this study were very high 
quality ‘bathroom style’ scales with large flat surfaces and no protruding dials as shown 
in Figure 1. Participants were therefore able to place their feet on the scales in any 
position without adapting their normal stance. The efficacy of this method may not 
therefore be applicable to scales of a different design or poorer quality. 
 
An individual’s perception of ‘personal space’ is the area surrounding them within 
which they do not comfortably tolerate the proximity of a stranger (251), and it was 
therefore postulated that a participant’s stance could be influenced by the proximity of 
the researcher with a tendency to move slightly towards or away from someone standing 
very close to them.  This phenomenon was assessed by comparing the right side 
calculated result with the result recorded by the researcher standing on the right side. 
The ICC between the right calculated and right recorded results was r = 0.77 indicating 
that participants’ balance was only minimally affected by the proximity of the 
researcher.  
 
To establish the short-term consistency of L/R WB tendencies, Group A participants 
were re-measured ten times after walking across the room and returning to stand on the 
scales. Their results demonstrated a short-term CV of 5.41% indicating that there is a 
small amount of short-term inconsistency/variation in participants L/R WB tendencies. 
The long-term CV over three visits at six month intervals for Group B was 7.01% 
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indicating a degree of L/R WB variation comparable to the short-term CV in a general 
population sample represented by Group A. As Group B participants were already 
engaged in time consuming data collection sessions for the main study, it was not 
considered appropriate to burden them with the further activity required to assess their 
short-term variation in L/R WB tendencies. Figure 3.3 shows the left side weight-
bearing variation of individual participants in Group B over the 12 month period and 
although a number of participants demonstrated considerable long-term variation in 
their weight-bearing, most showed a consistent tendency to bear more weight on a 
particular side.  
 
Fig.3.3. Group B – Left sided weight bearing, mean of 3 visits, expressed as percentage 
of total weight-bearing for individual participants (n=42) 
 
As participants from both Group A and B were fully mobile with no recent history of 
lower limb injury, it was not expected that either would demonstrate any notable 
difference in their left/right weight-bearing. Whilst a number of individuals exhibited 
large differences between their left and right weight-bearing, the percentage means for 
groups A & B were 50:50 and 49:51 respectively. It was therefore not anticipated that 
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significant differences would be apparent in the Group B left/right measures of BMD 
and this was confirmed by the results. A small but statistically significant correlation 
was however found for differences in LLTM and L/R WB differences. The reason for 
this result is unclear.  Whilst evidence from the literature suggests that any deficit in 
LLTM or BMD is attributable to reduced mechanical loading, it could also be feasible 
that weight-bearing inequalities are the result of unilaterally reduced muscle mass.   In a 
study of healthy young adults, Hoffman et al (252) found no difference in unilateral 
postural stability between the functionally dominant and non-dominant lower limbs and 
therefore leg dominance (comparable to left or right-handedness) is not thought to 
account for these side-to-side differences. Leg dominance was not however investigated 
in this study.    
 
In populations sustaining lower limb injury or surgery, it is possible for the range of 
unilateral weight-bearing to be 0-100% over the period from injury to full 
remobilization, potentially resulting in marked changes bilaterally in BMD & LLTM 
during the course of recovery. Although Group B participants had no history of leg or 
ankle fracture, 11 participants reported previous unilateral leg pathology, and 3 bilateral. 
These injuries or disabilities ranged in severity from minor arthritis to a ruptured patella 
tendon, and in incidence from 18 months to 40 years previously. The mean percentage 
L/R WB of these participants as a sub-group was not however significantly different to 
the non-injured controls; 49:51 compared to 51:49 respectively.  
 
Although the results in the current paper relate to a fully ambulatory population, in 
circumstances where injured participants use support from either walking sticks or 
crutches, weight bearing on their legs is measured by weighing them with the supports 
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resting on the adjacent floor in their normal standing, supported position. Relative 
left/right weight-bearing is then calculated as a percentage of their total unsupported 
weight. All participants in this study were able to provide an unsupported weight 
measurement.  
 
The major limitation of this dual-scales technique is that it measures weight-bearing in 
an upright stance and this may not be representative of typical weight-bearing during 
other activities including walking. Participants frequently commented that they rarely 
stand in this forward facing upright posture and adopt a more casual stance when 
standing for long periods. This may be less applicable to patient populations whose 
injuries limit their postural flexibility. It is acknowledged that this dual-scales method 
can only provide limited postural information on L/R weight distribution and the 
accuracy of this method has not been compared to the same parameter as measured by 
alternative, more sophisticated methods; nor does this study attempt to infer any 
information regarding other parameters of gait or balance. This method, using scales of 
suitable quality, does however afford sufficient refinement to discriminate between the 
relatively minor L/R WB inequalities demonstrated by a normal/control population with 
the greater left/right differences likely to be exhibited in patient populations affected by 
leg injuries or surgery. It has the advantage of being safe, easy to use and relatively 
inexpensive compared to alternative methods for weight-bearing assessment using 
equipment such as force plates or accelerometers. 
 
3.6 CONCLUSION 
The results demonstrate that total weight distributed over dual scales accurately reflects 
total weight measured on one scale, and this is an effective method for evaluating 
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weight distribution through the legs in a natural standing posture. The posture of 
participants was only minimally affected by the proximity of the researcher when 
recording the measurements. The short- and long-term L/R WB tendencies in Groups A 
and B respectively showed a similar level of variation.  In a healthy postmenopausal 
population, inequalities in L/R WB were not associated with any significant L/R 
differences in BMD at the hip, but were weakly correlated with L/R differences in leg 
muscle mass. 
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CHAPTER 4. EVALUATION OF 1.5 TESLA MRI FOR 
MEASUREMENT OF CORTICAL BONE AND MUSCLE  
 
4.1 INTRODUCTION 
This chapter investigates the efficacy of 1.5 Tesla MRI scanning for the measurement of 
cortical bone and muscle size at the proximal femur, in sub-groups from the main study 
of control participants and newly fractured patients treated by plaster of Paris (POP).   
 
DXA is the current gold standard for measuring a range of bone and muscle parameters 
including bone area, areal density, and regional lean tissue mass. It does not however 
differentiate between cortical and trabecular bone compartments. This can only be done 
effectively in vivo with CT imaging but this methodology has limitations both clinically 
and for research purposes due limited availability and the high radiation doses 
associated with CT examinations. A 1.5 Tesla Philips Intera MRI scanner is available at 
the research centre where the main study was conducted which afforded an opportunity 
to assess the use of MRI to directly measure the thickness of cortical bone and muscle 
mass at the proximal femur, and to monitor changes in these measurements over a 
period of twelve months. 
 
4.2  AIMS AND OBJECTIVES  
The objective of this aspect of the study was to assess the precision of repeat 
measurements, performed at various cortical bone and muscle sites at the proximal 
femur, from images obtained by 1.5 Tesla MRI in various planes and scan modes, and  
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to compare these to the measurement precision of  bone and muscle parameters obtained 
by DXA scanning.  
 
4.3 BRIEF METHODS & STATISTICS 
The methods are described in full in Chapter 2. Section 2.3.2 details the methods for 
analyzing the scan images. Scans were performed using the protocols and sequences 
described in Table 2.6 with measurements taken at the sites shown in Table 2.8 and 
Figure 2.9. Volunteer subgroups from the main study were selected for MRI scanning at 
the same intervals as their DXA scans. Due to contraindications to MRI scanning i.e. 
the presence of new prosthetics or metallic components used in internal fixation of 
fracture, recruitment was limited to the control group and those newly fractured patients 
who had been treated by plaster of Paris only.  
 
• Raw data acquired from the MRI scanner were downloaded in DICOM format 
onto DVD and imported as images to Apple Macintosh hardware using OsiriX 
v.3.9.4 software to analyse the images.  
• Due to unavoidable tilt and rotation in patient positioning on the scanner, a 
given slice (either coronal or axial) did not always provide comparable anatomy 
on left and right sides of the body, as demonstrated in Fig 4.1. It was therefore 
necessary to use subjective judgement to select different slices providing the 
appropriate anatomical view on the right and left sides from which 
measurements could be taken.  
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Figure 4.1 Coronal slice through the pelvis demonstrating unequal anatomical views on 
right and left sides due to tilt and rotation in the body position. 
 
• It was important that slice selection should be consistent and as accurate as 
possible as the measurement criteria involved using levels at fixed distances 
from selected bone landmarks. The bone landmarks selected were the mid-
femoral neck and the superior aspect of the greater trochanter. Slices were 
selected where the superior aspect of the greater trochanter was most 
prominently demonstrated in the image. 
• The measurement levels were selected at fixed distances from the bone 
landmarks as shown in Table 2.8 and Figure 2.9.  As it was only intended to 
compare changes in individuals over time and not to compare the exact 
equivalent anatomical position between individuals, these distances were the 
same for all participants regardless of their height or femur length. The distances 
of 9 cm and 14 cm were selected as appropriate sites at which to take 
measurements based on the anatomy of a participant whose overall height 
represented the mean for the original sample. Measurements were taken at the 
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selected levels, perpendicular to the endosteal bone surface at the femoral neck 
or shaft. 
• Measurements were performed by two newly graduated medical imaging 
students from the University of Exeter. Both operators jointly assessed the 
appropriate slice from which to take measurements whilst a single individual 
performed all measurements to avoid inter-operator variability. 
• Measurements were attempted on the images obtained by the STIR TSE coronal 
and PDW SPAIR axial sequences but poor visual definition of the boundaries 
between tissues did not allow satisfactory analysis.  
• The coronal sections of the T1W TSE sequences were analysed initially because 
locating the bone landmarks, to identify the relevant slice, was more readily 
achieved than on the axial slices. Bone landmarks are difficult to pinpoint on 
axial slices as the differences in bone geometry at different levels is not obvious. 
Correctly locating equivalent slices either on left and right sides of the body, or 
on repeat scans, is highly subjective or requires precise calculation. This is a 
time-consuming exercise and as the precision results from the coronal sections 
were shown to be very poor, it was not considered to be a worthwhile use of 
time resources to proceed with analysis of the axial sections; therefore only the 
results from the T1W TSE coronal sections are reported in the results. 
• Precision of repeat MRI measurements was compared to that of repeat DXA 
measured parameters of BMD, bone area and muscle mass acquired at the same 
time points as the MRI scans. 
• Descriptive statistics were used for sample means and standard deviations in 
participant characteristics and measurements at Visit 1 (Microsoft Excel 97-
2003). Precision error in measurements, over three visits at six month intervals, 
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was calculated using the Root Mean Square Coefficient of Variation 
(RMSCV%) using the formula described by Glüer et al (253). The correlation 
between right and left side measurements at Visit 1 was calculated using paired 
samples correlation (SPSS version18.0).    
 
4.4 RESULTS  
 
4.4.1 SAMPLE 
A total of eleven controls and two fracture participants volunteered for the MRI study. 
A participant recruitment and retention summary is shown in Table 2.3 (Chapter 2). 
Two control participants were lost to the MRI element of the study because they were 
unable to enter the scanner due to claustrophobia. Four scanning sessions could not be 
completed at Visit 4 due to postponement of appointments by participants and 
unavailability of the MRI scanner at the rescheduled dates. Poor recruitment rates and 
the low number of fracture patients treated by POP alone, resulted in only two 
participants from Group 3 undertaking the MRI element of the study. As no meaningful 
conclusions about long-term changes in bone and muscle parameters would be available 
from the limited number of Group 3 participants completing the study, it was excluded 
from the final analysis. Poor image quality and anatomical irregularities in the scans for 
one control participant made measurement too arbitrary to be useful. Ultimately the data 
for 5 control participants only, who completed the whole study, were analysed. 
 
4.4.2 DESCRIPTIVES 
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Table 4.1.  Participant characteristics at Visit 1 - means and standard deviations (n=5) 
 
Mean SD 
Age (yrs) 72.6 9.9 
Weight (kg)  64.6 13.2 
Height (m)  1.6 0.1 
Body Mass Index (kg.m
2)
 24.9 4.8 
 
 
 
Table 4.2  MRI measurements at Visit 1 (cm) - means and standard deviations (n=5)  
  Right Left 
  Mean SD Mean SD 
Site 1 0.40 0.24 0.29 0.14 
Site 2 0.64 0.80 0.22 0.05 
Site 3 0.41 0.15 0.35 0.10 
Site 4 0.40 0.15 0.44 0.19 
Site 5 0.58 0.17 0.55 0.20 
Site 6 0.55 0.15 0.63 0.18 
Site 7 2.96 0.45 3.01 0.48 
Site 8 7.93 0.65 7.77 0.41 
Site 9 3.26 0.56 3.36 0.40 
Site 10 7.22 1.19 6.99 1.58 
 
 
 
Table 4.3  DXA measurements  at Visit 1 - means and standard deviations (n=5) 
 
Right Left 
 
Mean SD Mean SD 
BMD NOF (g/cm
2)
 0.81 0.10 0.79 0.12 
BMD Total Hip (g/cm
2)
 0.84 0.19 0.83 0.19 
BMD Femoral shaft (g/cm
 
) 0.99 0.24 1.00 0.27 
Area NOF (cm
2)
 5.05 0.28 5.11 0.61 
Area Total Hip (cm
2
) 30.76 2.43 30.69 3.52 
Area Femoral shaft (cm
2
) 13.92 0.34 13.51 0.39 
Lean leg tissue (g) 5976 436 5816 327 
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4.4.3 PRECISION ERROR 
 Table 4.4  Measurement variation (RMSCV%) over three visits - Coronal Sections T1W TSE 
  RIGHT CV% LEFT CV% 
Site 1 37.0 37.3 
Site 2 18.5 40.2 
Site 3 23.7 36.9 
Site 4 15.6 17.9 
Site 5 12.7 11.1 
Site 6 13.6 13.9 
Site 7 6.8 8.4 
Site 8 2.3 3.6 
Site 9 6.7 10.2 
Site 10 7.3 8.2 
 
Table 4.5 Measurement variation (RMSCV%) over three visits - DXA ROIs (n=5) 
 
RIGHT CV% LEFT CV% 
BMD NOF 2.08 2.15 
BMD Total Hip 1.48 1.34 
BMD Femoral shaft 2.09 1.55 
Area NOF 1.96 0.54 
Area Total Hip 0.09 1.21 
Area Femoral shaft 0.56 0.73 
Lean leg tissue  1.83 2.98 
 
 
4.4.4 CORRELATION BETWEEN RIGHT AND LEFT SIDE MEASUREMENTS 
 
Table  4.6  Correlation coefficient between right and left measurements at Visit 1 - MRI (n=5) 
      
Site 1: Cortical  bone - Lateral, perpendicular to Mid femoral neck 0.35   
Site 2: Cortical bone - Medial, perpendicular to Mid femoral neck 0.90 * 
Site 3: Cortical bone - Lateral, 9 cm  inferior to superior aspect of greater trochanter 0.58   
Site 4: Cortical bone -  Medial, 9 cm  inferior to superior aspect of greater trochanter 0.98 * 
Site 5: Cortical bone - Lateral, 14 cm  inferior to superior aspect of greater trochanter 0.97 * 
Site 6: Cortical bone - Medial, 14 cm  inferior to superior aspect of greater trochanter 0.50   
Site 7: Vastus lateralis muscle - Lateral, 9 cm  inferior to superior aspect of greater trochanter 0.91 * 
Site 8: Medial muscle compartment 9 cm  inferior to superior aspect of greater trochanter 0.95 * 
Site 9: Vastus lateralis muscle - Lateral, 14 cm  inferior to superior aspect of greater trochanter 0.40   
Site 10: Medial muscle compartment 14 cm  inferior to superior aspect of greater trochanter 0.73   
* Significant at 95% level 
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Table 4.7   Correlation coefficient  between right and left measurements at Visit 1 - DXA (n=5) 
BMD NOF 0.98 * 
BMD Total Hip 0.97 * 
BMD Femoral shaft 0.98 * 
Area NOF 0.50   
Area Total Hip 0.86   
Area Femoral shaft 0.16   
Lean leg tissue  0.87   
* Significant at 95% level     
 
 
4.5 DISCUSSION 
When considering the potential of MRI to measure changes in cortical bone and muscle 
mass, it is first necessary to establish the true changes in bone and muscle parameters in 
the study sample as measured by alternative reliable methods. DXA is an established 
modality for the measurement of BMD, bone area and muscle mass. The short term 
precision error at the NOF and Total Hip sites for the DXA scanner used in this study 
was shown to range between 0.85% and 2.00% depending on the BMI category of the 
participants (229). The study inclusion criteria selected postmenopausal females only 
and these would be expected to lose approximately 1% BMD over a twelve month 
period (100). The final data analysis was limited to the control participants and it was 
not anticipated that any significant changes in bone parameters would occur in this 
group over a one year period beyond the expected bone loss typically observed in 
postmenopausal women. The results from the DXA scans (Table 4.5), performed at the 
same time points as the MRI scans, demonstrate minimal variation with RMSCV% 
ranging from 0.54 (Area NOF) to 2.98 (Lean Leg Tissue). As these are in the same 
order of magnitude as the short-term precision error of the equipment, it is inferred that 
minimal change is occurring in the true values of the measured parameters. Whilst the 
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parameters measured by DXA are different to those in the MRI study, the low long-term 
variation in DXA results suggests that minimal variation would also be expected in 
direct measurement of cortical bone and muscle width using MRI. Results from the 
MRI measurements (Table 4.4), nevertheless demonstrate considerably higher 
RMSCV% at all sites with the exception of the medial muscle compartment (Site 8). 
RMSCV% range from 2.3% (Site 8) to 40.2% for cortical bone thickness at the medial 
aspect of the mid-femoral neck (Site 2). The highest variation occurs in measurement of 
the cortices at the femoral neck where the width dimensions are very small. The voxel 
size used in the acquisition of the MRI data was 1.97/2.11/5.00 mm. As the mean width 
of the cortices at Sites 1&2 are estimated to be in the range of 0.22 to 0.64 cm (Table 
4.2) i.e. only two to three pixels in width, a high percentage in measurement error at this 
resolution would be expected. This is due largely to partial volume effects whereby 
more than one tissue type can be present within a single voxel. In this situation the 
greyscale value attributed to that voxel will be averaged and the boundary at the 
interface of two tissue types will be indistinct resulting in inaccurate measurement. This 
will not be a significant source of measurement error where the dimensions of the tissue 
are of greater magnitude and it is evident that the precision error for the cortical widths 
at the femoral shaft (Sites 3-6) are of a lower order, and lower still for the muscle mass 
at Sites 7-10. Nonetheless, the differential is very large between the RMSCV% at MRI 
measurement sites and the RMSCV% in DXA measurements. This suggests that this 
method is imprecise and whilst it may provide approximate values for the dimensions of 
tissue at the measured sites, repeat measurements are unreliable for monitoring long-
term change. 
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Problems with this method include difficulties in identifying the correct slice for 
measurement analysis, particularly on axial sections.  There is a high degree of 
subjectivity in both the measurement process and locating equivalent slices in repeat 
scans using specific bone landmarks.  Further sources of measurement error arise as a 
result of difficulties in the reproducing the exact participant positioning for the follow-
up scans.  Small amounts of rotation and tilt of the limbs and torso are unavoidable and 
will vary to some extent upon repositioning causing variation in the way that tissues lay 
relative to the scan planes. Scans are performed in a supine position that causes soft 
tissue to compress and spread such that measurement variation could occur between 
repeat scans after repositioning even without any true difference in tissue mass or 
dimensions having occurred. This issue of repositioning accuracy is however also 
applicable to DXA scanning. When comparing the correlation between left and right 
side measurements using MRI and DXA (Tables 4.6 & 4.7), a comparable level of 
correlation is demonstrated in both methods suggesting that measurement error due to 
positioning is similar for both modalities and that selection of the appropriate MRI 
slices, for left and right analysis, was performed correctly and to an acceptable standard.  
 
The study was limited by the low number of data sets ultimately available for analysis; 
however the available data were adequate to provide a preliminary assessment of the 
utility of this technique. 
 
The width of cortical bone at the femoral head is minimal and trabecular bone forms the 
bulk of bone volume at the Total Hip sites measured by DXA.   The cortical tissue 
effectively forms a skin in these regions & separation of the cortical and trabecular 
components would make minimal difference to BMD measurements for diagnostic 
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purposes. Nevertheless, appositional growth and changes in cortical width may impact 
on the geometric properties of the femur affecting fracture risk. It would be valuable for 
research purposes to be able to monitor these changes as a result of disuse using a 
modality that is safe, readily available and acceptable to study participants. Further 
work could be valuable to assess the efficacy of this method using higher image 
resolution to achieve greater accuracy and precision. 
 
4.6 CONCLUSION 
Results from the DXA scans, show minimal variation in measurements of bone and 
muscle parameters over a 12 month period and the CVs are of comparable magnitude to 
the precision error of the equipment, even before allowing for an expected loss of 
approximately 1% BMD in female postmenopausal participants.  Although measuring 
different parameters to those assessed by MRI, the DXA results suggest that only 
minimal change in bone and muscle mass is occurring in the control sample. In contrast, 
large variation is demonstrated in the parameters measured by MRI that are inconsistent 
with the DXA results suggesting that this variation is primarily due to large 
measurement precision errors resulting from inadequate image resolution and ambiguity 
in interpreting the MRI images. In conclusion, repeat 1.5 Tesla MRI T1W TSE coronal 
scan images, at the resolutions used in this study, may be useful for approximating the 
dimensions of cortical bone and muscle at the proximal femur but do not afford 
sufficient accuracy and reliability to be valid for monitoring change.  
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CHAPTER 5. RESULTS – MEDICAL AND LIFESTYLE HISTORY 
RELATING TO BONE HEALTH, AND LONGITUDINAL CHANGES IN 
FUNCTIONAL AND TREATMENT PARAMETERS 
 
5.1 INTRODUCTION AND AIMS 
This chapter presents the results relating to the medical and lifestyle history of participants, 
relevant to their bone health at baseline. Longitudinal changes in levels of activity, function, 
weight-bearing, pain, treatments, therapies and health perceptions are reported. The chapter 
aims to evaluate differences between groups of postmenopausal women who have had 
periods of immobilisation due to leg injury or surgery. Three groups; newly fractured 
patients, patients with fractures from more than one year previously, and total knee 
replacement patients are compared to an age matched control group. 
 
 
5.2 OBJECTIVES  
 
 To describe participant characteristics at baseline. 
 To assess risk factors for compromised bone health at baseline and to compare 
differences between groups.  
 To assess changes in parameters of activity, function, weight-bearing, pain levels, 
treatments, therapies and health perceptions over a twelve month period and to 
compare these between groups. 
 To investigate the relationship between physical function and parameters of recovery. 
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5.3 BRIEF METHODS AND & STATISTICS 
The methods are described in detail in Chapter 2, section 2.2.3. Statistical methods are 
described in Chapter 2, section 2.3.4. 
  
5.4 RESULTS  
5.4.1 PATIENT CHARACTERISTICS AND HISTORY RELATING TO BONE HEALTH 
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Table 5.1  Participant characteristics at baseline - visit 1 (Means/SD) 
 
Controls TKR 
 
#<3wks #>1yr 
 
n Mean SD 
 
n Mean SD 
 
n Mean SD 
 
n Mean SD 
 
Age (yrs) 43 64.7 7.7 
 
19 66.1 6.9 
 
9 62.6 7.2 
 
24 65.3 8.3 
 
Weight (kg) at visit 1 43 68.3 10.2 
 
19 83.1 16.1 ** 9 71.0 11.1 
 
24 74.3 15.8 
 
Height (m) at visit 1 43 1.6 0.1 
 
19 1.6 0.1 
 
9 1.7 0.1 
 
24 1.6 0.1 
 
BMI at visit 1 43 25.4 3.2 
 
19 32.2 7.1 ** 9 26.1 3.8 
 
24 28.4 5.5 * 
BMI  at age 21 39 22.0 2.6 
 
18 23.0 3.4 
 
9 22.1 3.1 
 
23 21.8 3.7 
 
Menarche age (yrs) 43 12.9 1.6 
 
19 13.0 1.7 
 
9 12.1 1.2 
 
24 13.3 1.7 
 
Menopause age (yrs) 41 50.2 4.8 
 
19 48.3 6.3 
 
9 47.9 6.2 
 
23 49.1 4.9 
 
HRT use (months) 21 54.2 55.3 
 
12 69.6 76.9 
 
6 56.1 68.8 
 
9 44.9 42.8 
 
OCP use (months) 31 92.0 78.4 
 
17 95.6 84.9 
 
7 79.2 141.7 
 
11 114.7 106.3 
 
Alcohol consumption (level 1 -5) 43 2.7 1.5 
 
19 1.7 1.3 * 9 2.0 0.7 * 24 2.0 1.4 
 
Caffeine consumption (level 1 -5) 43 1.0 0.6 
 
19 1.1 0.6 
 
9 1.2 0.4 
 
24 1.2 0.5 
 
Exercise 6 months pre-baseline (level 1 -5) 43 2.3 0.7 
 
19 1.3 0.9 ** 9 2.4 0.7 
 
24 2.0 1.0 
 
Number of other supplements taken#   43 1.1 1.6 
 
19 0.9 1.4 
 
9 1.2 1.1 
 
22 0.5 0.6 * 
Years as smoker 16 19.4 13.5 
 
5 8.2 3.0 ** 3 25.7 15.9 
 
6 19.5 10.5 
 
*p=<0.05 when compared to control group 
**p=<0.01 when compared to control group 
Notes: 
SD =standard deviation 
Alcohol consumption levels : 1 = social only, 2= 1-5, 3=6-10, 4=11-15, 5=16-20, 6=>21 units per day 
Caffeine consumption levels: 1=1-5, 2=6-10, 3=11-15 cups per day 
Exercise levels: 1-<0.5, 2=0.6-1, 3=>1 hour per day 
# Dietary supplements other than calcium, vitamin D or multivitamin 
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Table 5.2 Participant characteristics at baseline - visit 1 (percentages of group). 
 
Controls TKR #<3wks #>1yr 
 
n % 
  
n % 
  
n % 
  
n % 
  
White Caucasian ethnicity  43 100 
  
19 100 
  
9 100 
  
24 100 
  
Patients wearing plaster cast 43 0 
  
19 0 
  
9 100 
  
24 0 
  
Current smoker 43 0 
  
19 0 
  
9 0 
  
24 4 
  
Previous Total Knee Replacement 43 0 
  
19 32 
  
9 0 
  
24 0 
  
Previous Total Hip Replacement  43 0 
  
19 11 
  
9 0 
  
24 0 
  
Relative with hip/spine/wrist fracture 42 37 
  
18 26 
  
9 11 
  
24 38 
  
Relative with other fracture 42 35 
  
19 32 
  
9 44 
  
24 46 
  
Relative with osteoporosis 43 19 
  
18 5 
  
9 11 
  
24 21 
  
*p=<0.05 when compared to control group 
**p=<0.01 when compared to control group 
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Table 5.3  Participant characteristics at baseline- visit 1  -  Non parametric variables (Median/interquartile) 
  
 
Controls n=43 TKR n=19 #<3wks n=9 #>1yr n=24 
 
 
Median 25th Centile 75th centile  Median 
 
25th Centile 75th centile  Median 25th Centile 75th centile  Median 25th Centile 75th centile    
  Total co-
morbidities 
directly relating 
to bone health.  
1.0 0.0 1.0 1.0 
 
1.0 2.0 0.0 0.0 1.0 1.0 0.0 1.0 * 
  Total of all co-
morbidities  
1.0 0.0 2.0 2.0 
 
2.0 4.0 1.0 0.0 2.0 1.0 1.0 2.0 * 
  Previous 
fractures. 
0.0 0.0 1.0 0.0 
 
0.0 1.0 1.0 0.0 1.0 1.0 0.0 2.0 * 
  Total number of 
fractures 
including 
baseline fracture. 
0.0 0.0 1.0 0.0 
 
0.0 1.0 1.0 0.0 1.0 2.0 1.0 3.0 * 
  Number of 
children. 
2.0 1.0 3.0 2.0 
 
1.0 3.0 2.0 1.0 3.0 2.0 1.3 3.0   
  * Independent Samples Median Test. Null hypothesis: The medians of the parameter are the same across the groups. Null hypothesis rejected. Significance level 0.05  
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Table 5.4 Participant history of medical conditions relating to bone health (percentages of group). 
 
Controls TKR #<3wks #>1yr 
 
n % 
 
n % 
 
n % 
 
n % 
 
Rheumatoid arthritis 43 2.3 
 
19 15.8 
 
9 0.0 
 
24 0.0 
 
Osteoarthritis 43 27.9 
 
19 84.2 ** 9 22.2 
 
24 29.2 
 
Ankylosing spondylitis 43 0.0 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Diabetes  43 2.3 
 
19 10.5 
 
9 0.0 
 
24 0.0 
 
Hyperthyroid  43 0.0 
 
19 0.0 
 
9 0.0 
 
24 4.2 
 
Hypothyroid  43 9.3 
 
19 21.1 
 
9 0.0 
 
24 12.5 
 
Cancer Breast  43 7.0 
 
19 0.0 
 
9 11.1 
 
24 0.0 
 
Other cancer 43 7.0 
 
19 10.5 
 
9 0.0 
 
24 12.5 
 
Paget’s disease 43 0.0 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Liver disease 43 2.3 
 
19 0.0 
 
9 0.0 
 
23 0.0 
 
Kidney disease 43 4.7 
 
19 0.0 
 
9 0.0 
 
24 8.3 
 
Gastric pathology 43 2.3 
 
19 0.0 
 
9 11.1 
 
24 8.3 
 
Lactose Intolerance 43 4.7 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Cohn’s disease 43 0.0 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Coeliac disease 43 0.0 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Irritable bowel syndrome 43 9.3 
 
19 10.5 
 
9 0.0 
 
24 12.5 
 
Malabsorption 43 0.0 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Osteomalacia  43 0.0 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Bulimia  43 0.0 
 
19 5.3 
 
9 0.0 
 
24 0.0 
 
Anorexia  43 0.0 
 
19 5.3 
 
9 0.0 
 
24 4.2 
 
Hysterectomy  43 16.3 
 
19 21.1 
 
9 22.2 
 
24 12.5 
 
Oophrectomy (1 or 2) 42 14.3 
 
18 5.6 
 
9 33.3 
 
23 8.6 
 
*p=<0.05 when compared to control group 
**p=<0.01 when compared to control group 
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Table 5.5 Participant history of medications and dietary supplements relating to bone health (percentages of group). 
 
Controls TKR #<3wks #>1yr 
 
n % 
 
n % 
 
n % 
 
n % 
 
Steroids  43 4.7 
 
19 10.5 
 
9 0.0 
 
24 4.2 
 
Anticonvulsants  43 0.0 
 
19 5.3 
 
9 22.2 
 
24 0.0 
 
Diuretics  43 9.3 
 
19 26.3 
 
9 11.1 
 
23 17.4 
 
Chemotherapy 43 2.3 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Immunosuppressive agents  43 0.0 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Heparin  43 2.3 
 
19 5.3 
 
9 0.0 
 
24 4.2 
 
Thyroxin  43 9.3 
 
18 27.8 
 
9 0.0 
 
23 17.4 
 
Didronel  43 0.0 
 
19 0.0 
 
9 0.0 
 
24 4.2 
 
Fosamax  43 2.3 
 
19 10.5 
 
9 0.0 
 
24 29.2 * 
Calcitonin  43 0.0 
 
18 11.1 
 
9 0.0 
 
24 25.0 * 
Actonel  43 0.0 
 
19 0.0 
 
9 0.0 
 
24 16.7 * 
Teriparatide  43 0.0 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Protelos  43 0.0 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Pamidronate  43 0.0 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Zolendronate  43 0.0 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Ibandronate  43 0.0 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Fluoride  43 2.3 
 
19 0.0 
 
9 0.0 
 
24 0.0 
 
Multi vitamin  42 23.8 
 
19 57.9 ** 9 22.2 
 
22 4.5 * 
Calcium  42 28.6 
 
19 10.5 
 
9 11.1 
 
22 50.0 
 
Vitamin D 42 19.0 
 
19 10.5 
 
9 11.1 
 
22 40.9 
 
*p=<0.05 when compared to control group 
**p=<0.01 when compared to control group 
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5.4.2 FUNCTIONAL AND TREATMENT PARAMETERS AT BASELINE AND 
LONGITUDINAL CHANGES  
The following figures 5.1 to 5.7 depict the parameters where the greatest changes were 
observed during the study period. Significances of differences between groups and of 
changes within groups over the study period are reported in Tables 5.6 and 5.8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Changes in ipsilateral weight-bearing
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Figure 5.2. Changes in function scores (LEFS)
Interval (weeks)
0 10 20 30 40 50 60
Sc
o
re
  (
M
ea
n
/S
EM
)
10
20
30
40
50
60
70
80
Controls
TKR
#<3 weeks
#>1 year
Chapter 5 
[145] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. Changes in perceived health scores (EQ5D)
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Figure 5.4. Changes in pedometer readings
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Figure 5.5. Changes in activity scores (IPAQ)
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Figure 5.6. Changes in sitting scores (IPAQ)
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Figure 5.7. Changes in pain VAS 
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Table 5.6  Changes in functional parameters - (Means/SD)  
 
Controls TKR 
 
#<3wks #>1yr 
 
n Mean SD 
  
n Mean SD 
  
n Mean SD 
  
n Mean SD 
 
Weight (Kg) at visit 1 43 68.3 10.2 
  
19 83.1 16.1 ** 
 
9 71.0 11.1 
  
24 74.3 15.8 
 
Weight (Kg) at visit 2 0 
    
19 82.5 16.9 
  
9 71.5 10.8 
  
0 
   
Weight (Kg) at visit 3 43 68.3 9.8 
  
19 84.2 17.5 ** 
 
9 71.8 11.2 
  
0 
   
Weight (Kg) at visit 4 43 68.3 10.0 
  
19 85.1 18.4 ** 
 
9 72.1 11.0 
  
0 
   
Height (m) at visit 1 43 1.6 0.1 
  
19 1.6 0.1 
  
9 1.7 0.1 
  
24 1.6 0.1 
 
Height (m) at visit 2 0 
    
19 1.6 0.1 
  
9 1.7 0.1 
  
0 
   
Height (m) at visit 3 43 1.6 0.1 
  
19 1.6 0.1 
  
9 1.6 0.1 
  
0 
   
Height (m) at visit 4 43 1.6 0.1 
  
19 1.6 0.1 
  
9 1.6 0.1 
  
0 
   
BMI at visit 1 43 25.4 3.2 
  
19 32.2 7.1 ** 
 
9 26.1 3.8 
  
24 28.4 5.5 * 
BMI at visit 2 0 
    
19 31.7 7.2 
 
† 9 26.3 3.9 
  
0 
   
BMI at visit 3 43 25.4 3.0 
  
19 32.5 7.5 ** 
 
9 26.4 3.9 
  
0 
   
BMI at visit 4 43 25.4 3.1 
  
19 32.7 7.8 ** 
 
9 26.6 3.6 
  
0 
   
% Ipsilateral weight-bearing at visit 1 43 50.2 4.4 
  
19 43.5 9.9 ** 
 
9 23.7 25.7 * 
 
24 49.9 6.8 
 
% Ipsilateral weight-bearing at visit 2 0 
    
19 43.8 6.3 
  
9 45.6 12.3 
 
†† 0 
   
% Ipsilateral weight-bearing at visit 3 43 50.5 4.9 
  
19 48.5 5.9 
 
† 9 49.1 4.2 
 
† 0 
   
% Ipsilateral weight-bearing at visit 4 43 49.6 4.6 
  
19 48.5 5.7 
 
† 9 49.4 4.3 
 
† 0 
   
% Contralateral weight-bearing at visit  1 43 49.8 4.4 
  
19 55.7 11.3 * 
 
9 67.3 27.4 
  
24 49.6 6.2 
 
% Contralateral weight-bearing at visit  2 0 
    
19 55.8 6.6 
  
9 51.3 14.0 
 
† 0 
   
% Contralateral weight-bearing at visit  3 43 49.5 4.9 
  
19 51.5 5.9 
  
9 50.9 4.2 
  
0 
   
% Contralateral weight-bearing at visit  4 43 50.6 4.6 
  
19 51.5 5.7 
  
9 49.4 3.3 
  
0 
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LEFS Score at visit 1 43 73.7 8.6 
  
19 30.5 15.4 ** 
 
9 17.8 8.2 ** 
 
24 56.5 16.4 ** 
LEFS Score at visit 2 0 
    
19 34.2 12.7 
  
9 42.7 16.6 
 
†† 0 
   
LEFS Score at visit 3 43 72.9 9.7 
  
19 47.7 17.7 ** †† 9 62.9 17.3 
 
†† 0 
   
LEFS Score at visit 4 43 71.7 11.0 
  
19 49.8 15.7 ** †† 9 66.9 12.3 
 
†† 0 
   
EQ-5D Health state VAS at visit 1 42 88.3 11.3 
  
19 73.8 19.4 ** 
 
9 69.4 19.1 ** 
 
24 79.0 15.3 ** 
EQ-5D Health state VAS at visit 2 0 
    
19 77.6 15.5 
  
9 82.8 10.6 
 
† 0 
   
EQ-5D Health state VAS at visit 3 43 88.0 12.6 
  
19 78.7 18.4 * 
 
9 88.7 10.3 
 
†† 0 
   
EQ-5D Health state VAS at visit 4 42 87.0 12.6 
  
18 80.4 19.1 
 
† 9 86.7 11.7 
 
† 0 
   
Average pedometer steps at visit 1 41 9716 3596 
  
17 870 1283 ** 
 
9 1517 830 ** 
 
21 6801 3731 ** 
Average pedometer steps at visit 2 0 
    
19 2757 1895 
  
9 5178 3201 
 
†† 0 
   
Average pedometer steps at visit 3 41 8104 3415 
 
†† 19 4361 3046 ** †† 9 8277 3009 
  
0 
   
Average pedometer steps at visit 4 40 8626 3329 
 
† 15 4327 1950 ** †† 9 9029 2549 
  
0 
   
IPAQ (MET-minutes/week) at visit 1 40 7461 5963 
  
10 2178 1932 ** 
 
3 1701 1526 * 
 
19 5492 4339 
 
IPAQ (MET-minutes/week) at visit 2 0 
    
16 4097 3948 
  
7 5260 4911 
  
0 
   
IPAQ (MET-minutes/week) at visit 3 38 4917 4559 
 
†† 17 4493 4478 
  
8 5211 3451 
 
† 0 
   
IPAQ (MET-minutes/week) at visit 4 40 6206 6032 
 
† 13 4091 3617 
  
8 6448 4830 
  
0 
   
*p=<0.05 when compared to control group 
**p=<0.01 when compared to control group 
†p=<0.05 when compared to baseline for the same group 
††p=<0.01 when compared to baseline for the same group 
SD =standard deviation 
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Table 5.7 Changes in treatment and functional parameters (percentages of group). 
 
Controls TKR #<3wks #>1yr 
 
n % 
  
n % 
  
n % 
  
n % 
 
Full mobility at visit 1 43 100.0 
  
19 36.8 ** 
 
9 0.0 
  
24 95.8 
 
Full mobility at visit 2 0 
   
19 10.5 
  
9 0.0 
  
0 
  
Full mobility at visit 3 43 97.7 
  
19 52.6 ** 
 
9 66.7 
 
†† 0 
  
Full mobility at visit 4 43 93.0 
  
17 76.5 
 
† 9 100.0 
  
0 
  
Receiving physical therapy at visit 1 43 0.0 
  
19 42.1 
  
9 0.0 
  
24 0.0 
 
Receiving physical therapy at visit 2 0 
   
19 94.7 
 
†† 9 77.8 
 
†† 0 
  
Receiving physical therapy at visit 3 43 4.7 
  
19 52.6 ** 
 
9 22.2 
  
0 
  
Receiving physical therapy at visit 4 43 7.0 
  
19 31.6 * 
 
9 22.2 
  
0 
  
Receiving prescribed calcium at visit 1 43 0.0 
  
19 0.0 
  
9 0.0 
  
24 12.5 
 
Receiving prescribed calcium at visit 2 0 
   
19 5.3 
  
9 22.2 
  
0 
  
Receiving prescribed calcium at visit 3 43 7.0 
  
19 5.3 
  
9 22.2 
  
0 
  
Receiving prescribed calcium at visit 4 43 9.3 
 
† 19 10.5 
  
9 22.2 
  
0 
  
Receiving bisphosphonate + Ca at visit 1 43 2.3 
  
19 10.5 
  
9 0.0 
  
24 33.3 * 
Receiving bisphosphonate + Ca at visit 2 0 
   
19 10.5 
  
9 0.0 
  
0 
  
Receiving bisphosphonate + Ca at visit 3 43 14.0 
 
† 19 10.5 
  
9 22.2 
  
0 
  
Receiving bisphosphonate + Ca at visit 4 43 16.3 
 
† 19 15.8 
  
9 22.2 
  
0 
  
Using pain-killers for baseline injury at visit 1 43 0.0 
  
18 55.6 
  
9 66.7 
  
24 4.2 
 
Using pain-killers for baseline injury at visit 2 0 
   
19 84.2 
 
† 9 33.3 
  
0 
  
Using pain-killers for baseline injury at visit 3 42 0.0 
  
19 42.1 ** 
 
9 11.1 
  
0 
  
Using pain-killers for baseline injury at visit 4 43 0.0 
  
19 26.3 * 
 
9 11.1 
  
0 
  
*p=<0.05 when compared to control group 
**p=<0.01 when compared to control group 
†p=<0.05 when compared to baseline for the same group 
††p=<0.01 when compared to baseline for the same group 
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Table 5.8  Changes in functional parameters  - Non parametric variables (Median/interquartile)   
 
Controls n=43 TKR n=19 #<3wks n=9 #>1yr n=24   
 
Median 25th Centile 75th centile  Median 
 
25th Centile 75th centile  Median 
25th 
Centile 
75th centile  Median 25th Centile 75th centile    
Previous number of falls (not inc. 
baseline injury)  
0.00 0.00 0.00 0.00 
 
0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00   
Number of falls between visit 1&2  
   
0.00 
 
0.00 0.00 0.00 0.00 0.00 
   
  
Number of falls between visit 2&3 0.00 0.00 0.00 0.00 
 
0.00 0.00 0.00 0.00 0.00 
   
  
Number of falls between visit 3&4 0.00 0.00 0.00 0.00 
 
0.00 1.00 0.00 0.00 0.00 
   
  
Pain VAS at visit 1 0.00 0.00 5.00 50.00 
 
30.00 70.00 10.00 7.50 20.00 8.00 0.00 25.00 * 
Pain VAS at visit 2 
   
35.00 
 
5.00 55.00 10.00 2.50 20.00 
   
  
Pain VAS at visit 3 0.00 0.00 10.00 10.00 
 
5.00 50.00 1.00 0.00 40.00 
   
* 
Pain VAS at visit 4 1.00 0.00 10.00 9.00 † 0.00 28.75 0.00 0.00 25.00 
   
  
PHQ-9Total score at visit 1 1.00 0.00 3.00 4.00   1.00 6.00 2.00 1.00 8.00 2.50 0.00 6.50   
PHQ-9Total score at visit 2       6.00   1.00 9.00 3.00 0.50 3.50         
PHQ-9Total score at visit 3 1.00 0.00 4.00 1.00   0.00 8.00 2.00 0.50 4.50         
PHQ-9Total score at visit 4 1.00 0.00 4.00 3.00 † 1.00 6.00 0.00 0.00 6.00         
PHQ-9 Difficulty score  at visit 1 1.00 0.00 1.25 1.00   1.00 2.00 1.00 1.00 2.00 1.00 0.00 1.75   
PHQ-9 Difficulty score  at visit 2       2.00   1.00 2.00 1.00 0.50 2.00         
PHQ-9 Difficulty score  at visit 3 1.00 0.00 1.00 1.00   0.00 1.00 1.00 0.50 1.00         
PHQ-9 Difficulty score  at visit 4 1.00 0.00 1.00 1.00 † 1.00 1.00 0.00 0.00 1.50         
GAD-7 Total score at visit 1 1.00 0.00 3.00 2.00   1.00 7.00 1.00 0.00 5.00 1.00 0.00 4.00   
GAD-7 Total score at visit 2       2.00   0.00 4.00 1.00 0.00 4.00         
GAD-7 Total score at visit 3 0.00 0.00 3.00 1.00   0.00 3.00 0.00 0.00 3.00         
GAD-7 Total score at visit 4 0.00 0.00 3.00 2.00   0.00 6.00 0.00 0.00 3.00         
GAD-7 Difficulty score  at visit 1 1.00 0.00 1.00 1.00   0.00 2.00 1.00 0.00 1.50 1.00 0.00 1.00   
GAD-7 Difficulty score  at visit 2       1.00   0.00 2.00 1.00 0.00 2.00         
GAD-7 Difficulty score  at visit 3 0.00 0.00 1.00 1.00   0.00 1.00 0.00 0.00 1.00         
GAD-7 Difficulty score  at visit 4 0.00 0.00 1.00 1.00   0.00 1.00 0.00 0.00 1.00         
* Independent Samples Median Test. Null hypothesis: The medians of the parameter are the same across the groups. Null hypothesis rejected. Significance level 0.05  
† Related-Samples Friedman's Two-way Analysis of Variance by Ranks.  Null hypothesis: The distributions of the parameter across the four visits are the same. Null hypothesis rejected. Significance level 0.05 
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5.4.3 RELATIONSHIP BETWEEN PHYSICAL FUNCTION AND PARAMETERS 
OF RECOVERY 
Stepwise multiple regression analysis was performed to create a model for each group 
with significant explanatory factors for the dependent variable of physical function 
(LEFS). Models were created at baseline (visit 1) and two time points during recovery, 
6 months (visit 3) and 1year (visit 4). LEFS was selected as the dependent variable 
because return to optimal function is a key outcome measure of physical recovery and a 
marker of quality of life. The independent variables added into the model were: 
EQ5D Health state VAS  
Ipsilateral weight-bearing 
Pain VAS  
Pedometer average steps per day 
Number of co-morbidities relating to bone health  
Total of all co-morbidities  
Number of falls in the preceding 6 months (or since last visit)  
Physical therapy 
Age  
BMI 
Number of knee replacements  
PHQ9 Total score 
GAD7 Total score 
 
The resulting model summaries for each time point are shown in Tables 5.9 to 5.11 and 
reported below: 
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 VISIT 1 
 
Table 5.9.  Model Summary: Dependent variable LEFS at Baseline (visit 1) 
Group Model 
R 
R 
Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
  
TKR   1 .625
a .391 .350 12.387 
#>1yr 
  
1 .685b .469 .439 11.358 
2 .777c .603 .557 10.098 
a. Predictors: (Constant), Pedometer Average visit 1 
b. Predictors: (Constant), Pain VAS 1 
c. Predictors: (Constant), Pain VAS 1, Age Scan1 
 
 
 
 
Controls: No significant independent variables found. 
TKR:  Model 1 was an acceptable fit describing 39.1% of variance in LEFS (R
2
adj= 
35%), statistical significance F1,15= 9.62, p=0.007. With other variables held constant, 
function level (LEFS) was positively related to pedometer scores, increasing by 0.007 
points for every extra step (t=3.10, p=0.007). 
LEFS = 25.192 + 0.007 pedometer steps          (Eq.5.1)   
#<3 weeks: No significant independent were variables found. 
#>1yr: Model 2 was a good fit describing 60.3% of variance in LEFS (R
2
adj= 55.7%), 
statistical significance F2,17= 12.93, p=0.000. With other variables held constant, 
function level (LEFS) was negatively related to pain scores and age, decreasing by 
0.622 points for every extra point on the pain scale (t= -4.88, p=0.000) and 0.721 points 
for every extra year in age (t= -2.40, p=0.028). 
LEFS = 111.467 – 0.622 pain – 0.721 age          (Eq.5.2)   
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VISIT 3 
 
Table 5.10.  Model Summary: Dependent variable LEFS at visit 3 
Group Model 
R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
Controls   1 .737
a .543 .531 6.561 
TKR   1 .768
b .589 .565 11.652 
#<3wks 
  
1 .923b .853 .831 7.106 
2 .983c .966 .955 3.660 
3 .994d .988 .981 2.368 
a. Predictors: (Constant), EQ-5DHealth state VAS 3 
b. Predictors: (Constant), Pain VAS 3 
c. Predictors: (Constant), Pain VAS 3, EQ-5DHealth state VAS 3 
d. Predictors: (Constant), Pain VAS 3, EQ-5DHealth state VAS 3, PHQ-9Total score 3 
 
 
Controls: Model 1 was a good fit describing 54.3% of variance in LEFS (R
2
adj= 
53.1%), statistical significance F1,39= 46.28, p=0.000. With other variables held constant, 
function level (LEFS) was positively related to EQ5D health state scores, increasing by 
0.547 points for every extra health point (t=6.80, p=0.000). 
LEFS =  24.889 + 0.547 health state          (Eq.5.3)   
TKR:  Model 1 was a good fit describing 58.9% of variance in LEFS (R
2
adj= 56.5%), 
statistical significance F1,17= 24.41, p=0.000. With other variables held constant, 
function level (LEFS) was negatively related to pain, decreasing by 0.541 points for 
every extra point on the pain scale (t= -4.94, p=0.000). 
LEFS =  60.270 - 0.541 pain          (Eq.5.4)   
#<3 weeks: Model 3 was an excellent fit describing 98.8% of variance in LEFS (R
2
adj=  
98.1%), statistical significance F3,5=140.85, p=0.000. With other variables held constant, 
function level (LEFS) was negatively related to pain scores, decreasing by 0.643 points 
for every extra point on the pain scale (t= -14.15, p=0.000), and positively related to 
EQ5D health scores and PHQ-9 depression scores, increasing by 0.919 points for every 
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extra health point (t= 6.62, p=0.001) and by 2.124 points for every extra depression 
point (t= 3.01, p=0.028). 
LEFS =  -13.608 + 0.919 health state - 0.0.643 pain + 2.124 depression          (Eq.5.5)   
#>1yr: Not applicable. 
 
VISIT 4 
 
Table 5.11.  Model Summary: Dependent variable LEFS at visit 4 
Group Model 
R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
Controls 
  
1 .488a .238 .218 9.336 
2 .634b .402 .369 8.387 
#<3wks   1 .886
c .785 .754 6.113 
a. Predictors: (Constant), Pain VAS 4 
b. Predictors: (Constant), Pain VAS 4, Total all comorbidities  
c. Predictors: (Constant), Age  
 
Controls: Model 2 was an acceptable fit describing 40.2% of variance in LEFS (R
2
adj= 
36.9%), statistical significance F2,36= 12.09, p=0.000. With other variables held constant, 
function level (LEFS) was negatively related to pain scores and total number of co-
morbidities, decreasing by 0.307 points for every extra point on the pain scale (t= 3.56, 
p=0.001) and 4.608 points for every additional co-morbidity (t= 3.14., p=0.003). 
LEFS =  79.541 - 0.307 pain – 4.608 co-morbidities          (Eq.5.6)   
TKR:  No significant independent variables found. 
#<3 weeks: Model 1 was a very good fit describing 78.5% of variance in LEFS (R
2
adj= 
75.4%), statistical significance F1,7= 12.09, p=0.000. With other variables held constant, 
function level (LEFS) was negatively related to age, decreasing by 1.510 points for 
every extra year in age (t=5.05, p=0.001). 
LEFS = 161.445 – 1.510 age          (Eq.5.7)   
#>1yr: Not applicable. 
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Table 5.12.  Simplified summary of multiple regression analysis  
Significant explanatory factors (from same visit) for LEFS     
  Controls TKR #<3 wks #>1yr 
Visit 1 
 
↑ pedometer   ↓ pain 
   
 ↓ age 
       
Visit 2 
    
          
Visit 3 ↑ EQ5D health  ↓ pain ↓ pain 
 
   
↑ EQ5D health 
    ↑ PHQ-9 depression  
Visit 4 ↓ pain 
 
↓ age 
 
 
↓ co-morbidities  
   
     ↑ indicates increase in LEFS score i.e. improvement in function as the score for the independent variable 
increases 
↓ indicates decrease in LEFS score i.e. decline in function as the score for the independent variable 
increases 
 
 
 
5.5   DISCUSSION 
Baseline differences between groups: 
The results (Tables 5.1 to 5.3) show that participants were well matched in age and 
menopause age.  All participants were of white Caucasian ethnicity. The #<3weeks 
group had a lower age at onset of menarche, but this was not significant. The groups did 
not report significant differences in their BMI at age 21, but the TKR and #>1year 
groups had significantly higher BMI at the start of the study compared to the controls, 
(32.2±7.1, p=<0.01) and (28.4±5.5, p=<0.05) respectively. The high BMI for the TKR 
group, in the obese range as defined by the WHO criteria (254), is consistent with the 
fact that the main clinical indication for TKR is osteoarthritis, accounting for 94-97% of 
operations, and that the greatest risk factors for knee OA are age and obesity (255). 
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Nicholls et al (256) demonstrated that BMI at middle age is the strongest predictor for 
the necessity of TKR. The low BMI reported at age 21 (23.0±3.4), in the normal range, 
suggests that the TKR group was not originally at high risk for knee OA.  Whilst it is 
probable that a substantial increase in BMI in later life is the major cause of OA in this 
group, it cannot be stated with any certainty that their current high BMI level is not the 
result of low levels of function and activity due to OA. The BMI at age 21 is however a 
self-reported, retrospective estimate and potential bias in participants’ recollection 
should be considered. The TKRs reported significantly lower levels of exercise in the 6 
months preceding the baseline visit (p=<0.01) with a mean of less than half an hour per 
day compared to half to one hour for the other groups, confirming that they had poorer 
levels of function and activity than the other groups for a protracted period prior to 
surgery. 
 
All groups were comparable in their previous use of Hormone Replacement Therapy 
(HRT) and the Oral Contraceptive Pill (OCP) and all had a median of two children. 
Only one participant on the study was a current smoker from the #>1year group, and of 
those participants who were previous smokers, the TKR group smoked for significantly 
fewer years compared to the controls (p=<0.01). Caffeine consumption in the form of 
drinks such as coffee, tea and carbonated drinks was similar across the groups but 
alcohol consumption was lower in the TKRs (p=<0.05).  With regard to family history, 
no significant differences were found between the groups for the number of immediate 
relatives who had sustained hip, spine or other fractures. Nor were there significant 
differences for relatives with osteoporosis. It should be noted however, that participants’ 
awareness and recall of family history was often vague or incomplete. Participants were 
asked about their own history of fracture (excluding their current injury where 
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applicable) and the results showed significant differences between the groups with a 
median of 1 previous fracture for the #<3weeks and #>1year group compared to zero 
for the controls and TKRs. Fracture history included any fracture sustained at any age 
and due to any cause, and did not exclude traumatic and childhood injuries. This result 
is consistent with previous studies which demonstrate that previous fracture, at any site,  
is a risk factor for subsequent fractures, independent of BMD (257, 258). 
 
Table 5.4 gives the results for participants’ medical history of conditions that are known 
to have direct effects on bone health. The groups were well matched in this respect 
differing only in the incidence of osteoarthritis which was, as entirely expected, 
significantly higher (p=<0.01) in the TKR group where this pathology was the major 
contributor to the necessity for TKR surgery.  Indeed, 32% of the TKRs presented at 
baseline with a previous TKR, and 11% with a previous contralateral total hip 
replacement. With regard to the total number of co-morbidities suffered by participants 
(including those relating to bone health), significant difference (p=<0.05) was 
demonstrated with the TKR group having a median of two co-morbidities compared to 
one for the other groups, indicating generally lower levels of fitness in this group. Table 
5.5 summarises the use of medications known to impact on bone health, either 
positively or negatively, and again the groups were well matched with the notable 
exception of the #>1year group who were significantly higher users of bisphosphonate 
treatments (p=<0.05), prescribed calcium supplements and multivitamins but lower 
users (p=<0.05) of other supplements when compared to the controls.  
 
The most marked differences between groups at baseline are evident in their levels of 
function. Whilst mean weight-bearing on the ipsilateral leg was close to 50% for the 
Chapter 5 
[159] 
 
controls and #>1year groups, it was obviously minimal (mean 23.7%) for the #<3weeks 
group who were all wearing a plaster cast at their first visit. The TKR group, who were 
seen before their surgery, demonstrated mean ipsilateral WB of 43.5%. Large 
differences were seen between levels of function measured by LEFS, which was 
indicative of the participants’ ability to perform general daily activities. The control 
group mean score (73.7±8.6) was close to the maximum of 80, whereas the #>1year 
result was significantly poorer (56.5±16.4, p=<0.01), and the TKR and #<3weeks 
groups poorer still at (30.5±15.4, p=<0.01) and (17.8±8.2, p=<0.01) respectively. 
Activity in terms of pedometer readings of average steps per day, showed a similar 
pattern with the controls achieving levels close to the 10,000 steps per day (9716±3596) 
generally recommended for a healthy lifestyle (259). Readings were significantly lower 
for the #>1year (6801±3731, p=<0.01). As it was the intention to compare rates of 
recovery between groups, the TKR participants were asked to record pedometer 
readings for three days directly following surgery in order to be directly comparable to 
the #<3weeks  group. As expected, readings were extremely low, 870±1283, p=<0.01, 
and 1517±830, p=<0.01 for TKR and #<3weeks respectively.  Activity levels were also 
assessed by the self-reported IPAQ questionnaire which, whilst validated, is susceptible 
to a high degree of subjectivity and correlated poorly with activity measured by 
pedometer. The results for the group means nevertheless demonstrated the same pattern 
as pedometer activity (Fig. 5.5). These findings are reflected in the levels of mobility 
reported by participants. Thirty seven percent of TKRs regarded themselves as fully 
mobile at the pre-surgery visit (p=<0.01) whilst 4.2 % (n.s) of #>1year still did not 
consider themselves to be fully mobile.  A large percentage of both TKRs (55.6%, n.s) 
and #<3weeks (66.7%, n.s) were taking painkillers at baseline and reported levels of 
pain were very high for the TKR group (median score 50/100). The median pain scores 
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were zero for the control group but similar for #<3weeks and #>1year at 10/100 and 
8/100 respectively. Participants perceptions of their overall health state (not solely 
limited to their leg condition) conformed to the expected pattern, being best amongst the 
controls (88/100±11/100) and progressively lower (79/100±15/100, p=<0.01), 
(74/100±19.4/100, p=<0.01) and (69/100±19/100, p=<0.01) for the #>1year, TKR and 
#<3weeks groups respectively.  
 
In addition to measures of physical recovery, mental wellbeing was also considered as 
both an explanatory variable for physical outcomes and as an outcome measure in its 
own right. This was assessed by the levels of depression and anxiety reported by the 
PHQ-9 and GAD-7 questionnaires. The results are presented in Table 5.8 but are fully 
described and analysed in chapter 7. 
 
Longitudinal changes: 
For all of the key functional parameters, there is a consistent picture of improvement 
throughout the period of the study, although the extent of recovery varies between the 
TKR and #<3weeks groups.  Significant changes compared to baseline occurred in all 
of the following parameters of recovery at varying intervals over the one year study 
period. Figure 5.3 shows that the #<3weeks group return to 45.6±4.2% ipsilateral WB at 
visit 2 (p=<0.01) and are restored to the same levels as the controls by visit 3 (p=<0.05). 
The TKR group started from a higher baseline level than the fracture group but returned 
to similar levels of WB at the same time points. The LEFS scores (Fig.5.2) also 
followed the same trajectory with a progressive improvement in function returning to 
66.9±12.3, p=<0.01, just below control levels for the #<3weeks group at the final visit. 
Whilst the TKR group also improved steadily, their function scores (49.8±15.7, 
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p=<0.01) remained well below the controls at visit 4. This pattern was repeated for 
activity levels measured by pedometer (Fig. 5.4) where #<3weeks participants returned 
to control levels at visit 3 (n.s) but TKRs improved to only 2757±1895 steps at visit 
2(n.s) remaining at 4327±1950 (p=<0.01) steps at visit 4. 
 
Pain scores (Fig. 5.7) improved rapidly for the TKRs (35/100, n.s) at visit 2, and 10/100 
(n.s) at visit 3 but remained higher than the controls (9/100, p=<0.05) at visit 4.  At visit 
2, 84.2% of the TKR group were taking painkillers (p=<0.05) compared to baseline, but 
otherwise there were no significant changes in painkiller usage. Perceived health state 
(Fig 5.3) increased steeply (82.8±10.6, p=<0.05) for the #<3weeks group at visit 2, 
returning to control levels (88.7±10.3, p=<0.01) at visit 3, whilst the TKR group 
showed more gradual improvement culminating at 80.4±19.1 (p=<0.05) below control 
levels. Both TKRs and #<3weeks groups received some form of physical therapy 
throughout the study although the exact nature of this therapy varied considerably 
between patients, particularly for the TKRs for whom treatment could be a very 
minimal level of individual physiotherapy sessions, up to long term and regular gym 
sessions at the local hospital. However, at visit 2, 94.7% of TKRs and 77.8% of 
#<3weeks patients were receiving some form of physiotherapy, both p=<0.001 
compared to baseline respectively. This had reduced to 31.6% and 22.2% at the final 
visit. It should be noted that physiotherapy did not always relate directly to the leg 
injury/surgery as patients frequently suffered pain elsewhere, particularly at the hips and 
shoulders and this was generally assumed by them to result from alterations in their 
posture or the use of crutches during recovery. All #<3weeks patients and 76.5% of 
TKRs reported a return to full mobility at the final visit. It was expected that the levels 
of function for the #>1year group would be comparable, if not considerably better than 
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for the #<3weeks patients at the end of the study. Surprisingly, whilst all #<3weeks 
patients reported a return to full mobility at the final visit, 4.2 % of #>1year still did not 
consider themselves to be fully mobile at a mean interval of 3.2±2.5 years after their 
injury. They also reported median pain scores above the level of the controls and similar 
to the baseline scores for #<3weeks group when they were experiencing pain 
immediately post trauma. Whilst the #<3weeks patients scored 66.9 points on the final 
LEFS score, (close to control levels at 71.7), this was only 56.5 for the #>1year group. 
The two fracture groups were similar in that they had a higher level of previous 
fractures than the other groups but, given that the #<3weeks group returned to normal 
levels of function and activity at the end of the study, it is unclear why long-term 
impairments should remain in the #>1yr group.  It may be that the small sample 
available for the #<3weeks group has given misleading results or that the two fracture 
groups were not representative of comparable populations at the time when their 
fractures occurred. It is more probable that selection bias is responsible for the 
discrepancies between these two fracture groups. The difficulties in recruiting the newly 
fractured group have been described in chapter 2, section 2.1.5. Those subjects who 
were willing to participate, did so at some considerable inconvenience to themselves, 
particularly at the early stages of the study. They demonstrated a keen interest in 
research that overrode their difficulties in taking part; indeed three of the nine 
participants had occupational backgrounds in science and medicine and consequently 
had a clear understanding of the implications of the study. The Hawthorne effect is a 
well-known phenomenon in research whereby participants adapt their behaviour as a 
result of being observed (260).  This may have affected participants in the newly 
fractured group causing them to optimise their recovery. For this reason, it is possible 
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that the results for this group are not typical of patients with leg fractures and results for 
the #>1yr group may be more representative of post leg fracture outcomes. 
 
Falls history was recorded throughout this study but no significant differences were 
found between groups, or between visits. Osteoarthritis has been thought in the past to 
have a mitigating effect on fracture risk because it is associated high levels of BMD that 
are part of the pathogenesis of the disease (261). The incidence of low trauma fractures 
in OA patients has therefore been attributed to postural instability and either an 
increased occurrence or greater severity of falls (204, 206, 207). Whilst problems with 
stability can contribute to immobility, they can also, conversely, be the result of muscle 
atrophy and weakness due to immobility and chronic pain (79, 261). Results from a 
recent prospective multinational cohort study (GLOW) (262) on 51,386 postmenopausal 
women with  self-reported OA, showed that that they experienced 25% more falls that 
those without OA, suggesting that this contributed to a 20% increased risk of fractures 
in these women. Although no significant differences were found in falls incidence 
between the groups on this study, group numbers were relatively small and participants 
may have been exercising increased caution following their surgery. This may have 
resulted in an underestimation the incidence of falls compared to a wider population 
with OA.  
  
During the course of the study, numerous participants were diagnosed as osteopenic or 
osteoporotic and were prescribed either a calcium supplement or bisphosphonate plus 
calcium treatment as a result.  The most significant increase in the number of 
participants put onto prescription was amongst the controls 9.3 % for calcium 
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supplement and 16.3% for bisphosphonate plus calcium at the end of the study, both  
p=<0.05 compared to baseline. 
 
Relationship between physical function and parameters of recovery: 
It is apparent that the multifactorial nature of physical and functional impairment 
following injury or surgery presents an unclear picture regarding the processes of 
recovery. In order to assess the significant variables involved in restoration of physical 
function measured by LEFS, a multiple regression analysis was performed and is 
summarised in Table 5.12. The results present a mixed selection of significant variables 
that influence LEFS in the different groups and at different stages. Nevertheless pain is 
the most frequently occurring explanatory variable causing a reduction in function as 
pain increases in all groups. In addition, fewer co-morbidities, lower age, higher health 
perception and increased pedometer activity all contribute to improved function 
amongst the groups. An increase in depression in the #<3weeks at visit 3 is shown to 
improve LEFS, contrary to expectations, but this may possibly be an aberrant result as 
participants were asked to give their responses to the PHQ-9 question relating to any 
reason and not limited to their leg problems. 
 
Implications: 
These results have implications for the treatment of patients following either fracture or 
surgery. Return to optimal levels of function is an important outcome measure of 
recovery as it enables patients to improve their quality of life and return to activities that 
they either engage in for pleasure or are demanded by their occupation. Although most 
significant explanatory variables for LEFS are unmodifiable, such as age and number of 
co-morbidities, others could be changed to hopefully effect an improvement in patient 
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outcomes. As expected, increased pain has been demonstrated to be a significant factor 
for reduced function. The TKR group has a complex range of problems associated with 
pain, beyond the trauma of surgery itself, which inhibits good levels of functional 
recovery. Obesity, which has been shown to be common in this group, is itself a 
predictor of higher levels of knee pain. This may not be solely related to increased 
mechanical loading on the joints, but may also involve obesity-related inflammatory 
mechanisms (263). Participants often expressed a reluctance to take or rely on 
painkillers, particularly if they were also taking a range of additional medications. This 
is reflected in the relatively low use of painkillers in the #<3weeks group at visit 2, 
although usage is substantially higher for the TKRs. Better, more appropriate pain relief 
might benefit patients and help them return more quickly to an active lifestyle.  Higher 
pedometer scores were shown to improve LEFS for the TKR group. This may be the 
result of good surgical outcomes enabling patients to remobilize more quickly but it 
suggests that an early return to active exercise, as is already encouraged by medical 
practitioners, should be more rigorously encouraged following discharge from hospital. 
Overall, the results show the poorest functional outcomes for the TKR group and this is 
confirmed by Brandes et al (209) who monitored physical activity and health-related 
quality of life during the first year post TKR. They also found that the majority of 
patients did not achieve the levels of physical activity of healthy subjects 12 months 
post-surgery.  Wylde et al (264) investigated the mid-term outcomes of TKR, 5 to 8 
years post-operatively, and found that impairments persisted for TKA patients who 
experienced significantly greater functional limitations and pain levels than total hip 
replacement patients. Poorer long-term function, for both TKR and previous leg fracture 
patients, may also relate in part to ‘fear-induced activity limitation’ (265) or fear of 
falling, that inhibits a full return to normal activity. The range of physiotherapy services 
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available to patients in the study cohort was not consistent, with large variation in the 
rehabilitation programs that were offered. Patients from both fracture and TKR groups 
could benefit, in the short and long term, from strategies to improve their strength, 
balance and range of movement. Enhanced services for post-surgical exercise classes 
could assist patients to overcome psychological barriers to physical activity thereby 
reducing falls risk, mitigating bone and/or muscle loss and reducing the potential risk 
for future hip fracture. The group support afforded by such classes could also aid morale 
and encourage weight loss, potentially benefitting patients in their general health and 
recovery. 
 
Limitations: 
The study had several limitations, most notably the difficulties involved with 
recruitment and the potential for recruitment bias. The number of participants in the 
#<3weeks group was small due to the requirements of the study to attend data collection 
sessions close to the time of injury, and participants were generally limited to those with 
a strong support network of friends and relatives who could assist them with transport. 
The sample used in this study was 100% of white Caucasian ethnicity coming from a 
relatively affluent rural catchment area in the Southwest of England. The pedometer 
results suggest that the controls were a relatively active group for their age range and 
were frequently from backgrounds that afforded them the leisure to take part in the 
study.  Although the socio-economic status of participants was not investigated, many, 
particularly amongst the control group, appeared to have backgrounds of relative 
affluence and good education that are generally associated with healthier lifestyles.  
Participants may not therefore be fully representative of the broader population which 
potentially limits the generalisability of the results. Other limitations included the 
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subjectivity of some of the questionnaires, particularly with regard to levels of pain and 
health state. Control participants were fairly consistent however in their longitudinal 
responses to these questionnaires, indicating a reasonable degree of precision. The 
IPAQ form, which was given to participants to complete at home, was difficult to 
complete for many people and had a poor response rate with many missing data. The 
correlation with activity measured by pedometer was very poor (r=33%) and it was not 
therefore included as an independent variable in the modeling. There were many 
potential and unavoidable confounders due to the nature of the pathologies under 
investigation, such as the presence of co-morbidities, previous knee replacements and 
treatments for low bone density that were prescribed during the course of the study. 
Where appropriate and relevant to the outcome measures, these were added as 
explanatory variables in the analysis.  
 
 
 
5.6 CONCLUSION 
It is evident that there are notable differences between the groups at baseline. The TKR 
group is distinct in their high mean BMI and poor general levels of function, health and 
activity relative to the controls. It is not known whether their high BMI, at obese level, 
is due to low levels of function and activity resulting from the disabling effects of 
osteoarthritis, or  conversely, if high BMI was a contributory factor to the pathology 
that necessitated joint replacement. Despite showing an overall improvement in most 
areas of function and activity, the TKRs nonetheless fail to achieve the levels of the 
control group one year post surgery.  The BMI for this group ranged from 21.4 to 51.5 
kg.m
2
 but, contrary to expectations, BMI was not a significant explanatory factor for 
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poor levels of function in this group. The newly fractured patients (#<3weeks) are 
significantly different to the controls at baseline in a number of key functional areas that 
are the inevitable consequence of the immobilization caused by their injury. They do 
however recover well and reasonably quickly in most key areas of functional recovery. 
Both fracture groups have a history of previous fracture rates higher than the controls. 
The group of participants who sustained their fracture more than one year ago, but 
within the past ten years (#>1year), exhibit distinct differences to both the controls and 
the newly fractured group. They  differ from the other groups at baseline in significantly 
higher levels of bone sparing drug treatments and, relative to the controls, show 
significant impairment (p=<0.01) in scores for function, activity and perceived health 
state. These impairments do not persist at the end of the one year recovery period in the 
newly fractured group and it is not therefore clear why the #>1year should demonstrate 
long-term deficits in health and function in the longer term. The discrepancies between 
the two fracture groups may be a consequence of aberrant results due to the small 
number of participants in the #<3weeks group, but are potentially attributable to 
selection bias and the Hawthorne effect whereby behaviour may have been modified in 
the newly fractured participants, artificially optimising their recovery. The #>1year 
group may therefore be more representative of typical leg fracture patients than the 
newly fractured group. 
 
More appropriate pain relief and an improved regime of physiotherapy and exercise, 
may help to improve patient outcomes following leg injury or TKR and may mitigate 
the long-term impairments demonstrated in the #>1yeargroup. 
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Future work: 
Further work would be valuable to investigate whether improved pain relief and more 
consistently applied post-surgical exercise regimes, including group classes to 
encourage compliance, would be beneficial to the functional outcomes for both TKR 
and fracture patients in the immediate and long-term. 
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CHAPTER 6. RESULTS – DENSITOMETRY 
 
6.1 INTRODUCTION AND AIMS 
This chapter investigates the parameters of bone quantity, quality and geometry measured by 
densitometry, trabecular bone score (TBS) and advanced hip assessment (AHA). Body 
composition results derived from DXA total body scans are also assessed. The chapter aims 
to evaluate differences, at baseline and over a one year period of recovery, between groups of 
postmenopausal women, who have had periods of immobilisation due to leg injury or 
surgery. Three groups; newly fractured patients, patients with fractures from more than one 
year previously, and total knee replacement patients are compared to an age matched control 
group. 
 
 
 
6.2 OBJECTIVES  
 
 
 To describe differences between groups at baseline. 
 To assess differences between ipsilateral and contralateral sides at baseline. 
 To investigate differences between groups in longitudinal changes over a twelve 
month period in parameters of bone quantity, quality and geometry. 
 To investigate differences between groups in longitudinal changes over a twelve 
month period in parameters of body composition. 
 To investigate relationships between bone & body composition changes and 
functional, physical and emotional recovery. 
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6.3 BRIEF METHODS AND & STATISTICS 
The methods are described in detail in Chapter 2, section 2.2.3. Statistical methods are 
described in Chapter 2, section 2.3.4. 
 
6.4 RESULTS  
6.4.1 PARTICIPANT CHARACTERISTICS 
Participant characteristics are summarised in chapter 5, Tables 5.1 to 5.3. 
 
6.4.2 DENSITOMETRY RESULTS AT BASELINE AND CHANGES OVER THE STUDY 
PERIOD 
The following figures 6.1 to 6.22 depict the ipsilateral and contralateral bone and tissue 
measurements, expressed as group means and standard errors of the mean, where the greatest 
changes over the study period were observed.  Significances of differences between groups 
and of changes within groups over the study period are reported in Tables 6.2 and 6.3. 
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Figure 6.1. Changes in BMD ai ipsilateral Neck of Femur
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Figure 6.2. Changes in BMD at contralateral Neck of Femur
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Figure 6.3. Changes in BMD at ipsilateral Total Hip
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Figure 6.4. Changes in BMD at contralateral Total Hip
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Figure 6.5. Changes in BMD at ipsilateral Greater Trochanter
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Figure 6.6. Changes in BMD at contralateral Greater Trochanter
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Figure 6.7. Changes in BMD at ipsilateral Femoral Shaft
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Figure 6.8. Changes in BMD at contralateral Femoral Shaft
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Figure 6.9. Changes in BMD at ipsilateral Wards Triangle
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Figure 6.10. Changes in BMD at contralateral Wards Triangle
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Baseline data removed for #<3 weeks group wearing plaster cast 
Figure 6.11. Changes in ipsilateral leg fat
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Figure 6.12. Changes in contralateral Leg Fat
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Figure 6.13. Changes in ipsilateral Leg Lean Tissue
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Figure 6.14. Changes in contralateral Leg Lean Tissue
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Figure 6.15. Changes in ipsilateral Hip Strength Index
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Figure 6.16. Changes in contralateral Hip Strength Index
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Figure 6.17. Changes in ipsilateral Hip Axis Length
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Figure 6.18. Changes in contralateral Hip Axis Length
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Figure 6.19. Changes in ipsilateral Hip CSMI
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Figure 6.20. Changes in contralateral Hip CSMI
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Figure 6.21. Changes in ipsilateral Hip CSA
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Figure 6.22. Changes in contralateral Hip CSA
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The results reported in Table 6.1 give the longitudinal change in BMD at the ipsilateral NOF 
as both absolute values and as percentage change. Although the differences in group means 
are not statistically significant, means are not matched by the nature of the study design. As 
the mean is used as the denominator when calculating percentage change, differences in the 
means can result in a misleading impression of the equivalence of the percentage results i.e. 
an equal percentage change in BMD does not reflect an equal change in absolute BMD 
values nor does it reflect the increase in fracture risk due to bone loss. This effect is more 
clearly illustrated in Table 6.1 by applying a 10% BMD reduction to each group. This 
demonstrates that an equal percentage bone loss across the groups does not equate to BMD 
loss in absolute terms nor does it reflect the change in fracture risk as calculated by FRAX 
applied to the typical study participant aged 65 years, height 1.6m, weight 73kg, BMI  27.6 
and no other risk factors (GE Lunar Prodigy).
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Table  6.1.  Change in BMD at Ipsilateral NOF over 4 visits expressed as absolute BMD and percentage change 
 Controls TKR #< 3wks 
 (g/cm2) %  (g/cm2) %  (g/cm2) %  
Baseline BMD at NOF (g/cm
2
) 0.896 - 0.949 - 0.920 - 
Change from baseline at 6 week visit  0.000 0.000 -0.007 -0.738 -0.011 -1.196 
Change from baseline at 6 month visit  0.003 0.330 -0.013 -1.370 -0.017 -1.848 
Change from baseline at 12 month visit  -0.008 -0.893 -0.016 -1.686 -0.005 -0.543 
Change from baseline post 10% reduction 0.090 10.000 0.095 10.000 0.092 10.000 
% Fracture risk - major osteoporotic fracture - at baseline* - 7.0 - 6.5 - 6.7 
% Fracture risk - major osteoporotic fracture -post 10% BMD reduction* - 8.5 - 7.5 - 7..9 
% Increase in fracture risk - major osteoporotic fracture -post 10% BMD reduction - 21.4 - 15.4 - 17.9 
% Hip fracture risk at baseline** - 0.6 - 0.4 - 0.5 
% Hip fracture risk post 10% BMD reduction** - 1.2 - 0.8 - 1.0 
% Increase in  hip fracture riskpost 10% BMD reduction - 100.0 - 100.0 - 100.0 
* 10 year probability for major osteoporotic fracture calculated by FRAX based on a 65 year old female, Height 1.6m, Weight 73kg,  BMI  27.56and no other risk factors (GE Lunar Prodigy) 
**10 year probability for hip fracture calculated by FRAX based on a 65 year old female, Height 1.6m, Weight 73kg, BMI 27.6 and no other risk factors (GE Lunar Prodigy) 
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Figure 6.23. Relationship between baseline BMD and change in 
ipsilateral total hip BMD at visit 2
TKR
#<3wks
 
Figure 6.23 shows the correlation between ipsilateral total hip BMD at baseline, and the 
loss/gain in BMD at 6 weeks post baseline.    
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The following figures 6.24 and 6.25 depict changes in spine BMD L1-L4 and TBS 
measurements observed during the study period.  Significances of differences between groups 
and of changes within groups over the study period are reported in Table 6.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.24. Changes in BMD at Lumbar Spine L1-L4
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Figure 6.25. Changes in TBS 
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Although the overall measurements were higher for the TKR group and lower for the 
#<3weeks group, the baseline results for BMD at the hip and lumbar spine did not reveal any 
statistically significant differences compared to the controls. The results were however 
significant for the #>1year group who demonstrated lower BMD at all sites (p=<0.05), 
(ipsilateral Ward’s triangle p=<0.01), with the notable exception of the contralateral total hip, 
greater trochanter and femoral shaft. 
 
No significant changes occurred from baseline in bone or body composition parameters in the 
control group, except for a reduction in ipsilateral BMD at the NOF (p=<0.05) at visit 4 and a 
reduction in contralateral total hip BMD (p=<0.05) at visit 3. No significant changes occurred 
on the contralateral side, for any of the other groups, in any parameter of bone or body 
composition except for a significant increase in leg fat in the #<3weeks group (5274±1474g, 
p=<0.05) at visit 2, and a reduction in LLTM for the TKRs at visit 2.  Significant changes 
were however observed for the TKR and #<3weeks groups in the ipsilateral leg and are 
shown in figures 6.1 to 6.22. The TKR group demonstrated the greatest number of significant 
changes. BMD at the ipsilateral NOF declined progressively from 0.949±0.126 g/cm
2
 at 
baseline to 0.936±0.134 g/cm
2
, (p=<0.05) at visit 3, remaining at that level at visit 4 (Fig.6.1). 
BMD at the ipsilateral total hip reduced rapidly from baseline 0.981±0.126 g/cm
2
, to 
0.969±0.132 g/cm
2
, (p=<0.05) at visit 2, and further declined to 0.966±0.129 g/cm
2
, 
(p=<0.05) at the final visit (Fig.6.3). A comparable pattern of bone loss was also 
demonstrated in the greater trochanter and femoral shaft (Figs. 6.5 and 6.7). In each case the 
BMD at the end of the study was significantly (p=<0.05) lower than at baseline. By contrast, 
the #<3weeks group sustained initial rapid losses from baseline (0.927±0.137 g/cm
2
) in BMD 
at the ipsilateral total hip, to 0.916±0.151, (p=<0.05) at visit 2, but improved thereafter to a 
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level of 0.946±0.135, (n.s) at the end of the study, above the baseline measurement (Fig.6.3). 
Again, the same pattern was repeated for the greater trochanter with a highly significant 
improvement at visit 4 (0.763±0.109g/cm
2
, p=<0.01) from baseline (0.726±0.107g/cm
2
) 
(Fig.6.5).  The improvement to above baseline at the end of the study, in this group, may 
possibly be accounted for by the delay after the initial injury in taking baseline 
measurements. The mean interval between injury and surgery was 20 days  and as bone loss 
appears to be a very rapid response to immobilization, participants were likely to have 
already sustained some reduction in BMD by the time that they presented at the baseline visit. 
Measurements were higher for both the total hip and greater trochanter on the contralateral 
side (n.s compared to the ipsilateral side) and these contralateral measurements are probably 
indicative of the original ipsilateral BMD at the time of the injury. 
 
The differences between mean ipsilateral and contralateral measurements at baseline were 
compared for all groups and all parameters. Significant differences were only revealed for the 
two fracture groups. The #<3weeks group appeared to have higher fat (5212±5006g, 
p=<0.05) and lean (6317±587g, p=<0.05) tissue mass in the ipsilateral leg but this is probably 
erroneous as participants were all wearing plaster casts at their baseline visit which would 
have affected the DXA tissue measurements at this visit. The #>1year group had lower 
ipsilateral total hip BMD (0.860±0.119g/cm
2
, p=<0.05), greater trochanter BMD 
(0.724±0.107g/cm
2
, p=<0.05), and higher fat tissue (5204±2083g, p=<0.05) and lean tissue 
(6313±6145g, p=<0.05) compared to the contralateral leg. 
 
The results for TBS at the lumbar spine (Table 6.2) did not demonstrate any significant 
differences between the groups at baseline, and no significant changes occurred over the one 
year study period in either TBS or BMD for any of the groups. A disparity between TBS and 
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BMD measurements is evident in the TKR group (Figs. 6.24 and 6.25). Whilst TBS and 
lumbar spine BMD are broadly equivalent for the other groups at baseline, the TKRs have 
higher mean L1-L4 BMD compared to controls but lower TBS.  
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Table 6.2 Densitometry results - bone 
 
Controls TKR 
 
#<3wks #>1yr 
 
n Mean SD 
  
n Mean SD 
  
n Mean SD 
  
n Mean SD 
  
(1) Mean TBS Spine 43 1.300 0.092 
  
19 1.265 0.141 
  
9 1.302 0.111 
  
24 1.248 0.137 
  
(3) Mean TBS Spine 43 1.293 0.105 
  
19 1.253 0.133 
  
9 1.3 0.097 
  
0 
    
(4) Mean TBS Spine 43 1.296 0.100 
  
19 1.256 0.127 
  
9 1.292 0.126 
  
0 
    
1BMD L1-L4 43 1.143 0.192 
  
19 1.21 0.233 
  
9 1.1 0.137 
  
24 1.038 0.220 * 
 
2 BMD L1-L4 0 
    
0 
    
0 
    
0 
    
3 BMD L1-L4 43 1.138 0.178 
  
19 1.197 0.242 
  
9 1.115 0.137 
  
0 
    
4 BMD L1-L4 43 1.139 0.180 
  
19 1.199 0.238 
  
9 1.125 0.124 
  
0 
    
1Ipsi Femur BMD NOF 43 0.896 0.133 
  
19 0.949 0.126 
  
9 0.92 0.119 
  
24 0.816 0.105 * 
 
2 Ipsi Femur BMD NOF 0 
    
19 0.942 0.128 
  
9 0.909 0.131 
  
0 
    
3 Ipsi Femur BMD NOF 43 0.899 0.136 
  
19 0.936 0.134 
 
† 9 0.903 0.117 
  
0 
    
4 Ipsi Femur BMD NOF 43 0.888 0.130 
 
† 19 0.933 0.135 
  
9 0.915 0.117 
  
0 
    
1Contra Femur BMD NOF 43 0.903 0.126 
  
17 0.937 0.140 
  
9 0.897 0.119 
  
24 0.831 0.135 * 
 
2 Contra Femur BMD NOF 0 
    
17 0.942 0.143 
  
9 0.896 0.105 
  
0 
    
3 Contra Femur BMD NOF 43 0.899 0.124 
  
17 0.933 0.152 
  
9 0.897 0.123 
  
0 
    
4 Contra Femur BMD NOF 43 0.899 0.120 
  
17 0.931 0.156 
  
9 0.9 0.124 
  
0 
    
1IpsiFemur BMD Total Hip 43 0.948 0.149 
  
19 0.981 0.126 
  
9 0.927 0.137 
  
24 0.86 0.119 * 
 
2 IpsiFemur BMD Total Hip 0 
    
19 0.969 0.132 
 
† 9 0.916 0.151 
 
† 0 
    
3 IpsiFemur BMD Total Hip 43 0.948 0.150 
  
19 0.965 0.131 
 
†† 9 0.93 0.146 
  
0 
    
4 IpsiFemur BMD Total Hip 43 0.945 0.144 
  
19 0.966 0.129 
 
† 9 0.946 0.135 
  
0 
    
1Contra Femur BMD Total Hip 43 0.953 0.151 
  
17 0.994 0.148 
  
9 0.933 0.139 
  
24 0.881 0.136 
  
2Contra Femur BMD Total Hip 0 
    
17 0.991 0.145 
  
9 0.928 0.136 
  
0 
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3 Contra Femur BMD Total Hip 43 0.948 0.146 
 
† 17 0.995 0.153 
  
9 0.933 0.136 
  
0 
    
4 Contra Femur BMD Total Hip 43 0.950 0.142 
  
17 0.993 0.150 
  
9 0.935 0.124 
  
0 
    
1Ipsi Femur BMD Greater troch 43 0.773 0.134 
  
19 0.8 0.119 
  
9 0.726 0.107 
  
24 0.704 0.107 * 
 
2 Ipsi Femur BMD Greater troch 0 
    
19 0.786 0.131 
 
† 9 0.719 0.119 
  
0 
    
3 Ipsi Femur BMD Greater troch 43 0.771 0.136 
  
19 0.788 0.124 
 
† 9 0.743 0.122 
  
0 
    
4 Ipsi Femur BMD Greater troch 43 0.776 0.128 
  
19 0.787 0.119 
 
† 9 0.763 0.109 
 
†† 0 
    
1ContraFemur BMD Greater troch 43 0.777 0.135 
  
17 0.821 0.146 
  
9 0.767 0.116 
  
24 0.729 0.116 
  
2 ContraFemur BMD Greater troch 0 
    
17 0.817 0.139 
  
9 0.762 0.111 
  
0 
    
3 ContraFemur BMD Greater troch 43 0.771 0.129 
  
17 0.829 0.142 
  
9 0.767 0.111 
  
0 
    
4 ContraFemur BMD Greater troch 43 0.775 0.124 
  
17 0.825 0.138 
  
9 0.769 0.098 
  
0 
    
1Ipsi Femur BMD Wards 43 0.733 0.164 
  
19 0.732 0.155 
  
9 0.711 0.127 
  
24 0.617 0.113 ** 
 
2 Ipsi Femur BMD Wards 0 
    
19 0.722 0.137 
  
9 0.697 0.125 
  
0 
    
3 Ipsi Femur BMD Wards 43 0.730 0.160 
  
19 0.717 0.159 
  
9 0.703 0.125 
  
0 
    
4 Ipsi Femur BMD Wards 43 0.723 0.163 
  
19 0.73 0.162 
  
9 0.706 0.115 
  
0 
    
1Contra Femur BMD Wards 43 0.726 0.162 
  
17 0.736 0.158 
  
9 0.701 0.106 
  
24 0.627 0.128 * 
 
2 Contra Femur BMD Wards 0 
    
17 0.744 0.163 
  
9 0.688 0.097 
  
0 
    
3 Contra Femur BMD Wards 43 0.726 0.161 
  
17 0.731 0.160 
  
9 0.692 0.100 
  
0 
    
4 Contra Femur BMD Wards 43 0.722 0.155 
  
17 0.731 0.162 
  
9 0.691 0.098 
  
0 
    
1IpsiFemur BMD Shaft 43 1.137 0.191 
  
19 1.166 0.161 
  
9 1.121 0.182 
  
24 1.024 0.157 * 
 
2 IpsiFemur BMD Shaft 0 
    
19 1.15 0.166 
 
† 9 1.114 0.199 
  
0 
    
3 IpsiFemur BMD Shaft 43 1.137 0.189 
  
19 1.146 0.167 
 
† 9 1.124 0.194 
  
0 
    
4 IpsiFemur BMD Shaft 43 1.130 0.188 
  
19 1.147 0.161 
  
9 1.135 0.180 
  
0 
    
1Contra Femur BMD Shaft 43 1.142 0.204 
  
17 1.186 0.189 
  
9 1.115 0.186 
  
24 1.044 0.178 
  
2 Contra Femur BMD Shaft 0 
    
17 1.178 0.187 
  
9 1.105 0.184 
  
0 
    
3 Contra Femur BMD Shaft 43 1.138 0.200 
  
17 1.18 0.196 
  
9 1.11 0.181 
  
0 
    
4 Contra Femur BMD Shaft 43 1.137 0.194 
  
17 1.185 0.200 
  
9 1.11 0.169 
  
0 
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1Total Body BMD Ipsi leg 43 1.208 0.127 
  
19 1.21 0.139 
  
9 1.111 0.074 * 
 
24 1.152 0.139 
  
2 Total Body BMD Ipsi leg 0 
    
19 1.242 0.150 
  
9 1.152 0.115 
  
0 
    
3 Total Body BMD Ipsi leg 43 1.200 0.128 
  
19 1.221 0.146 
  
9 1.144 0.119 
  
0 
    
4 Total Body BMD Ipsi leg 43 1.211 0.127 
  
19 1.177 0.177 
  
9 1.148 0.115 
  
0 
    
1Total Body BMD Contra Leg 43 1.211 0.131 
  
19 1.206 0.124 
  
9 1.165 0.089 
  
24 1.124 0.125 * 
 
2 Total Body BMD Contra Leg 0 
    
19 1.203 0.124 
  
9 1.159 0.091 
  
0 
    
3 Total Body BMD Contra Leg 43 1.205 0.130 
  
19 1.199 0.123 
  
9 1.165 0.098 
  
0 
    
4 Total Body BMD Contra Leg 43 1.217 0.130 
  
18 1.159 0.166 
  
9 1.154 0.088 
  
0 
    
*p=<0.05 when compared to control group   
**p=<0.01 when compared to control group 
 
†p=<0.05 when compared to baseline for the same group 
 
††p=<0.01 when compared to baseline for the same group 
 
SD =standard deviation 
 
Notes: 
SD =standard deviation 
BMD (g/cm2) 
Ipsi=ipsilateral, contra= contralateral 
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Table 6.3 Densitometry results - body composition and AHA 
 
Controls TKR 
 
#<3wks #>1yr 
 
n Mean SD 
  
n Mean SD 
  
n Mean SD 
  
n Mean SD 
  
1Fat Android 43 2209 912 
  
19 3544 1432 ** 
 
9 2628 966 
  
24 2941 1325 * 
 
2 Fat Android 0 
    
19 3437 1546 
  
9 2708 1054 
  
0 
    
3 Fat Android 43 2220 940 
  
19 3542 1577 
  
9 2664 1038 
  
0 
    
4 Fat Android 43 2263 930 
  
19 3508 1798 ** 
 
9 2745 1013 
  
0 
    
1Fat Gynoid 43 4652 1324 
  
19 6058 1883 ** 
 
9 5254 1182 
  
24 5426 1884 
  
2 Fat Gynoid 0 
    
19 6096 2164 
  
9 5367 1322 
  
0 
    
3 Fat Gynoid 43 4591 1227 
  
19 6273 2080 ** 
 
9 5353 1150 
  
0 
    
4 Fat Gynoid 43 4628 1296 
  
19 6057 2645 * 
 
9 5392 1326 
  
0 
    
1Lean Android 43 2809 291 
  
19 3202 529 ** 
 
9 2825 373 
  
24 2978 472 
  
2 Lean Android 0 
    
19 3250 666 
  
9 2840 325 
  
0 
    
3 Lean Android 43 2838 297 
  
19 3219 510 ** 
 
9 2900 361 
  
0 
    
4 Lean Android 43 2845 303 
  
19 3104 874 
  
9 2922 402 
 
† 0 
    
1Lean Gynoid 43 5682 620 
  
19 5975 792 
  
9 5693 714 
  
24 5720 795 
  
2 Lean Gynoid 0 
    
19 5872 861 
  
9 5481 498 
  
0 
    
3 Lean Gynoid 43 5727 621 
  
19 5897 768 
  
9 5649 614 
  
0 
    
4 Lean Gynoid 43 5649 632 
  
19 5707 1499 
  
9 5616 574 
  
0 
    
1Total Fat 43 24969 8249 
  
19 36775 11661 ** 
 
9 28859 8267 
  
24 30577 11731 * 
 
2 Total Fat 0 
    
19 36402 12169 
  
9 29494 8415 
  
0 
    
3 Total Fat 43 24911 7882 
  
19 37950 12760 ** 
 
9 29038 8495 
  
0 
    
4 Total Fat 43 25100 8193 
  
19 36820 15183 ** 
 
9 29524 8488 
  
0 
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1Total Lean 43 39864 3455 
  
19 42070 4922 * 
 
9 38845 3073 
  
24 39949 4207 
  
2 Total Lean 0 
    
19 41427 5267 
  
9 38360 2712 
  
0 
    
3 Total Lean 43 39896 3613 
  
19 41581 5128 
  
9 39083 3167 
  
0 
    
4 Total Lean 43 39810 3459 
  
19 40357 8278 
  
9 38880 3195 
  
0 
    
1Fat Ipsi Leg 43 4287 1284 
  
18 6313 2103 ** 
 
9 5212 1448 
  
24 5204 2083 * 
 
2 Fat Ipsi Leg 0 
    
18 6294 2117 
  
9 5266 1464 
  
0 
    
3 Fat Ipsi Leg 43 4209 1161 
  
18 6814 2447 ** † 9 5266 1424 * 
 
0 
    
4 Fat Ipsi Leg 43 4286 1269 
  
18 6572 2935 ** 
 
9 5103 1395 
  
0 
    
1Fat Contra  Leg 43 4274 1268 
  
19 6244 2021 ** 
 
9 5006 1464 
  
24 5037 1893 
  
2 Fat Contra  Leg 0 
    
19 6260 1923 
  
9 5274 1474 
 
† 0 
    
3 Fat Contra  Leg 43 4181 1117 
  
19 6658 2301 ** 
 
9 5223 1418 * 
 
0 
    
4 Fat Contra  Leg 43 4261 1229 
  
19 6360 2727 ** 
 
9 5234 1478 * 
 
0 
    
1Lean IpsiLeg 43 6311 766 
  
18 6398 878 
  
9 6317 587 
  
24 6318 763 
  
2 Lean IpsiLeg 0 
    
18 6043 1094 
 
† 9 6039 490 
 
† 0 
    
3 Lean IpsiLeg 43 6313 828 
  
18 6173 933 
  
9 6230 673 
  
0 
    
4 Lean IpsiLeg 43 6334 755 
  
18 6138 1148 
  
9 6015 588 
  
0 
    
1Lean Contra Leg 43 6300 791 
  
19 6461 888 
  
9 6061 594 
  
24 6145 691 
  
2 Lean Contra Leg 0 
    
19 6135 787 
 
† 9 6041 420 
  
0 
    
3 Lean Contra Leg 43 6273 743 
  
19 6155 768 
  
9 6180 545 
  
0 
    
4 Lean Contra Leg 43 6307 734 
  
19 6056 858 
  
9 6153 528 
  
0 
    
1Ipsi Femur CSMI 43 10630 2453 
  
19 10622 3009 
  
9 9936 2647 
  
24 8503 2114 ** 
 
2 Ipsi Femur CSMI 0 
    
19 10702 3046 
  
9 10009 2473 
  
0 
    
3 Ipsi Femur CSMI 43 10590 2535 
  
19 10658 3105 
  
9 9704 2406 
 
† 0 
    
4 Ipsi Femur CSMI 43 10682 2353 
  
19 10845 3287 
  
9 9871 2764 
  
0 
    
1Contra  CSMI 43 10623 2217 
  
17 9856 2464 
  
9 10115 2465 
  
24 9092 3279 * 
 
2 Contra  CSMI 0 
    
17 10304 2778 
  
9 10031 2289 
  
0 
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3 Contra  CSMI 43 10567 2224 
  
17 9974 2667 
  
9 9553 2536 
  
0 
    
4 Contra  CSMI 43 10621 2320 
  
17 10000 3026 
  
9 9864 2374 
  
0 
    
1Ipsi Femur SI 43 1.598 0.4 
  
19 1.401 0.3 
  
9 1.634 0.3 
  
24 1.277 0.4 ** 
 
2 Ipsi Femur SI 0 
    
19 1.36 0.3 
  
9 1.584 0.4 
  
0 
    
3 Ipsi Femur SI 43 1.573 0.5 
  
19 1.304 0.3 * 
 
9 1.519 0.3 
 
† 0 
    
4 Ipsi Femur SI 43 1.583 0.4 
  
19 1.323 0.3 * 
 
9 1.596 0.3 
  
0 
    
1Contra SI 43 1.644 0.4 
  
17 1.33 0.3 ** 
 
9 1.529 0.2 
  
24 1.317 0.3 ** 
 
2 Contra SI 0 
    
17 1.348 0.2 
  
9 1.586 0.3 
  
0 
    
3 Contra SI 43 1.654 0.4 
  
17 1.346 0.3 ** 
 
9 1.446 0.3 
  
0 
    
4 Contra SI 43 1.611 0.4 
  
17 1.312 0.3 ** 
 
9 1.485 0.2 
  
0 
    
*p=<0.05 when compared to control group   
**p=<0.01 when compared to control group 
 
†p=<0.05 when compared to baseline for the same group 
 
††p=<0.01 when compared to baseline for the same group 
 
SD =standard deviation 
 
Notes: 
SD =standard deviation 
Fat and lean (g) 
Ipsi=ipsilateral, contra= contralateral 
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The results for body composition (Table 6.3) revealed highly significant differences 
(p=<0.01) between the TKR group and controls with much higher measurements of android, 
gynoid, ipsilateral & contralateral leg and total body fat, as expected given the high BMI 
(32.2±7.1, p=<0.01) of this group. There were no significant differences in this group for lean 
tissue measurements with the exception of higher levels of android lean tissue (3202±529g, 
p=<0.01). The body composition measurements for the #<3weeks group were not 
significantly different to the controls at baseline, although bilateral measurements of leg fat 
increased post injury and became significant at visit 3.  Body composition for the #>1year 
group did not differ greatly from the controls except with regard to higher levels of android, 
ipsilateral leg and total body fat (p=<0.05) consistent with their higher BMI (28.4±5.5, 
p=<0.05). 
 
Body composition changes were demonstrated in the TKR group with a significant increase 
in ipsilateral leg fat at visit 3 (6814±2447g, p=<0.05) which reduced again close to baseline 
level at visit 4 (6572±2935, n.s). Both ipsilateral and contralateral legs showed a marked and 
rapid reduction in LLTM at visit 2 (p=<0.05) with mean losses of 355±643g and 326±614g 
respectively. This muscle loss was not restored at visit 4 (Figs 6.13 and 6.14).  The #<3weeks 
group appeared to lose LLTM only at the ipsilateral leg, with a mean reduction of 278±292g 
(p=<0.05) at visit 2, but this is possibly an anomaly resulting from the presence of plaster 
casts at the baseline visit.  
 
The results for AHA (Table 6.3) demonstrate no significant differences  at baseline between  
controls and the TKR group in measurements of ipsi- and contralateral CSMI, or ipsilateral 
SI but the contralateral SI is significantly lower (1.33±0.3, p=<0.01) compared to 1.64±0.4 
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for the controls. No significant differences exist between the #<3weeks group and controls 
but the #>1year demonstrate significant differences in all AHA parameters being lower than 
the controls in ipsilateral CSMI (8503±2114, p=<0.01), contralateral CSMI (9092±3279, 
p=<0.05), ipsilateral SI (1.28±0.4, p=<0.01) and contralateral SI (1.32±0.3, p=<0.01). 
 
The only significant changes in AHA parameters were seen in the #<3weeks group who 
sustained a reduction in CSMI at visit 3 (9704±2406, p=<0.05) that improved again at visit 4 
(Fig.6.19). A commensurate change in SI (Fig.6.15) was shown, as would be expected since 
the calculation of SI is derived from CSMI. 
 
 
 
 
Table 6.4 Participants Z scores at baseline - visit 1 
  Controls n=43 TKR n=19 #<3wks n=9 #>1yr n=24 
BMD total hip - contralateral 0.66 0.66 0.34 0 
BMD total hip - ipsilateral 0.62 0.5 0.27 -0.16 
BMD spine L1-L4 0.96 1.16 0.41 -0.08 
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6.4.3 RELATIONSHIPS BETWEEN BONE & BODY COMPOSITION CHANGES 
AND FUNCTIONAL, PHYSICAL AND EMOTIONAL RECOVERY 
Stepwise multiple regression analysis was performed to create a model of significant 
explanatory factors for changes in BMD at the ipsilateral total hip and changes in 
ipsilateral LLTM as dependent variables, at three time points during recovery, 6 weeks 
(visit2), 6 months (visit 3) and 1year (visit 4). These dependent variables were selected 
because they demonstrated the most significant changes during the study period and are 
potentially the greatest risk factors for future hip fracture and falls. As it was expected 
that there would be some delayed effect on bone loss resulting from the processes of 
recovery, the independent variables from the preceding visit (for which all appropriate 
data were available), for each time point of measures of the dependent variable, were 
used in the model. The resulting model summaries for each time point are shown in 
Tables 6.5 to 6.11 and reported below: 
 
CHANGES IN BMD AT THE IPSILATERAL TOTAL HIP 
The independent variables added into the model were: 
Change in Ipsilateral LLTM  
EQ5D Health state VAS  
Prescribed calcium treatment   
Bisphosphonate treatment 
Ipsilateral weight-bearing 
Pain VAS  
Pedometer average steps per day 
LEFS Score  
Number of co-morbidities relating to bone health  
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Total of all co-morbidities  
Physical therapy 
Age  
BMI 
Number of knee replacements  
PHQ9 Total score 
GAD7 Total score 
 
VISIT 2 
 
Table 6.5.  Model Summary: Dependent variable - Changes in BMD at the ipsilateral total hip  at visit 2 
Group Model 
R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
TKR   1 .507
a .257 .204 .013011 
#<3wks   1 .729
b .531 .464 .016164 
a. Predictors: (Constant), LEFS Score 1 
b. Predictors: (Constant), Pedometer Average  visit 1 
 
 
Controls: Not applicable. 
TKR:  Model 1 was a poor fit describing only 25.7% of variance in change in total hip 
BMD at visit 2 (R
2
adj= 20.4%), statistical significance F1,14= 4.85,  p=0.045. With other 
variables held constant, change in total hip BMD at visit 2 was negatively related to 
LEFS at visit 1, decreasing by 0.0005 g/cm
2
 for every extra LEFS point (t= -2.20, 
p=0.045). 
Change Ipsi Total Hip BMD = 0.00034 – 0.00050 LEFS          (Eq.6.1)   
#<3 weeks: Model 1 was an acceptable fit describing 53.1% of variance in change in 
total hip BMD at visit 2 (R
2
adj= 46.4%), statistical significance F1,7= 7.92,  p=0.026. 
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With other variables held constant, change in total hip BMD at visit 2  was negatively 
related to average number of daily pedometer steps at visit 1, decreasing by 0.00002 
g/cm
2
 for every extra step (t=-2.81, p=0.026). 
Change Ipsi Total Hip BMD = 0.01909 - 0.0002 pedometer steps          (Eq.6.2)   
#>1yr: Not applicable. 
 
 
 
VISIT 3 
 
Table 6.6.  Model Summary: Dependent variable - Changes in BMD at the ipsilateral total hip  at visit 3 
Group Model 
R 
R 
Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
  TKR   1 .502
a .252 .198 .020 
a. Predictors: (Constant), Bisphosphonate1 
 
 
Controls: No significant independent variables found. 
TKR:  Model 1 was a poor fit describing only 25.2% of variance in change in total hip 
BMD at visit 3 (R
2
adj= 19.8%), statistical significance F1,14= 4.71,  p=0.048. With other 
variables held constant, change in total hip BMD at visit 3 was positivelyrelated to 
bisphosphonate use at visit 1, increasing by 0.034g/cm
2
 for bisphosphonate use (t= -
2.20, p=0.045). 
Change Ipsi Total Hip BMD = -0.019 + 0.34 bisphosphonate           (Eq.6.3)   
#<3 weeks: No significant independent variables found. 
#>1yr: Not applicable. 
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VISIT 4 
 
Table 6.6 
7.  Model Summary: Dependent variable - Changes in BMD at the ipsilateral total hip  at visit 4 
Group Model 
R R Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
Controls 
  
1 .447a .200 .179 .015009 
2 .535b .286 .249 .014358 
TKR   1 .702
a .493 .461 .018788 
#<3wks   1 .746
c .556 .493 .013804 
a. Predictors: (Constant), Bisphosphonate3 
b. Predictors: (Constant), Bisphosphonate3, Age  
c. Predictors: (Constant), GAD-7 Total score 3 
 
 
Controls: Model 2 was a poor fit describing only 28.6% of variance in change in total 
hip BMD at visit 4 (R
2
adj= 24.9%), statistical significance F2,38= 7.62,  p=0.002. With 
other variables held constant, change in total hip BMD at visit 4 was positively related 
to age and bisphosphonate use at visit 3, increasing by 0.001 g/cm
2
 for every extra year 
in age (t= 2.12, p=0.038) and by 0.019 g/cm
2
 for bisphosphonate use at visit 3 (t= 3.03, 
p=0.004). 
Change Ipsi Total Hip BMD = -0.047 + 0.019 bisphosphonate + 0.001 age         (Eq.6.4)    
TKR:  Model 1 was an acceptable describing 49.3% of variance in change in total hip 
BMD at visit 4 (R
2
adj= 46.1%), statistical significance F1,16= 15.55,  p=0.001. With other 
variables held constant, change in total hip BMD at visit 4 was positively related to 
bisphosphonate use at visit 3, increasing by 0.056 g/cm
2
 for bisphosphonate use at visit 
3 (t= 3.94, p=0.001). 
Change Ipsi Total Hip BMD = -0.021 + 0.056 bisphosphonate          (Eq.6.5)   
#<3 weeks: Model 1 was an acceptable describing 55.6% of variance in change in total 
hip BMD at visit 4 (R
2
adj= 49.3%), statistical significance F1,7= 8.775,  p=0.021. With 
other variables held constant, change in total hip BMD at visit 4 was negatively related  
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to anxiety at visit 3, decreasing by 0.010 g/cm
2
 for every extra GAD-7 point at visit 3 
(t= 2.96, p=0.021). 
Change Ipsi Total Hip BMD = 0.032 – 0.010 anxiety          (Eq.6.6)   
#>1yr: Not applicable. 
 
 
 
 
 
 
Table 6.8.  Simplified summary of multiple regression analysis 
Significant explanatory factors (from preceding visit) for change in BMD at the ipsilateral total hip 
  Controls TKR #<3 wks #>1yr 
Visit 1 
    
          
Visit 2 
 
↓ LEFS ↓ pedometer 
 
          
Visit 3 
 
↑bisphosphonate use 
  
          
Visit 4 ↑ age ↑ bisphosphonate use ↓ GAD-7 anxiety 
 
↑ bisphosphonate use 
  
     ↑ Indicates mitigation of loss in BMD at the ipsilateral total hip as the score for the independent variable 
increases 
↓ Indicates promotion of loss in BMD at the ipsilateral total hip as the score for the independent variable 
increases 
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CHANGES IN IPSILATERAL LLTM 
The independent variables added into the model were: 
EQ5D Health state VAS  
Ipsilateral weight-bearing  
Pain VAS  
Pedometer average steps per day 
LEFS Score  
Total of all co-morbidities  
Physical therapy 
Age  
BMI  
Number of knee replacements  
PHQ9 Total score 
GAD7 Total score 
 
 
VISIT 2 
 
Controls: No significant independent variables found. 
TKR: No significant independent variables found.  
#<3 weeks: No significant independent variables found. 
#>1yr: Not applicable. 
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VISIT 3 
 
Table 6.9.  Model Summary: Dependent variable - Changes in ipsilateral LLTM at visit 3 
Group Model 
R R Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
#<3wks   1 .726
a .526 .459 363.294 
a. Predictors: (Constant), Pedometer Average visit 1 
 
 
Controls: No significant independent variables found. 
TKR: No significant independent variables found.   
#<3 weeks: Model 1 was a good fit describing 52.6% of variance in change in 
ipsilateral LLTM at visit 3 (R
2
adj= 45.9%), statistical significance F1,17= 7.78,  p=0.027. 
With other variables held constant, change in LLTM at visit 3 was negatively related to 
average daily pedometer steps at visit 1, decreasing by 0.432g for every extra step (t= -
2.79, p=0.027).  
Change in ipsilateral LLTM = 568.144 – 0.432 pedometer steps          (Eq.6.7)   
#>1yr: Not applicable. 
 
 
 
VISIT 4 
 
Table 6.10.  Model Summary: Dependent variable - Changes in ipsilateral LLTM at visit 4 
Group Model 
R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
TKR   1 .614
a .377 .338 749.291615 
#<3wks   1 .689
b .474 .399 409.002181 
a. Predictors: (Constant), Total all co-morbidities 
b. Predictors: (Constant), Age Scan1 
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Controls: No significant independent variables found. 
TKR: Model 1 was an acceptable fit describing 37.7% of variance in change in 
ipsilateral LLTM at visit 4 (R
2
adj= 33.8%), statistical significance F1,16= 9.662,  p=0.007. 
With other variables held constant, change in LLTM at visit 4 was positively related to 
the total number of co-morbidities, increasing by 421.72g for every extra co-morbidity 
(t= 3.11, p=0.007).  
Change in ipsilateral LLTM = -13130.578 + 421.723 co-morbidities          (Eq.6.8)   
 
#<3 weeks: Model 1 was an acceptable fit describing 47.4% of variance in change in 
ipsilateral LLTM at visit 4 (R
2
adj= 39.9%), statistical significance F1,7= 6.313,  p=0.040. 
With other variables held constant, change in LLTM at visit 4 was negatively related to 
age, decreasing by 50.25g for every extra year (t=-2.51, p=0.040). 
Change in ipsilateral LLTM = 2844.948 – 50.254 age          (Eq.6.9)   
 
#>1yr: Not applicable. 
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Table 6.11.  Simplified summary of multiple regression analysis 
Significant explanatory factors (from preceding visit) for change in ipsilateral LLTM   
 
Controls TKR #<3 wks #>1yr 
Visit 1 
    
          
Visit 2 
    
          
Visit 3 
  
↓ pedometer 
 
          
Visit 4 
 
↑ co-morbidities ↓ age 
 
     
     ↑ Indicates mitigation of  loss in ipsilateral  LLTM as the score for the independent variable increases 
↓ Indicates promotion of loss in ipsilateral LLTM as the score for the independent variable increases 
 
 
 
6.5 DISCUSSION 
The consequences of immobilisation on bone and muscle loss are well known and have 
been reported in previous studies. Jarvinen and Kannus (11) provide a comprehensive 
review of studies, up to 1997, of injuries to the lower extremities and their effect on 
bone density. The studies are grouped into knee injuries, femoral shaft, tibial shaft and 
ankle fractures.  It is evident from all of these studies that varying degrees of bone loss 
are associated with lower limb injury, including bone density changes in the 
contralateral limb. Several studies include measurement of BMD changes in the 
proximal femur/hip (6-9, 12, 187, 266). These studies, with one exception (8), showed  
long-term bone loss in the ipsilateral proximal femur/hip to a varying degree as a result 
of lower limb injury.  The length of follow up period and the sample populations, in 
terms of age and sex, varied greatly in these studies. In each case the sample size was 
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very small, maximum 29 participants. No studies have emerged that specifically relate 
to bone loss at the hip in postmenopausal populations as a result of lower limb 
immobilization.  Most studies were retrospective in design using bone density in the 
contralateral leg as a control. As bone loss may have occurred on both the ipsilateral and 
contralateral sides following injury, using the contralateral side as a control, without 
accounting for the possibility of a long-term residual bone deficit on that side, 
potentially underestimates the full extent of bone loss in the ipsilateral leg. To avoid 
these confounding effects, this study aimed to quantify these losses immediately 
following fracture or surgery and to compare these changes to an uninjured control 
group.  
 
It is customary in the literature relating to bone densitometry to report longitudinal 
change as percentages rather than absolute figures alone. In order to calculate 
percentage change in any variable, the mean value of that variable for any given group 
is used as the denominator. Reporting percentage change is logical when comparing 
groups with matched means but, by the nature of this study, the means for the groups 
were not matched and there were, for example, distinct differences in baseline BMD at 
the NOF, although not statistically significant, as illustrated in Table 6.1. As the means, 
and therefore the denominators, for the groups were different, percentage change in 
BMD is not equivalent across the groups i.e. an equal reduction in BMD in percentage 
terms for the groups is not equivalent in either absolute terms nor in terms of increased 
fracture risk and change in percentage terms was not therefore reported for the 
remaining results. 
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The control group demonstrated consistency throughout the study and provided a 
meaningful contrast to the remaining groups. Although some age related bone loss was 
expected over the one year period in this postmenopausal population, apart from a 
reduction in ipsilateral/left-side BMD at the NOF at visit 4 and in the contralateral/right-
side total hip BMD at visit 3, no significant changes occurred from baseline in either 
bone or body composition parameters. Age was nevertheless included in the multiple 
regression modelling as an explanatory variable to take account of its confounding 
effects on bone density.  
 
Although the effects of immobilisation have been studied in a range of patient groups 
with varying pathologies, including spinal cord injury (176) and stroke (177-179), this 
has not been specifically studied in patients immediately following total knee 
replacement. The results (chapter 5) show that the TKR participants had a protracted 
period of reduced exercise and activity prior to surgery, with lower levels of daily 
exercise compared to all of the other groups.  Given this functional impairment prior to 
surgery, and the fact that patients are encouraged to remobilize very quickly following 
their operation, it may have been reasonably expected that their knee replacement would 
afford a relatively rapid improvement in their condition and not greatly reduce their 
mobility and weight-bearing. Results from this study have demonstrated that this is not 
the case, and recovery in all areas of physical and functional parameters was slow and 
incomplete one year after surgery. Although they did not demonstrate the extremes of 
mechanical unloading on their ipsilateral leg shown by the fracture patients (having 
mean ipsilateral weight-bearing of 43.8±6.3 % at 6 weeks after surgery), TKR patients 
returned to full function and activity much more slowly, resulting in significant 
ipsilateral bone loss at the hip with bilateral muscle atrophy. This study employed a 
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recently developed software tool, Trabecular Bone Score, which is designed to evaluate 
bone microarchitecture at the lumbar spine from grey-level pixel variations in the raw 
DXA image data (267). An interesting disparity was revealed between TBS and BMD 
measurements in the TKR group (Figs. 6.24 and 6.25). Whilst TBS and lumbar spine 
BMD are broadly equivalent for the other groups at baseline, TKRs have higher mean 
L1-L4 BMD compared to controls but lower TBS. Previous research on bone affected 
by osteoarthritis has suggested that the higher bone mass associated with OA is 
protective against fracture and that the conditions of OA and osteoporosis are mutually 
exclusive (198, 199). Arden et al report evidence from large population studies where 
levels of BMD are up to 15% higher in OA patients compared to controls (203). A study 
by van Hove et al, investigating osteocyte morphology in human tibial bone from 
different pathological states, observed significant differences in OA and OP affected 
bone suggesting that the two conditions are quite distinct (53). More recent research 
indicates that the relationship between OA and OP is more complex than originally 
proposed (200). Glowacki (199) reports that several studies using DXA assessed BMD, 
demonstrate an incidence of occult OP in 20-29% of both men and women with OA. A 
study by Drees et al (201) found that in 82 osteoarthritic, postmenopausal females, (who 
subsequently required knee or hip replacement), 23.2% were affected by OP reflecting 
the normal distribution of OP in the general female population. Kumarasinghe et al 
(268) observed an altered state of trabecular bone remodelling and microarchitecture in 
primary hip OA. These studies suggest that, although higher BMD is part of the 
pathogenesis of OA, this potentially disguises poorer quality of sclerotic bone and 
inferior fracture resistance. Whilst some caution should be used in interpreting the 
results from TBS, as this software has not been fully validated for clinical use (267), the 
disparity between BMD and TBS in the TKR group is an interesting phenomenon that 
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supports the possibility that the relatively high BMD associated with OA potentially 
disguises poorer bone quality reflected by bone structural parameters. As increased 
BMD is generally associated with reduced fracture risk it might also be expected that 
OA patients would demonstrate reduced fracture prevalence.  A number of studies 
however indicate that this is not the case (203-206). The reasons for this increased 
fracture risk  are not clear but may be attributable to a variety of functional impairments 
associated with OA that possibly contribute to an increased propensity for falls and 
greater severity of injuries. These include reduced agility, reduced muscle strength, 
postural instability and heightened pain levels (203, 207). A study by Prieto-Alhambra 
et al (210) showed that patients with knee OA, from the General Practice Research 
Database (UK), have a non-significantly lower hip fracture incidence than controls in 
the year preceding total knee replacement (TKR), but a significantly increased hip 
fracture incidence in the year following surgery (RR 1.58; 95% CI) that only returns to 
the same level as the control group 3 years post-operatively. These results were 
supported by a further study using the Dutch PHARMO Record Linkage System (211). 
Whilst possible reasons for this phenomenon (propensity for falls etc.) are discussed, 
the extent of disuse-related bone loss at the hip following TKR and its potential 
contribution to post-surgical hip fracture risk has not been reported. Bone loss at the 
tibial and femoral diaphyses has been previously demonstrated following TKR and this 
was most marked in the operated leg for one year post-operatively (212). Post-surgical 
bisphosphonate use (BPU) has been found to be associated with a 50-55% hip fracture 
risk reduction in a TKR population (213). As BPU would be expected to alleviate the 
effects of disuse-related bone loss, this finding supports the hypothesis that the post-
surgical disuse found in the TKR patients in this study, may play an important 
contributory role in hip fracture following TKR (214). Obesity in this TKR group is an 
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additional factor that could influence fracture risk. Obesity has not been generally 
considered as a risk factor for bone fracture as high BMI has generally been associated 
with higher BMD and it has also been suggested that fat tissue has a protective function 
in postmenopausal women by increasing remodelling associated with weight-bearing 
and possibly by cushioning against falls (161).  The effects of obesity on bone are 
potentially complex as it is associated with altered hormone levels including higher 
serum concentrations of human parathyroid hormone (hPTH) and lower circulating 25-
hydroxy-vitamin D both of which influence bone maintenance and quality (162). In 
terms of mechanical risk, applied loads during activity can create resultant forces many 
times greater than during normal stance and excessive stresses can be placed on bones, 
particularly during high impact activities (27). The adequacy of bones to support the 
greater loads to which they are subjected in obese people is becoming an area of 
increasing interest (161, 162). Skeletal alignment in obese people may also be a factor 
in increasing fracture risk. Alignment of the lower limb bones and joints can be 
substantially altered by increased soft tissue mass between the legs that compromises 
normal stance and gait (163). The altered efficiency of load distribution throughout the 
leg may potentially contribute to fracture risk. This may be further exacerbated by 
alterations in gait due to knee pain in OA sufferers with consequent instability and 
heightened risk for falling (261). Despite these complications, a study by Prieto-
Alambra et al (269) found that the association between obesity and fracture in 
postmenopausal women was site-dependent and that obesity had a protective effect 
against hip fracture, possibly related to a padding effect of larger volume of soft tissue 
in the hip region. 
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The newly fractured group demonstrated relatively minimal changes over the study 
period, in any parameters of bone or body composition compared to the TKR group 
and, after an initial and statistically significant decline in BMD at the total hip, 
demonstrated good recovery in both physical and functional parameters over the one 
year period. By the end of the study they had returned to BMD levels comparable to the 
controls in all hip ROIs. In the case of the ipsilateral total hip and greater trochanter, 
there appears to be an improvement in BMD at the end of the study, to above the 
baseline level. This may possibly be accounted for by the delay after the initial injury in 
taking baseline measurements. The mean interval between injury and surgery was 20 
days & and as bone loss appears to be a very rapid response to immobilization, 
participants were likely to have already sustained some reduction in BMD by the time 
that they presented at the baseline visit. Although the results for the #<3weeks group 
indicate a significant loss in ipsilateral muscle mass immediately following fracture, this 
may be due to the presence of plaster casts at the baseline visit causing erroneous DXA 
measurement of the lean leg tissue. Whilst there were bilateral fluctuations in LLTM in 
this group over the study period, they were not significant and the #<3weeks group 
completed the study with ipsilateral LLTM comparable to their contralateral leg at 
baseline. Nevertheless, it is notable that this group has lower muscle mass and higher 
leg fat bilaterally at all stages of the study compared to the controls. The only 
significant changes in AHA parameters were seen in the #<3weeks group who sustained 
a significant (p=<0.05) reduction in CSMI at visit 3 that improved again at visit 4 
(Fig.6.19).  It is not clear whether this has any relevance particularly as it was a very 
temporary change and is most probably due to the relatively high AHA precision errors, 
reported in chapter 2, table 2.5, which can arise from patient positioning differences 
between scans. Following the initial decline, the #<3weeks group present a picture of 
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good levels of recovery in all physical and functional parameters, but these findings 
were not supported by the results for the cross-sectional group who scored significantly 
below the control group in almost all key outcomes. The reasons for these contradictory 
results are not readily explained. It may be that the small sample available for the 
#<3weeks group has given misleading results or that the two fracture groups were not 
representative of comparable populations at the time their fractures occurred. Other than 
having lower muscle mass and higher leg fat bilaterally, the #<3weeks group did not 
demonstrate any significant differences from the controls and it is possible therefore that 
the #<3weeks group did not represent any difference in terms of fracture risk from their 
age-matched peers. Indeed the Z scores (Table 6.4) for the #<3weeks group were 0.34 
and 0.27 for the contralateral & ipsilateral total hip, and 0.41 for the lumbar spine. As Z 
scores of zero would be representative of the average subject in the NHANES database, 
on which DXA diagnostics are based, this tends to suggest that the newly fractured 
group was not at any heightened risk for fracture on the basis of their BMD. For both 
fracture groups, the majority of injuries occurred at the ankle. Ankle fractures are not 
generally regarded as osteoporotic fractures (270) therefore it is consistent with this 
assertion that the occurrence of ankle fractures in the #<3weeks group is unrelated to 
low BMD.  Z scores for the #>1yr group were 0, -0.16 and -0.08, i.e. below the level of 
age-matched peers on the NHANES database, except for the contralateral total hip. As 
their bone density status was not known at the time of their fracture, it is not possible to 
state whether they were at increased risk of fragility fracture at the time of their injury, 
although many were put onto bisphosphonate &/or calcium treatment shortly after their 
injury. It is notable however that the #>1yr group did not have significantly lower BMD 
at their contralateral total hip, greater trochanter and femoral shaft compared to controls 
suggesting that at the time of injury, their hip BMD was comparable to the control 
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group and the deficit in BMD on the ipsilateral side is the long-term consequence of the 
fracture and an impairment in general levels of function and activity post injury.  Given 
that the #<3weeks group returned to normal levels of function and activity at the end of 
the study, it is unclear why these impairments in function and activity should be evident 
in the #>1yr group. As discussed in chapter 5, it is feasible that selection bias has 
influenced the results for the #<3weeks group and, due to their interest in the research 
topic, they may have been susceptible to the Hawthorne effect, modifying their 
behaviour to optimize their recovery. The outcomes for the #>1year group may 
therefore be more representative of patients sustaining leg fractures than the #<3weeks 
group. Regardless of whether or not the original injury for the #>1yr group was due to 
bone fragility, the study results show a long-term impairment in function, activity that 
may have contributed to an ipsilateral deficit in bone mass at the hip and reduced 
bilateral muscle mass compared to controls, which may predispose them to increased 
hip fracture risk in the future. 
 
Relationships between bone & body composition changes and functional, physical and 
emotional recovery:  
The most significant and important changes, in terms of potential fracture risk, that 
occurred during the study were reductions in BMD at the total hip and in bilateral 
LLTM. The explanatory factors for these dependent variables were assessed using 
multiple regression analysis and the results are summarised in tables 6.8 and 6.11. The 
models, explaining variation in total hip BMD change, produced a mixed picture for the 
different groups with some results contradicting expectations. Bisphosphonate use 
predicted mitigation of bone loss for the controls at visit 4 and for the TKRs at visit 3 
and 4. Anxiety predicted bone loss at visit 4 for the #<3weeks group. A reduction in 
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function and pedometer steps were shown to mitigate bone loss at visit 2 for the TKRs 
and #<3weeks group respectively. Whilst this initially appears to be counter-intuitive, 
the measurements for function and activity from the visit preceding the measurement of 
BMD change had been used in the model to allow for the delayed effects of the 
explanatory variables. As function and activity, immediately following fracture or 
surgery, were extremely low for both groups at baseline, minor variations may have 
caused aberrant results. The mitigating effect of age on bone loss in the control group at 
visit 4 is contrary to expectations, however this may be explained, in part, to sclerotic 
effects and degenerative changes in the spine associated with increasing age.  
 
The models for changes in LLTM did not produce any enlightening results. Only three 
significant explanatory variables were produced, two of which appear to conflict with 
general assumptions. An  increase in the number of co-morbidities mitigated muscle 
loss in the TKR group at visit 4 whilst an increase in pedometer steps promoted muscle 
loss in the #<3weeks group at visit 3.  Consistent with expectations, increased age of the 
fracture patients promoted bone loss at visit 4 for the #<3weeks group. 
 
Implications: 
The implications of reductions in lower-limb bone and muscle mass may be an 
increased risk of hip fracture, exacerbated by an additional risk of falls resulting from 
pain, poor postural stability and muscle weakness. As the TKR group had relatively 
high mean hip BMD at baseline, the reductions in BMD in absolute terms may not 
represent a major increase in fracture risk for the average patient, as assessed by tools 
such as FRAX that use hip BMD as a predictor. However, the disparity between TBS 
scores and BMD at the lumbar spine suggests that the high BMD in these participants 
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may not reflect bone quality and structural integrity. An equivalent of TBS is not 
currently available for use at the hip, although it is in development. If the relationship of 
TBS and BMD at the spine also applies at the hip, any reduction in hip bone quantity 
could seriously compromise bone structure and quality in that region and potentially 
exacerbate fracture risk. This potential disparity between bone quantity and quality at 
the hip is supported by the AHA results which show a significantly lower hip strength 
index, 1.33±0.3 (p=<0.01) for the TKRs, compared to 1.64±0.4 for the controls, despite 
BMD values for the TKRs being higher than the controls.  The mean values for hip 
BMD were not significantly different statistically from the control group for either TKR 
or #<3wks participants, although they appear relatively high in the TKR group. 
Participants at the lower extreme of both groups, had BMD in the osteopenic or 
osteoporotic range and many were on prescription (calcium supplements or 
bisphosphonates + supplements) at varying stages throughout the study. Whilst the 
mean absolute reduction in bone mass is relatively small, it is important to note that 
there is a correlation, for both TKR and #<3wks, between bone density at baseline and 
absolute loss of density at visit 2, r=0.26 (n.s) and r=0.57 (n.s) respectively. Participants 
with the lowest bone density at baseline lose more absolute BMD than those with high 
BMD (Fig.6.23) and therefore, in percentage terms, lose proportionately even more. 
There is an exponential relationship between BMD and fracture risk such that an 
equivalent absolute reduction in bone mass in participants with low BMD values, causes 
a proportionately greater increase in fracture risk than for a participant with higher 
BMD. Any bone loss may therefore present a substantial increase in hip fracture risk for 
participants with pre-existing low hip BMD.  Lower muscle mass has implications for 
general function, mobility and risk of falls (203, 207) that may further increase hip 
fracture risk.  As the initial reduction in muscle mass was not restored at the end of the 
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study in the TKR group, and both TKRs and #<3wks participants had lower muscle 
mass compared to the controls at visit 4, this may have an additional impact on their 
susceptibility to future hip fracture over and above any loss in hip BMD. The 
combination of reduced BMD and muscle atrophy may explain the increased incidence 
of hip fractures in the year following knee replacement reported by Prieto-Alhambra et 
al (210). Fracture risk may be further exacerbated by the high BMI of this patient 
category due to the greater impact forces on the leg bones during weight-bearing 
activity (161, 162), although obesity has been observed to have a protective effect 
against hip fracture, possibly related to reduced impact during falls from soft tissue 
padding in the hip region (269).      
 
The two fracture groups shared a trait of higher rates of previous fracture compared to 
the other two groups. The BMD results for the newly fractured group were not however 
consistent with the results from the cross-sectional study of patients who sustained their 
fractures in the recent past.  The former group had recovered losses in hip BMD by the 
end of the study reaching levels close to, or above, the contralateral leg and not 
significantly different to the controls.  In contrast, at a mean interval of 3.2±2.5 years 
after injury, the #>1yr group had significant deficits in BMD at all sites, relative to the 
controls, with the exception of the contralateral total hip, greater trochanter and femoral 
shaft. They also demonstrated significantly lower scores in all AHA parameters, on both 
ipsi- and contralateral sides. If these participants retain a long-term deficit in bone 
density on the ipsilateral side, together with reduced levels of function and activity that 
inhibit restoration of BMD, they may be at heightened risk for future fragility fractures 
at the hip. 
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Whilst the implications of bone and muscle losses are evident, the causes are less clear. 
Parameters of general function and weight-bearing were included in the modelling but 
were not shown to have statistically significant effects on bone or muscle loss. It should 
be acknowledged that the sample size used in this study is relatively small. A larger 
sample is more reliable for detecting significant associations in multiple regression, 
requiring increasing sample size for each additional predictor variable added to the 
model (271). It is therefore feasible that more of the independent variables would have 
been shown to have significant associations with the outcome variables had the sample 
size been larger; and whilst the multiple regression models are valid for the sample, they 
may not necessarily be generalisable to a population model. Although the results from 
the multiple regression analysis were far from clear or consistent, bisphosphonate use 
appeared, predictably, to be the best explanatory factor for change in BMD at the total 
hip, showing (overall) a mitigating effect on bone loss.  This supports the findings of 
Prieto-Alhambra et al (213) who demonstrated a 50-55% reduction in hip fracture 
incidence following TKR amongst participants using post-surgical bisphosphonate 
treatments. 
 
Limitations: 
As discussed in the previous chapter, the sample used in this study was 100% of white 
Caucasian ethnicity coming from a rural catchment area in the Southwest of England. 
Control participants frequently appeared to come from backgrounds of relative 
affluence and good education that are generally associated with healthier lifestyles; the 
complete absence of smokers and the high results for activity levels supported this 
assumption. Participants may not therefore be fully representative of the broader 
population. To be equivalent to the population used for the NHANES database, on 
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which DXA diagnostics are based, control participants would exhibit mean Z-scores of 
zero. However the mean Z–scores for contralateral and ipsilateral total hip BMD, and 
for lumbar spine BMD, were 0.66, 0.64 and 0.96 respectively (Table 6.4), indicating 
that they were above average in terms of densitometry results. Nevertheless, they 
represented the typical population for the catchment area of the study and were 
therefore an appropriate control for the other groups. Caution should be used however 
in generalising results to a wider population. 
 
A further limitation was the size of the #< 3 wks group. Due to recruitment difficulties, 
this group was smaller than anticipated and the analyses of results may be 
underpowered. Caution should therefore be used when interpreting results and this may 
account, in part, for the differences between this and the #>1yr group. 
 
Whilst the groups were well matched in the majority of baseline characteristics, the 
TKRs were a distinct category in terms of significantly higher BMI. There is a known 
association of BMI with BMD that may be a confounding factor, possibly accounting 
for some of the variation in BMD compared to the controls. As the study was primarily 
concerned with monitoring ‘within group’ changes, no adjustment was made for BMI. 
BMI has however been included as an independent variable in the multiple regression 
analysis to account for it as an explanatory factor. Obesity has also been shown to affect 
precision error in repeat measurements of BMD and TBS as discussed in chapter 2. The 
effects of this are most relevant for BMD measurements at the spine and are of minimal 
significance for TBS or BMD measurements of the hip. As no changes of any 
consequence occurred at the lumbar spine in any of the groups, this issue has not been 
addressed and is not thought to have affected the outcomes from the study. 
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7.6 CONCLUSION 
The consequences of immobilization, following leg fracture or surgery, were an 
immediate loss of ipsilateral bone mass at the hip. Whilst these results were not 
statistically significant for bone loss at the NOF in the #<3wks group, this lack of 
significance may be due in part to the small numbers in this group. This bone loss was 
accompanied by bilateral muscle atrophy in the case of knee replacement patients, 
associated with minor fluctuations in fat mass. Although bone losses at the total hip 
were subsequently followed by recovery in fracture patients, returning to baseline 
values, or above, at the end of one year, TKR participants continued a gradual loss over 
the following 6 months and maintained that loss one year after surgery. This pattern of 
loss and recovery was replicated in the results for leg muscle loss in the TKRS who 
completed the study with bilateral deficits in LLTM compared to their baseline 
measurements, and below the levels for the control group. The potential consequences 
of these reductions in hip BMD are an increased risk of hip fracture that may be 
exacerbated by muscle loss/weakness that could affect patients’ gait and postural 
stability thereby increasing the risk of falls. As the TKR group had relatively high mean 
hip BMD at baseline, the reductions in BMD in absolute terms may not represent a 
major increase in fracture risk as assessed by tools such as FRAX that use hip BMD as a 
predictor. However, the disparity between TBS scores and BMD at the lumbar spine 
suggests that the high BMD in these participants does not reflect bone quality and 
structural integrity; and this disparity may also be reflected in the low hip strength index 
for this group relative to their hip BMD. Although the mean reduction in bone mass was 
relatively small in absolute terms, a correlation was found, for both TKR and #<3wks 
groups, such that participants with the lowest bone density at baseline lost more 
absolute BMD than those with high BMD. The exponential relationship which exists 
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between BMD and fracture risk means that an equivalent absolute reduction in bone 
mass in participants with low BMD values, causes a proportionately greater increase in 
fracture risk than for a participant with higher BMD. Any bone loss may therefore 
present a substantial increase in hip fracture risk for participants with pre-existing low 
hip BMD.   
 
After an initial deterioration in hip BMD and general function, the newly fractured 
group demonstrated good recovery in physical and functional parameters, returning to 
levels comparable to the controls at the end of the study. These findings were not 
however supported by the results for the cross-sectional group who sustained their 
fractures at a mean interval of 3.2±2.5 years previously. This group scored significantly 
below the control group in almost all key outcomes suggesting a long-term impairment 
in function and bone health.  It is not possible to state that these impairments are 
attributable to the consequences of the fracture but these participants present as a 
distinct group compared to the controls and the #<3weeks group, and the reasons for the 
differences they exhibit may merit further investigation. The long-term deficit in hip 
bone density on the ipsilateral side, together with reduced levels of function and activity 
that inhibit restoration of BMD, may represent a heightened risk for future fragility 
fractures at the hip in this group. 
 
Results from the multiple regression analysis show that bisphosphonate use is the best 
overall predictor for change in BMD at the total hip, having a mitigating effect on bone 
loss. This suggests that prophylactic treatment may benefit patients at the highest risk of 
hip fracture. DXA screening, before surgery for TKRs or immediately following 
fracture, would be valuable to identify patients at the greatest risk for bone loss and to 
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assess the need for treatment. The #>1yr and the TKR groups had higher BMI than the 
controls, in the overweight and obese categories (as defined by the WHO criteria (254)) 
respectively, and both might benefit from exercise regimes to improve function and 
activity generally, and also encourage weight loss to reduce impact forces on the legs. 
 
 
Future work: 
As the recently fractured group used in this study was small and may have been 
influenced by selection bias, further work would be valuable to assess bone and muscle 
loss in a larger sample to confirm the validity of the results.  It would be desirable to 
follow up the current cohort of participants at a later stage, of three to five years post 
baseline, to investigate longer-term changes in BMD and any hip fracture incidence. It 
would be useful to apply the hip equivalent of TBS (if this is developed in the near 
future) to the DXA hip scan data already acquired, to see what this reveals about 
changes in the microstructural properties of trabecular bone at the proximal femur 
following disuse. 
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CHAPTER7. RESULTS – MENTAL WELLBEING AND 
ASSOCIATIONS WITH PARAMETERS OF FUNCTIONAL 
RECOVERY AND BONE QUALITY 
 
7.1 INTRODUCTION AND AIMS 
This chapter investigates the prevalence of depression and anxiety in groups of 
postmenopausal women who have had periods of immobilisation due to leg injury or surgery. 
Three groups; newly fractured patients, patients with fractures from more than one year 
previously, and total knee replacement patients are compared to an age matched control 
group. Mental wellbeing at baseline and changes over the twelve month study period are 
investigated, and associations with parameters of pain, perceived health state, activity levels, 
physical function and co-morbidities assessed.  
 
Sudden injury or the need for surgery invariably impact on patient’s lives and depending 
upon their personal circumstances (work, family commitments etc.) may cause major 
disruption to their normal activities, potentially resulting in cumulative stress beyond the 
physical pain and discomfort associated with the injury or pathology itself. Some level of 
anxiety, and a sense of loss of control, is highly probable for people who require medical 
services and/or hospitalisation (272). Participants requiring knee replacement surgery will 
have endured some degree of chronic pain and disability prior to their surgery that will have 
inevitably affected their levels of physical function and quality of life. Co-morbidities, 
reliance on medication and dependence on help from family, friends or outside sources, may 
be the cause of further distress. In many instances, people’s livelihoods are severely affected 
by limitations in their physical ability to continue their existing occupation with financial 
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implications that may further impact on their wellbeing (273). Improvement in physical 
function is often the primary measure of patient outcomes, although it is recognised that 
psychological factors also influence outcomes of TKR (274). A systematic review by Vissers 
et al (275) found strong evidence that, in short-term follow-ups of less than one year, 
postoperative function was not influenced by preoperative depression; however in long-term 
follow-up, lower preoperative mental health was associated with poorer function and pain 
scores. It is unclear whether preoperative depression and anxiety contribute to, or result from, 
knee pain (276).  Pain may persist for protracted periods after injury or surgery.  A study of 
632 TKR patients by Wylde et al (109) found that, 3-4 years after surgery, 44% of patients 
experienced persistent pain of a varying degree of severity, with 15% suffering severe or 
extreme pain. In the latter group, an association was found between major depression, 
additional pain problems elsewhere and post-surgical pain.  Depression and anxiety are 
common in the general population and may be particularly prevalent in the age group 
represented in this study due to physiological and sociological factors associated with 
menopause, aging and declining health (277). By comparing the prevalence of depression and 
anxiety in the patient groups to the controls, information is sought to establish the additional 
impact of injury or surgery on mental wellbeing and the associations of mental health with 
physical and functional recovery rates. 
In addition to the effects of depression and anxiety on functional recovery after injury or 
surgery, depression is a condition that is significantly associated with low BMD (101-103). 
The reasons for this association are highly complex involving a number of factors 
independent of the effects of reduced weight-bearing activity that result from limited function 
and activity. Depression may cause a number of behavioural responses which are risk factors 
for secondary osteoporosis e.g. increased smoking or alcohol consumption, poor diet and a 
more sedentary lifestyle that may limit exposure to sunlight with consequent reduction in  
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vitamin D levels (105). Changes in the bone remodelling balance may be attributable in part 
to hormonal changes during depressive episodes including increased plasma cortisol levels 
resulting from stress (106). Pharmacological treatments for depression, i.e. selective serotonin 
reuptake inhibitors (SSRIs), have also been shown to contribute to reduced BMD due to their 
action on the seratonin system, which is thought to have a regulatory effect on bone mass 
(104, 105).  
The effects of pain and post-surgical nerve damage and their implications for bone loss are 
discussed in Chapter 1 section 1.3.3. As both pain and depression have been demonstrated to 
be significant problems for patients following injury or surgery, these factors merit further 
investigation to assess their impact on bone loss and fragility.  
 
 
7.2 OBJECTIVES 
 
This chapter investigates: 
 Differences between groups, at baseline and during recovery in: 
 Levels of depression and anxiety measured by PHQ-9 and GAD-7 questionnaires. 
 Rates of clinical levels of depression & anxiety assessed by scores of PHQ-9>9 
and GAD-7>7. 
 Associations between depression & anxiety and parameters of functional recovery. 
 Associations between depression & anxiety and bone loss at the ipsilateral total hip. 
 Differences in recovery between participants with sub-clinical levels of depression or 
anxiety and those with clinical levels will be considered. 
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7.3 BRIEF METHODS AND & STATISTICS 
The methods are described in detail in Chapter 2, section 2.2.3. Statistical methods are 
described in Chapter 2, section 2.3.4. 
Data were analysed for all participants who completed the 1 year study. Analysis of 
subgroups was based on participants with sub-clinical levels of depression or anxiety and 
those with clinical levels. These groups were classified by the following thresholds (278): 
PHQ-9 scores above 9 are considered to represent clinical level depression. 
GAD-7 scores above 7 are considered to represent clinical level anxiety. 
 
7.4 RESULTS  
 
7.4.1 DESCRIPTIVES 
Participant characteristics and results for parameters of physical, functional, emotional 
recovery and densitometry are reported in chapters 5 and 6, Tables 5.1, 5.3, 5.6, 5.7, 5.8, 6.2 
and 6.3. 
 
7.4.2 CHANGES IN DEPRESSION SCORES OVER 1 YEAR - PHQ-9 
Figure 7.1 shows the changes in depression scores, assessed by the PHQ-9 questionnaire over 
the twelve month study period, expressed as medians/inter-quartile range. The maximum 
possible score for the PHQ-9 is 27. Significances of differences between groups and of 
changes within groups over the study period are recorded in Chapter 5, Table 5.8; and 
reported in the following text where appropriate.  
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The scores at baseline were highest in the TKR, #>1yr and #<3wks groups, 4.0 and 2.5 and 
2.0 respectively, compared to 1.0 in the control group.  Differences across the groups were 
not statistically significant at the 0.05 level using Fisher’s exact test for non-parametric data. 
The control group started the study at low levels of depression and remained stable over the 
course of one year. Median depression worsened in the TKR and #<3wks groups at the 6 
week visit with PHQ-9 scores increasing to 6.0 (n.s) and 3.0 (n.s) respectively. These scores 
declined as the study progressed and the TKRs completed visit 4 at a level significantly 
below their baseline (3, p=<0.05) but remaining higher than the controls (n.s) and the #<3wks 
group. 
 
Figure 7.2 shows the changes in depression level of difficulty scores, assessed by the PHQ-9 
questionnaire over the twelve month study period, expressed as medians/inter-quartile range.  
Figure 7.1. Changes in PHQ-9 Total Scores
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The significance of differences between groups and in changes over the study period is 
recorded in Chapter 5, Table 5.8; and reported in the following text where appropriate. 
Participants were asked to rate the extent to which their experience of depression affected 
their lives in terms of difficulty. A score of zero = no depression reported, 1= depression but 
not causing any difficulty, 2= depression causing some difficulty, 3= depression causing 
substantial difficulty and 4= depression causing extreme difficulty.  
 
 
 
 
 
 
 
 
 
 
 
 
Despite the differential in the depression scores between groups at baseline, the median 
difficulty scores were low, and the same for all groups (1.0, n.s).  Although difficulty 
increased initially for the TKR group, this returned to the same levels as the other groups at 
the 6 month visit. 
 
 
Figure 7.2. Changes in PHQ-9 Difficulty Scores
Interval (weeks)
0 10 20 30 40 50 60
Sc
o
re
 (
M
ed
ia
n
/i
n
te
rq
u
ar
ti
le
 r
an
ge
)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
Controls
TKR
#<3 weeks
#>1 year
Chapter 7 
[229] 
 
 
Figures 7.3 to 7.11 show the depression scores and changes over the study period for the 
individual domains of the PHQ-9 questionnaire (questions 1-9) expressed as 
median/interquartile range. The score for each domain ranges from 0 to 3.  
 
Question 1: Interest and pleasure in doing things.  
 
 
Question 2: Feeling down, depressed or hopeless. 
 
 
Question 3: Trouble with sleep  
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Question 4:  Feeling tired or having little energy 
 
 
 
 
 
 
Question 5: Poor appetite or overeating. 
 
 
 
 
 
Question 6: Feeling bad about oneself or that one is a failure or has let one’s family down 
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Question 7: Trouble concentrating. 
 
 
 
 
 
 
 
Question 8: Slowness in speech or movement, or restlessness. 
 
 
 
 
 
 
 
Question 9:  Thoughts that one would better off dead or hurting oneself. 
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The results for the individual domains of the PHQ-9 questionnaire demonstrate that the 
highest scores for all groups at baseline related to trouble sleeping together with feelings of 
tiredness and lack of energy; the highest scores were in the TKR group. The Pearson 
correlation for pain and sleep problems, for the entire study population at the baseline visit, 
was r=18.9%, n.s. The longitudinal pattern of initial deterioration and subsequent recovery 
demonstrated for the PHQ-9 total scores was also reflected (overall) in the individual 
domains. 
 
7.4.3 CHANGES IN ANXIETY SCORES OVER 1 YEAR - GAD-7 
Figure 7.12 shows the changes in anxiety scores, assessed by the GAD-7 questionnaire over 
the twelve month study period expressed as median/interquartile range. The maximum 
possible score for the GAD-7 is 21. The significance of differences between groups and in 
changes over the study period is recorded in Chapter 5, Table 5.8; and reported in the 
following text where appropriate. 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.12. Changes in GAD-7 Total Scores
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The GAD-7 total scores at baseline were highest in the TKR group (2.0, n.s), but the same for 
the remaining groups (1.0, n.s).  Median anxiety scores were lower than depression scores for 
all groups at the outset of the study and changes throughout the year were not statistically 
significant. 
 
 
Figure 7.13 shows the changes in anxiety level of difficulty scores, assessed by the GAD-7 
questionnaire over the twelve month study period, expressed as median/interquartile range. 
The significance of differences between groups and in changes over the study period is 
recorded in Chapter 5, Table 5.8; and reported in the following text where appropriate. 
Participants were asked to rate the extent to which their experience of anxiety affected their 
lives in terms of difficulty. A score of zero = no anxiety reported, 1= anxious but not causing 
any difficulty, 2= anxiety causing some difficulty, 3= anxiety causing substantial difficulty 
and 4= anxiety causing extreme difficulty. 
 
 
 
 
 
 
 
 
 
 
Figure 7.13. Changes in GAD-7 Difficulty Scores
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The median scores for difficulty associated with symptoms of anxiety, were low at baseline 
and the same for all groups (1.0, n.s); scores did not change significantly throughout the one 
year period. 
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Figures 7.14 to 7.20 show the anxiety scores and changes over the study period for the 
individual domains of the GAD-7 questionnaire (questions 1-7) expressed as 
median/interquartile range. The score for each domain ranges from 0 to 3.  
 
 
 
 
 
 
Question 2:  Not being able to  
stop or control worrying. 
 
Question 3:  Worrying too much  
about different things. 
 
Question 4: Trouble relaxing. 
Question 1:  Feeling nervous,  
anxious or on edge. 
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The results for the individual domains of the GAD-7 questionnaire demonstrate comparable 
scores for all aspects of anxiety, although relatively minimal with regard to “feeling afraid as 
if something awful might happen”. 
 
 
Question 5: Being so restless that 
 it’s hard to sit still. 
Question 6: Becoming easily annoyed 
or irritated. 
Question 7: Feeling afraid as if 
something awful might happen. 
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7.4.4 RELATIONSHIP BETWEEN DEPRESSION AND PARAMETERS OF 
PHYSICAL AND FUNCTIONAL RECOVERY  
Stepwise multiple regression analysis was performed to create a model of significant 
explanatory factors for depression as the dependent variable at each time point during 
the study, baseline (visit 1), 6 weeks (visit 2), 6 months (visit 3) and 1year (visit 4). The 
independent variables added into the model were: 
GAD7 Total score 
EQ5D Health state VAS  
Age  
Pain VAS  
LEFS Score  
Pedometer average steps per day 
Number of falls in the preceding 6 months (or since last visit)  
Total of all co-morbidities  
BMI 
 
The resulting model summaries for each time point are shown in Tables 7.1 to 7.5 and 
reported below:  
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VISIT 1 
 
Table 7.1.  Model Summary: Dependent variable – PHQ-9 Depression score at visit 1 
  
Group Model R R Square Adjusted R Square 
 
 Controls   1 .687a 0.472 0.457 
 TKR   1 .820a 0.673 0.651 
 
#<3wks   
1 .864b 0.747 0.711 
 2 .967c 0.936 0.914 
 
#>1yr   
1 .870a 0.757 0.743 
 2 .928d 0.861 0.845 
 a. Predictors: (Constant), GAD-7 Total score 1 
b. Predictors: (Constant), EQ-5DHealth state VAS 1 
c. Predictors: (Constant), EQ-5DHealth state VAS 1, Pedometer Average visit 1 
d. Predictors: (Constant), GAD-7 Total score 1, Previous falls (not including baseline injury)  
 
 
Controls: Model 1 was an acceptable fit describing 47.2% of variance in the PHQ-9 
depression score at visit 1 (R
2
adj= 45.7%), statistical significance F1,17= 33.02,  p=0.000. 
With other variables held constant, depression score at visit 1 was positively related to 
GAD-7 anxiety scores at visit 1, increasing by 0.895 points for every extra anxiety point 
(t=5.75, p=0.000). 
Depression =  0.508 + 0.895 anxiety          (Eq.7.1)   
TKR: Model 1 was a good fit describing 67.3% of variance in the PHQ-9 depression 
score at visit 1 (R
2
adj= 65.1%), statistical significance F1,15= 30.81,  p=0.000. With other 
variables held constant, depression score at visit 1 was positively related to GAD-7 
anxiety scores at visit 1, increasing by 1.068 points for every extra anxiety point 
(t=5.55, p=0.000).  
Depression = 1.420 + 1.068 anxiety          (Eq.7.2)   
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#<3 weeks: Model 2 was a very good fit describing 93.6% of variance in the PHQ-9 
depression score at visit 1 (R
2
adj= 91.4%), statistical significance F2,6= 43.54, p=0.000. 
With other variables held constant, depression score at visit 1 was negatively related to 
the EQ5D health score at visit 1 decreasing by 0.126 points for every extra health score 
point at visit 1 (t= -4.91, p=0.003), and positively related to average daily pedometer 
scores at visit 1, increasing by .002 points for every extra step (t=4.19, p=0.006). 
Depression =  9.112 – 0.126 health state + 0.002 pedometer steps         (Eq.7.3)   
#>1yr: Model 2 was a very good fit describing 86.1% of variance in the PHQ-9 
depression score at visit 1 (R
2
adj= 91.4%), statistical significance F2,17= 52.62, p=0.000. 
With other variables held constant, depression score at visit 1 was positively related to 
the GAD-7 anxiety score  and the total of previous falls in the previous 6 months, 
increasing by 1.006 points for every extra  anxiety point at visit 1 (t= -9.38, p=0.000), 
and by 2.509 points for every extra fall (t=3.57, p=0.002). 
Depression =  0.601 + 1.006 anxiety + 2.509 falls          (Eq.7.4)   
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VISIT 2 
 
Table 7.2.  Model Summary: Dependent variable – PHQ-9 Depression score at visit 2 
 
Group Model R R Square 
Adjusted R 
Square  
 
TKR   
1 .636a 0.404 0.369 
 2 .764b 0.584 0.532 
 
#<3wks   
1 .891c 0.793 0.764 
 2 .952d 0.907 0.875 
 a. Predictors: (Constant), GAD-7 Total score 2 
b. Predictors: (Constant), GAD-7 Total score 2, Pain VAS 2 
c. Predictors: (Constant), LEFS Score 2 
d. Predictors: (Constant), LEFS Score 2, Total all comorbidities   
 
Controls: Not applicable. 
TKR: Model 2 was a good fit describing 58.4% of variance in the PHQ-9 depression 
score at visit 2 (R
2
adj= 53.2%), statistical significance F2.16= 11.23,  p=0.001. With other 
variables held constant, depression score at visit 2 was positively related to GAD-7 
anxiety score and pain score a visit 2, increasing by 1.140 points for every extra anxiety 
point (t=4.44, p=0.000) and 0.088 points for every extra pain score point (t=2.63, 
p=0.018). 
Depression =  -0.119 +1.140 anxiety + 0.88 pain          (Eq.7.5)   
#<3 weeks: Model 2 was a very good fit describing 90.7% of variance in the PHQ-9 
depression score at visit 2 (R
2
adj= 87.5%), statistical significance F2.6= 29.11,  p=0.001. 
With other variables held constant, depression score at visit 2 was negatively related to 
LEFS at visit 2 and total co-morbidities, decreasing by 0.111 points for every extra 
LEFS point (t= -7.50, p=0.000) and 0.716 points for every extra co-morbidity (t=2.70, 
p=0.036). 
Depression = 7.831 – 0.111 LEFS – 0.716 co-morbidities          (Eq.7.6)   
#>1yr: Not applicable. 
Chapter 7 
[241] 
 
 
VISIT 3 
 
Table 7.3.  Model Summary: Dependent variable – PHQ-9 Depression score at visit 3 
Group Model 
R R Square 
Adjusted R 
Square 
Controls   1 .613
a .375 .359 
TKR 
  
1 .784b .615 .592 
2 .871c .759 .729 
#<3wks   1 .757
d .573 .512 
a. Predictors: (Constant), GAD-7 Total score 3 
b. Predictors: (Constant), EQ-5DHealth state VAS 3 
c. Predictors: (Constant), EQ-5DHealth state VAS 3, TOTAL ALL comorbidities 
d. Predictors: (Constant), Falls 3  coded 
 
 
Controls: Model 1 was an acceptable fit describing 37.5% of variance in the PHQ-9 
depression score at visit 3 (R
2
adj= 35.90%), statistical significance F1,39= 23.439,  
p=0.000. With other variables held constant, depression score at visit 3 was positively 
related to anxiety, increasing by 0.816 points for every extra GAD-7 point (t=4.84, 
p=0.000). 
Depression =  1.195 + 0.816 anxiety          (Eq.7.7)   
 
TKR: Model 2 was a very good fit describing 75.9% of variance in the PHQ-9 
depression score at visit 3 (R
2
adj= 72.9%), statistical significance F2,16= 25.182, p=0.000. 
With other variables held constant, depression score at visit 3 was positively related to 
total number of all co-morbidities increasing by 1.331 points for every extra co-
morbidity (t= 3.10, p=0.007), and negatively related to  EQ5D health scores at visit 3, 
decreasing by 0.201 points for every extra health point (t= -6.030, p=0.000). 
Depression =  16.192 + 1.331 co-morbidity – 0.201 health state          (Eq.7.8)   
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#<3 weeks: Model 1 was a good fit describing 57.3% of variance in the PHQ-9 
depression score at visit 3 (R
2
adj= 52.1%), statistical significance F1.7= 9.389, p=0.018. 
With other variables held constant, depression score at visit 3 was positively related to 
number of falls in the previous 6 months increasing by 5.875points for each extra fall 
(t= 3.06, p=0.018).  
Depression =  2.125 + 5.875 falls           (Eq.7.9)   
 
#>1yr: Not applicable. 
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VISIT 4 
 
Table 7.4.  Model Summary: Dependent variable – PHQ-9 Depression score at visit 4 
 
Group Model R R Square Adjusted R Square 
 
 
Controls   
1 .592a 0.35 0.332 
 2 .705b 0.498 0.47 
 3 .750c 0.562 0.524 
 
TKR   
1 .801a 0.642 0.609 
 2 .874d 0.764 0.717 
 #<3wks   1 .968a 0.938 0.929 
 a. Predictors: (Constant), GAD-7 Total score 4 
b. Predictors: (Constant), GAD-7 Total score 4, Age  
c. Predictors: (Constant), GAD-7 Total score 4, Age, EQ-5DHealth state VAS 4 
d. Predictors: (Constant), GAD-7 Total score 4, EQ-5DHealth state VAS 4 
 
Controls: Model 3 was a good fit describing 56.2% of variance in the PHQ-9 
depression score at visit 4 (R
2
adj= 52.4%), statistical significance F3.35= 14.965, p=0.000. 
With other variables held constant, depression score at visit 4 was positively related to 
GAD-7 anxiety score at visit 4 and age,  increasing by 0.820 points for each extra  Gad-
7 point (t= 4.99, p=0.000)  and by 0.176 points for each extra year in age (t= 3.32, 
p=0.002) .  It was negatively related to EQ5D health score at visit 4 decreasing by 0.71 
points for every extra health point (t= -2.27, p=0.030).  
Depression =  4.009 + 0.820 anxiety + 0.176 age – 0.71 health state          (Eq.7.10)   
TKR: Model 2 was a very good fit describing 76.4% of variance in the PHQ-9 
depression score at visit 4 (R
2
adj= 71.7%), statistical significance F2,10= 16.19, p=0.001. 
With other variables held constant, depression score at visit 4 was positively related to  
GAD-7 anxiety score at visit 4 increasing by 0.329 points for every extra GAD-7 point 
(t= 3.47, p=0.006).  It was negatively related to EQ5D health scores at visit 4, 
decreasing by 0.098 points for every extra health point (t= -2.28, p=0.046). 
Depression =  10.120 + 0.329 anxiety – 0.098 health state          (Eq.7.11)   
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#<3 weeks: Model 1 was a very good fit describing 93.8% of variance in the PHQ-9 
depression score at visit 4 (R
2
adj= 92.9%), statistical significance F1,7= 105.41, p=0.000. 
With other variables held constant, depression score at visit 4 was positively related to 
GAD-7 anxiety score at visit 4 increasing by 1.714 points for every extra GAD-7 point 
(t= 10.27, p=0.000).   
Depression =  0.429 + 1.714 anxiety           (Eq.7.12)   
#>1yr: Not applicable. 
 
 
 
 
 
 
Table 7.5.  Simplified summary of multiple regression analysis 
Significant explanatory factors (from same visit) for Depression (PHQ-9 score)   
  Controls TKR #<3 wks #>1yr 
Visit 1 ↑ GAD-7 anxiety ↑ GAD-7 anxiety ↓ EQ5D health 
↑ GAD-7 
anxiety 
   
↑ pedometer ↑ previous falls 
       
Visit 2 
 
↑ pain ↓ LEFS 
 
  
↑ GAD-7 anxiety ↓ co-morbidities  
        
Visit 3 ↑ GAD-7 anxiety  ↑ co-morbidities  ↑ previous falls  
 
  
↓ EQ5D health 
 
     
 
 
Visit 4 ↑ GAD-7 anxiety ↑ GAD-7 anxiety 
 
 
↑ age ↓ EQ5D health 
 
 
↓ EQ5D health 
  ↑ indicates an  increase in PHQ-9 score, i.e. decline in depression state, as the score for the independent 
variable increases 
↓ indicates decrease in PHQ-9 score i.e. improvement in depression state, as the score for the independent 
variable increases 
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7.4.5 RELATIONSHIP BETWEEN BONE AND LOSS AND DEPRESSION 
Stepwise multiple regression analysis was performed to assess the contribution of 
depression and anxiety variables to bone loss at the total hip region as the dependent 
variable, at three time points during recovery, 6 weeks (visit2), 6 months (visit 3) and 1 
year (visit 4). Bone loss at this site was selected as it demonstrated significant change in 
the TKR group.  Although it was expected that there would be some delayed effect on 
bone loss resulting from depression and anxiety, this has been considered in chapter 6; 
the independent variables from the same time point as measures of the dependent 
variable were therefore used in the following models. The independent variables added 
into the model were: 
PHQ9 Total score 
GAD7 Total score 
 
The resulting model summaries for each visit are shown in Tables 7.6 to 7.8 and 
reported below:  
 
VISIT 2 
 
Table 7.6.  Model Summary: Dependent variable - Changes in BMD at the ipsilateral total hip  at visit 2 
Group Model R R Square Adjusted R Square 
#<3wks   1 .819a 0.67 0.623 
a. Predictors: (Constant), PHQ-9Total score 2 
 
 
Controls: Not applicable. 
TKR: No significant independent variables found. 
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#<3 weeks: Model 1 was a good fit describing 67.0% of variance in change in total hip 
BMD at visit 2 (R
2
adj= 62.3%), statistical significance F1,7= 14.22,  p=0.007. With other 
variables held constant, change in total hip BMD at visit 2 was negatively related to 
PHQ-9 depression score at visit 2, decreasing by 0.009 g/cm
2
 for every extra PHQ-9 
point (t= -3.77, p=0.007). 
Change in ipsi total hip BMD = 0.012 – 0.009 depression          (Eq.7.13)   
#>1yr: Not applicable. 
 
 
VISIT 3 
 
Table 7.7.  Model Summary: Dependent variable - Changes in BMD at the ipsilateral total hip  at visit 3 
Group Model 
R R Square Adjusted R Square 
Controls   1 .368
a .135 .114 
#<3wks   1 .845
b .714 .673 
a. Predictors: (Constant), PHQ-9Total score 3     
b. Predictors: (Constant), GAD-7 Total score 3  
 
 
 
Controls: Model 1 was a very poor fit describing only 13.5% of variance in change in 
total hip BMD at visit 3 (R
2
adj= 11.4%), statistical significance F1,41= 6.42,  p=0.015. 
With other variables held constant, change in total hip BMD at visit 3 was positively 
related to PHQ-9 depression score at visit 3, increasing by 0.002 g/cm
2
 for every extra 
PHQ-9 point (t= 2.53, p=0.015). 
Change in total hip BMD =  -0.006 + .002 depression          (Eq.7.14)   
TKR: No significant independent variables found. 
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#<3 weeks: Model 1 was a very good fit describing only 71.4% of variance in change in 
total hip BMD at visit 3 (R
2
adj= 67.3%), statistical significance F1,7= 17.44,  p=0.004. 
With other variables held constant, change in total hip BMD at visit 3 was negatively 
related to anxiety at visit 3, decreasing by 0.012 g/cm
2
 for every extra GAD-7point (t= -
4.18, p=0.004). 
Change in total hip BMD = 0.017 – 0.012 anxiety          (Eq.7.15)   
 
#>1yr: Not applicable. 
 
 
VISIT 4 
 
Controls: No significant independent variables found. 
TKR: No significant independent variables found. 
#<3 weeks: No significant independent variables found. 
#>1yr: Not applicable. 
 
 
Table 7.8.  Simplified summary of multiple regression analysis 
Significant explanatory factors (from same visit) for change in BMD at the ipsilateral total 
hip 
  
  Controls TKR #<3 wks #>1yr 
 Visit 1 
                   
Visit 2 
  
↓ PHQ-9 depression   
               
Visit 3 ↑ PHQ-9 depression   ↓ GAD-7 anxiety 
                
Visit 4 
              ↑ indicates mitigation of  BMD loss at the ipsilateral total hip as the score for the independent variable 
increases 
↓ indicate promotion of  BMD loss at the ipsilateral total hip as the score for the independent variable 
increases 
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7.4.6 SUBGROUP ANALYSIS OF PARTICIPANTS WITH CLINICAL LEVELS OF 
DEPRESSION AND ANXIETY  
As the medians for all groups in depression and anxiety scores were below the levels 
that would be considered to be of clinical importance, i.e. scores below 9 for PHQ-9 and 
below 7 for GAD-7, it was considered worthwhile to investigate the prevalence of 
clinical depression and anxiety in the groups, and to consider if there were any notable 
differences in the subgroups for relationships between BMD changes and depression. 
 
Figures 7.21 and 7.22 show the percentage of each participant group with depression 
and anxiety scores at clinical levels, at each stage of the study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
At all stages of the study, prevalence of clinical depression and anxiety are highest in 
the TKR group, with the exception of visit 1 when the #<3wks group is slightly higher 
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at 22.2% of the group compared to 21.2% of TKRs. All groups were substantially 
higher than the controls at baseline (2.3% of group). There were no #<3wks participants 
with clinical depression or anxiety after the baseline visit. The #>1yr group had a high 
incidence of both depression and anxiety relative to the controls, 16.8% v 2.3% for 
clinical depression and 12.6% v. 2.3% for clinical anxiety. 
 
 
Table 7.9  Participants on antidepressant medication at baseline - visit 1 
Controls n=43 TKR n=19 #<3wks n=9 #>1yr n=24 
  3       0      0      0   
 
 
Table 7.9 shows that only 3 participants on the study, all in the control group, were on 
anti-depressant medication.  
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Figures 7.23 to 7.25 show the relationship between PHQ-9 depression scores and 
changes in BMD at the ipsilateral total hip, in categories of TKR participants with 
subclinical and clinical levels of depression, at visits 2, 3 and 4. No differences are 
apparent at any of the visits, between the groups ‘above’ and ‘below’ the clinical 
depression thresholds. 
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Figure 7.23. Correlation at Visit 2 between depression 
scores and change from baseline in BMD at ipsilateral 
Total Hip
TKR PHQ >9 TKR PHQ9 <10
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Figure 7.24. Correlation at Visit 3 between depression 
scores and change from baseline in BMD at ipsilateral 
Total Hip
TKR PHQ >9 TKR PHQ9 <10
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Figure 7.25. Correlation at Visit 4 between depression 
scores and change from baseline in BMD at ipsilateral 
Total Hip
TKR PHQ >9 TKR PHQ9 <10
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7.5 DISCUSSION 
 
Baseline differences between groups and longitudinal changes: 
The results (Fig. 7.1) demonstrate that, although differences were not statistically 
significant between the groups, depression levels at baseline were highest in the TKR 
group, and that the #>1yr and #<3wks groups were both relatively high compared to the 
controls. Nevertheless the level of difficulty caused to participants, in their general life, 
by their depressive symptoms was low, and similar for all groups (Fig. 7.2). The highest 
scores for all groups at baseline related to trouble sleeping, feelings of tiredness and 
lack of energy, with the highest scores demonstrated in the TKR group.  
Whilst highest in the TKR group, the scores for anxiety at baseline were low and at a 
comparable level for the remaining groups. The levels of difficulty, caused to 
participants by their symptoms of anxiety, were the same for all groups (Fig 7.13). The 
higher anxiety scores for the knee replacement patients may, in part, reflect the 
anticipation of imminent surgery and hospitalization together with ongoing concerns 
about their recovery. Despite this, scores for question 7, “feeling afraid as if something 
awful might happen”, were low compared to all other domains of the GAD-7 
questionnaire and it is inferred that participants did not suffer any undue sense of fear 
about the outcomes of their surgery. 
Whilst the median depression scores worsened in the TKR and #<3wks groups at the 6 
week visit, these scores declined again as the study progressed suggesting an overall 
improvement as patients started to recover physically and functionally. However, 
although the TKRs completed visit 4 at a level significantly below their baseline, their 
depression scores remained higher than the controls and the #<3wks group, indicating 
that recovery in terms of mental well-being was not complete. The patterns of initial 
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deterioration and subsequent recovery in depression scores were reflected (overall) in 
the individual domains for the PHQ-9 questionnaire but problems relating to sleep and 
tiredness, whilst improved, were unresolved for the TKRs in particular, remaining 
higher than for the other groups at the end of the study. Problems with sleep correlated 
poorly with pain and were not statistically significant.  
 
Clinical levels of depression and anxiety: 
Although the medians for all groups in depression and anxiety scores were below the 
levels that would be considered to be of clinical importance, an analysis of subgroups 
with scores above 9 for PHQ-9 and above 7 for GAD-7, (Figures 7.21 and 7.22) showed 
a higher prevalence of clinical depression and anxiety at baseline in all patient groups 
compared to the controls. This situation did not pertain for the #<3wks group beyond 
the first visit but rates of clinical level depression remained high for the TKR group 
throughout the study. Although numerous participants would meet the criteria for 
clinical level depressive symptoms using the thresholds above, only 3 participants on 
the study (table 7.9), all in the control group, were on anti-depressant medication. The 
limited numbers of participants on medication suggests that clinical depression, in the 
study groups, may be clinically under-diagnosed.  
 
Thus far, a picture emerges of generally poorer mental wellbeing in the TKR group. 
This result might reasonably be expected as it is associated with poor rates of physical 
recovery compared to the newly fractured patients. The reasons for relatively high rates 
of depression in the #>1yr group are however less obvious but may be associated with 
the significantly poorer levels of function and activity compared to controls, as 
discussed in chapter 5. 
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Relationship between depression and parameters of physical and functional recovery: 
As anticipated, results from the multiple regression analysis (Table 7.5) demonstrated 
significant relationships between anxiety and depression with a worsening in depression 
as anxiety increases. This relationship was evident for all groups, and at different stages 
of the study, with the exception of the #<3wks group. A less obvious association 
emerged between depression and previous experience of falls in the #<3wks and #>1yr 
groups. This may involve a complex relationship between depression, poor physical 
function and fear of falling (265). Pain was a significant factor only for the TKR group 
at visit 2, alongside a higher number of co-morbidities at visit 3 and reduced perceptions 
of health at visits 3 and 4. Health state was also a significant factor for the controls and 
#<3wks groups with worsening depression associated with poorer scores for perceived 
health state. Increased age was only an explanatory factor for depression in the controls 
at visit 4. The #<3wks group demonstrated worsening depression with lower pedometer 
scores at visit 1 and with reduced function scores at visit 2 suggesting that their 
depression was significantly related to their inability to perform their normal activities 
early on in their recovery. As many in this group were in employment, these functional 
problems may have been the cause of greater difficulty than for the TKRs for whom 
these factors did not appear to be significant. The TKRs would have already been 
experiencing long-term impairment in their function and activity prior to surgery and 
may therefore have become more accustomed to their functional limitations, adapting 
their lifestyles accordingly. The only counter-intuitive relationship that was revealed in 
the modelling was an improvement in depression with a higher number of co-
morbidities in the #<3wk group at visit 2.  
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Relationship between bone loss and depression: 
Depression and anxiety were included as independent variables in a multiple regression 
analysis, reported in chapter 6, with changes in BMD at the ipsilateral total hip as the 
dependent variable. In that analysis, independent variables were used from the visit 
preceding the measurement of BMD change to allow for delayed effects on potential 
bone loss. It did not reveal any significant relationships of BMD change with 
depression, and showed only one significant relationship with anxiety in the #<3wks 
group, for whom bone loss was mitigated at visit 4 as anxiety reduced at visit 3. The 
results in Table 7.8 report the analysis using depression and anxiety scores from the 
same visit as the bone change measurements and showed a significant association of 
depression and anxiety with bone change at visits 2 and 3 respectively for the #<3wks 
group, whereby bone loss was promoted by an increase in depression and anxiety 
scores. Although this relationship was reversed in the result for the control group at visit 
3,  this is nonetheless an interesting result in relation to previous studies which observe 
an association between depression, decreased BMD and increased fracture risk (101, 
105, 279) The sub-analysis  of participants with clinical levels of depression (Figs 7.23 
to 7.25) show the rates of bone loss, in the TKR group, at the ipsilateral total hip (at 
visits 2, 3 and 4) as depression scores increase. No differences, at any of the visits, 
between the ‘above’ and ‘below’ clinical depression groups are apparent; however 
caution should be used in interpreting results from such small samples. 
 
Implications: 
It is arguable that, notwithstanding any possible effects of depression on bone loss, 
psychological recovery from the trauma of injury or surgery is as important as physical 
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and functional recovery.  The interaction of the variables in recovery (pain, function, 
activity etc.) is complex; depression and anxiety may be either the cause or the result of 
pain and poor physical or functional outcomes. Depression and anxiety can have a 
major impact on a patient’s quality of life; and mental wellbeing should be considered 
as both an explanatory variable for physical outcomes and as an outcome measure in its 
own right.   
The control group exhibited substantially lower mean scores for both depression and 
anxiety compared to the other groups at baseline and this was consistent for the 
remainder of the study.  How well this reflects depression and anxiety in the wider 
population has not been evaluated and it may be that a bias in research volunteers to 
have a higher socio-economic status and a better general health background, has 
influenced the results for this group. Whilst highest in the TKR group, anxiety scores 
were lower than depression scores for all groups throughout the study. For all groups, 
the greatest contribution to depression scores was due to sleep problems and tiredness. 
There are interesting disparities between the #<3wks and #>1yr groups. The #<3wks 
group had higher levels of depression and anxiety than the controls at the outset of the 
study, particularly at their 6 week visit, but recovered to the same levels as the controls, 
or below, at the finish, suggesting that their symptoms of depression and anxiety were 
largely related to their poorer physical condition and reduced function levels 
immediately following injury. This is supported by the results of the multiple regression 
analysis which demonstrated an increase in depression as pedometer scores reduced at 
visit 1 and as function scores reduced at visit 2. A very different picture emerged for the 
#>1yr who, alongside poorer results for physical and functional parameters discussed in 
chapters 5 and 6, also demonstrated higher levels of depression than either the #<3wks 
group or the controls at the same time point. The multiple regression analysis 
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demonstrated that this was associated with anxiety and a previous history of more falls. 
An increased number of falls in the previous 6 months was also a significant 
explanatory factor for depression in the #<3wk group at visit 3 and it is possible that 
this relates to a complex relationship between depression, poor physical function and 
fear of falling (265) For newly fractured patients, there is little that can be changed in 
the early stages to improve their functional recovery during the process of fracture 
healing and reduced weight-bearing, therefore the inevitable frustrations of limited 
function and activity are unavoidable. As pain does not appear to contribute 
significantly to depression in this group and most participants are well medicated 
following injury, there may be limited potential to improve the patient experience in this 
group other than possibly offering some aids to sleep alongside appropriate exercise 
strategies, following fracture healing, to improve muscle strength and stability thereby 
aiding avoidance of falls. 
 
The results for the TKR group demonstrated higher levels of depression and anxiety 
throughout the study (except for visit 3) and although they showed significant 
improvement from their baseline scores, they did not return to control levels at the final 
visit. Clinical levels of depression and anxiety were also highest in this group 
throughout the study. Results from the multiple regression analysis indicate that 
depression in this group was significantly associated with pain, poor perceptions of 
health, a higher number of co-morbidities and anxiety. It is possible that the patient 
experience and clinical outcomes for the TKR group could be considerably improved. 
Although there is service provision in the form of advice, physiotherapy and supervised 
exercise classes, both before and after surgery, the interventions offered to individuals 
(in the setting of this study) are very inconsistent and the expectations of different 
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patients, with regard to the speed and extent of their recovery, were very varied.  
Despite a reluctance of many patients to rely on drugs, improvements in pain levels or 
sleep problems could be achieved by encouraging adherence to medications or offering 
alternative, non-pharmaceutical therapies. Depression and anxiety have been identified 
to have a high incidence in 1,212,413 patients undergoing total joint arthroplasty in the 
United States between the years of 2000 and 2008. More than one in fourteen  patients 
had a diagnosis of depression, anxiety or both which were associated with higher 
healthcare costs and resources (107). A small scale study by Caracciolo and Giaquinto 
(280), including thirty-six TKR patients, showed that 58% were above the  Hospital 
Anxiety and Depression (HAD) threshold and that psychological distress and 
depression were significantly associated with reduced functional rehabilitation. These 
studies are consistent with the high incidence of clinical levels of depression and 
anxiety found in the TKR group from this study, and suggests that a formal assessment 
for these conditions is indicated whereby patients could benefit from advice or 
counseling to alleviate their symptoms and potentially improve functional recovery. As 
the potential for anti-depressant drugs to exacerbate bone loss is a subject of ongoing 
research, the use of these treatments in this group should be considered with caution. In 
every regard, patients might benefit from group interventions. Group exercise classes 
could be a cost-effective option for healthcare services, benefiting patients by improving 
their function and activity levels whilst also encouraging weight loss. As some 
association has been shown between bone loss and depression, social networks forged 
through these groups may afford peer support to aid mental wellbeing and could help 
patients to have more realistic expectations for their progress in recovery. As use of 
antidepressant drugs is also thought to be associated with bone loss, opportunities for 
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peer support or counseling, to avoid the need for pharmaceutical interventions, might 
also prove valuable in prevention of future hip fractures in these patients. 
 
Limitations: 
 
The study has a number of limitations including the small sample size of the #<3wks 
group and a potential recruitment bias in the control group that has been discussed in 
previous chapters.  There may also be some bias with the TKRs and #<3wks groups due 
to their dependence on a support network to participate in the study. The study had a 
largely rural catchment area and as many participants were required to travel large 
distances to attend the data collection sessions at a time when they were prohibited from 
driving, only those patients with appropriate support were able to take part. This 
suggests that many of them enjoyed a level of social support that may have influenced 
their general state of wellbeing such that the study results could have underestimated the 
levels of depression and anxiety in a wider population. 
 
In order to be comparable to the control group, participants were asked to answer 
questions on depression and anxiety relating to any issues, not solely with regard to 
their current physical condition. Some of the participants with leg pathology were 
coincidentally experiencing other major problems in their lives resulting in very high 
levels of anxiety. They may therefore appear as outliers in the data but reporting the 
results as median scores will have eliminated these effects. 
 
Subjectivity in responses to questionnaires is always a difficulty in research, particularly 
with regard to questions that require a rating of levels of pain or perception of health. 
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Instructions in answering questions were as specific as possible, but some differences in 
participants’ interpretation were unavoidable.  
 
8.6 CONCLUSION 
The influences on depression and the patterns of recovery in the various groups were 
distinct. TKR patients experienced the worst levels of depression and anxiety with the 
poorest recovery, whilst the newly fractured patients recovered well after an initial 
period of poor scores following their injury. Depression in the TKR group mostly 
related to pain, anxiety, a higher number of co-morbidities and poor perceptions of their 
health, whilst for the #<3wks group it related largely to poorer  function, activity and a 
higher rate of falls. Despite the evident good recovery in the newly fractured group, 
participants from the cross-sectional arm of the study showed distinctly different results 
with a relatively high level of depression associated with anxiety and a previous history 
of more falls. Poor sleep was a key factor for depression in all of the groups but is not 
significantly related to pain.  
A significant association was shown between depression and bone loss in the #<3wks 
group that supports findings from previous studies that show an association of 
depression with reduced BMD and increased fracture risk. This may have implications 
for the treatment of depression in patients following fracture or surgery as the use of 
antidepressants is also associated with reduced BMD which could exacerbate fracture 
risk in patients already at risk of bone loss as a consequence of their injury. An analysis 
of sub-groups, above the thresholds for clinical depression and anxiety, demonstrated 
the highest levels of both conditions in the TKR group throughout the entire study 
period.  An attempt was made to compare rates of bone loss at the ipsilateral hip 
between the clinically and non-clinically depressed sub-groups of the TKRs and, whilst 
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it was a useful exercise, the sample numbers were too small to reliably differentiate 
between them.  
Although the possibilities are more limited for fracture patients, who are required to be 
immobile during the initial period of fracture healing, cost-effective opportunities may 
be available to support TKR patients in their recovery via the use of group exercise 
classes and improved advice and treatment for depression, pain and sleep problems. 
 
 
Future work: 
This study has only provided a fairly superficial overview of the prevalence of 
depression and anxiety in these participant groups and a more ‘in depth’ assessment of 
the causes of these conditions would be valuable. It would be particularly interesting to 
establish the reasons for higher levels of depression in the #>1yr group and whether 
these are attributable in any way to the outcomes of their leg fracture. 
As the #<3wks group was smaller than desired, further work on a larger sample would 
be useful to validate the results from this study. Also, the study could be extended to a 
larger sample of TKR patients to enable an investigation into the effects on bone loss of 
depression in subgroups above and below clinical thresholds. 
Finally, an assessment of the interventions, suggested in the discussion section of this 
study, could be implemented to establish if these could prove useful and cost-effective 
in improving outcomes & recovery in the TKR group. 
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CHAPTER  8. SUMMARY OF RESULTS AND CONCLUSIONS 
 
The primary aim of this study was to investigate the effects of immobilisation and 
reduced weight-bearing on leg fracture and knee replacement patients, in order to 
quantify bone and muscle loss and to monitor recovery over a one year period. A 
postmenopausal population was chosen because they are already losing bone density 
systemically, are at an already increased fracture risk and may be at greater risk of 
further bone loss following immobilisation. The original aim of the study was to assess 
differences at baseline and over the course of twelve months recovery between four 
groups; controls, total knee replacement patients, patients with new leg fractures treated 
with internal fixation and those treated with plaster of Paris only. Due to difficulties 
with recruitment, an additional group was added as a cross-sectional arm to the study; 
these participants had sustained leg fractures more than one year previously but within 
the previous ten years. Factors including activity, function, weight-bearing, pain, 
treatments, therapies, health perceptions and mental wellbeing, that potentially 
contribute to bone loss and recovery, were also investigated. The primary goal was to 
provide information relating to increased future hip fracture risk that may lead to 
treatment options to alleviate bone loss and improve physical and functional recovery in 
these groups. The final groups recruited to the study and included in the analysis were: 
43 controls, 19 total knee replacement patients (TKR), 9 newly fractured patients 
(#<3wks) and 24 patients with longstanding leg fracture (#>1yr).  
 
Key findings 
The main results from the study demonstrated that there were notable differences 
between the groups at baseline and in the progress of their recovery over the course of 
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the twelve month follow-up. It was evident that a complex interaction of numerous 
factors contributed to loss and recovery of bone and muscle mass, alongside functional 
and emotional recovery. The effects of poor function and depression, whilst debilitating 
in their own right, also have potential to exacerbate the bone and muscle loss, which 
results from reduced mechanical loading due to immobilisation. Bone loss at the hip, 
and muscle atrophy, following leg injury or surgery has implications for increased risk 
of hip fracture particularly for participants with pre-existing low hip BMD at the time of 
their injury or surgery. 
 
Results - Controls  
The control group demonstrated consistency throughout the study in all parameters 
under investigation providing a meaningful contrast to the remaining groups, and 
although some age related bone loss was expected over the one year period in this 
postmenopausal control population, few statistically or clinically significant changes 
occurred from baseline in either bone or body composition parameters. 
 
Results - TKR 
The results indicate that recovery following TKR surgery was slow and incomplete one 
year after the event. The effects of immobilization following surgery in this group were 
an immediate and statistically significant loss of ipsilateral bone mass at the total hip 
and at the NOF (after 6 months), accompanied by significant bilateral muscle atrophy 
that continued gradually over the following 6 months and remained one year after 
surgery. The clinical significance of these reductions in hip BMD are an increased risk 
of hip fracture that may be exacerbated by muscle loss/weakness that could affect 
patients’ gait and postural stability thereby increasing the risk of falls. The TKR group 
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had relatively high mean hip BMD at baseline, probably resulting from general obesity 
levels in this group, and the reductions in BMD in absolute terms may not represent a 
major increase in fracture risk for the average patient. However, these data support the 
increased hip fracture rate reported in the year following TKR, and those patients at 
higher risk of hip fracture at baseline may require consideration for bone-sparing 
therapy to reduce their risk. Although the mean reduction in bone mass was relatively 
small in absolute terms for the average TKR participant, a correlation was found 
whereby participants with the lowest bone density at baseline lost more absolute BMD 
than those with high BMD. An exponential relationship exists between BMD and 
fracture risk which means that an equivalent absolute reduction in bone mass in 
participants with low BMD values, causes a greater increase in fracture risk than for a 
participant with higher BMD. Any bone loss may therefore present a substantial 
increase in hip fracture risk for participants with pre-existing low hip BMD, further 
supporting the requirement for baseline monitoring and therapeutic intervention for at-
risk patients.  Despite showing an overall improvement in most areas of function and 
activity over the twelve month duration of the study, the TKRs nonetheless failed to 
achieve the levels of the control group one year post surgery. TKR patients experienced 
the worst levels of depression and anxiety amongst the groups with the poorest recovery 
over the study period. Depression in this group mostly related to pain, anxiety, poor 
perceptions of health and a higher number of co-morbidities. Poor sleep was a key 
factor for depression in all of the groups but was not significantly related to pain.  
 
Results – Fracture patients  
The newly fractured patients (#<3weeks) were significantly different to the controls at 
baseline in a number of key functional areas that were the inevitable consequence of the 
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immobilization caused by their injury. The consequence of immobilization following 
leg fracture in the #<3wk group, was an immediate and statistically significant loss of 
ipsilateral bone mass at the total hip. These immediate bone losses were subsequently 
followed by recovery, returning to baseline values, or above, at the end of one year. 
Although the mean reduction in bone mass was relatively small for this group in 
absolute terms, as with the TKR group, a correlation was found whereby participants 
with the lowest bone density at baseline, lost more absolute BMD than those with high 
BMD such that, due to the exponential relationship which exists between BMD and 
fracture risk, those participants with pre-existing low BMD are potentially at a 
substantially heightened risk of hip fracture risk following bone loss. However, after an 
initial deterioration in hip BMD and general function, the newly fractured group 
demonstrated good recovery in physical and functional parameters, returning to levels 
comparable to the controls at the end of the study.  
 
The #>1year group exhibited distinct differences to both the controls and the #<3wk 
group, differing from the other groups at baseline in significantly higher levels of bone 
sparing pharmacological treatments. This group scored significantly below the control 
group in almost all key outcomes suggesting that a long-term impairment in function 
and bone health may persist following injury.  They demonstrated a long-term deficit in 
hip bone density on the ipsilateral side, which together with reduced levels of function 
and activity that inhibit restoration of BMD, may represent a heightened risk for future 
hip fracture. It is not possible to state that these impairments were attributable to the 
consequences of the fracture but as these participants presented as a distinct group 
compared to the controls and the #<3weeks group, the reasons for the differences they 
exhibit may merit further investigation. Despite the evident good recovery in the newly  
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fractured group at the end of the one year study period, participants from the cross-
sectional arm of the study showed distinctly different results with a relatively high level 
of depression associated with anxiety and a previous history of more falls.  The reasons 
for the apparent discrepancies between the two fracture groups are not clear but may be 
a consequence aberrant results due to the small number of participants in the #<3weeks 
group. They may also be potentially attributable to selection bias and the Hawthorne 
effect whereby behaviour may have been modified in the newly fractured participants, 
artificially optimising their recovery. The results from the #<3wk group are possibly 
therefore less representative of typical leg fracture patients than the #>1year group. A 
further longitudinal study across multiple centers to recruit sufficient participants is 
required to investigate this further. 
 
With regard to depression, the newly fractured patients recovered well after an initial 
period of poor scores following their injury. The #<3wks group demonstrated 
worsening  depression with lower pedometer scores at visit 1 and with reduced function 
scores at visit 2 suggesting that their depression was significantly related to their 
inability to perform their normal activities early on in their recovery. An interesting 
association emerged from the multiple regression analysis between depression and 
previous experience of falls in both the #<3wk and #>1yr groups that may involve a 
complex relationship between depression, poor physical function and fear of falling 
(265). Both the newly fractured group and the longstanding fracture groups had a 
history of previous fracture rates higher than the controls.  
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Implications  
It is important to state that for the majority of women, loss of BMD at the hip following 
injury or surgery will present a very minimal increase in hip fracture risk. Whilst bone 
loss at the hip has been shown to be statistically significant in both the TKR and newly 
fractured groups, in a clinical context, the changes demonstrated for the average patients 
in this study are relatively small. Nevertheless the study sample is above average in 
densitometry terms compared with the NHANES database and is not therefore 
representative of the general population where mean BMD values would be lower. It is 
possible therefore that the results from this study underestimate the impact of post-
fracture or post-surgical bone loss in the wider population. Although the group means 
for BMD at the hip sites were relatively high in the TKR and #<3wk groups, a 
proportion of each group had BMD scores in the osteopenic and osteoporotic range, 
indeed nine additional participants in these groups (4 and 5 participants respectively) 
were put onto bone sparing treatments as a consequence of reporting their densitometry 
results from the study. Epidemiological evidence has demonstrated a significantly 
increased hip fracture incidence in the year following TKR surgery (210, 211) and it is 
possible that apparently minor BMD changes in some patients in the lower BMD range 
could, in part, account for this. However, it is not known from these papers whether 
post-surgical hip fractures occurred on the ipsi- or contralateral sides and information in 
this regard would help to ascertain whether changes in ipsilateral bone density 
potentially contribute to this increased hip fracture risk alongside other factors such as 
muscle loss/weakness, impaired gait and an increased propensity for falls.  
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A further factor that may be of relevance in contributing to future fracture risk is 
obesity. The relationship between fracture risk and obesity is currently unclear and 
appears to be site-dependent. Past research has shown an association of obesity with 
higher rates of ankle and leg fracture in postmenopausal women (269) and it is also 
known to be the primary risk factor for knee OA: indeed the TKR group in this study 
was distinct in their high mean BMI relative to the other groups. Leg, particularly ankle, 
fractures are common in incidence in postmenopausal women (270) and TKR 
operations are increasing in frequency, doubling in the United States from 1999 to 2008 
(281).  Both leg fracture and OA are associated with increased age (255, 270) and as 
populations increase in longevity and the incidence of obesity and osteoarthritis rises, 
the prevalence of leg fractures and TKR procedures is likely to rise in the future. As the 
incidence of both conditions/procedures is high, a small increase in hip fracture risk 
resulting from either, could translate into large numbers of individuals ultimately 
affected by hip fracture with concomitant personal distress and financial costs to 
healthcare providers. 
 
Results from the multiple regression analysis demonstrated that bisphosphonate use was 
the best overall predictor for change in BMD at the total hip, having a mitigating effect 
on bone loss. This suggests that prophylactic treatment may benefit patients at the 
highest risk of hip fracture. Currently there is no routine clinical pathway for DXA 
screening before surgery for TKRs or immediately following leg fracture and this would 
be valuable to identify patients at the greatest risk for bone loss and to assess the need 
for treatment. Interestingly, bisphosphonate use in TKR patients has also been shown to 
improve implant survival time after primary knee arthroplasty and to reduce revision 
rates; treatment may therefore confer an additional benefit to these patients beyond 
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fracture prevention (282). Relative to the financial cost of TKR surgery and the 
potential costs of subsequent hip fracture, screening and appropriate treatment could be 
a valuable and cost effective precaution. 
 
Multiple regression analysis presented a mixed selection of variables that significantly 
influenced function (LEFS) in the different groups and at different stages of the study. 
Pain was the most frequently occurring explanatory variable causing a reduction in 
function as pain increased in all groups. In addition, less co-morbidity, lower age, 
higher health perception and increased pedometer activity all contributed to improved 
function amongst the groups. These results suggest that more appropriate or alternative 
methods for pain relief and an improved regime of physiotherapy and exercise, could 
potentially benefit patients and mitigate the long-term functional impairments 
demonstrated in the TKR and #>1year groups. As the #>1yr and the TKR groups had 
higher BMI than the controls, in the overweight and obese categories respectively, both 
might benefit from exercise regimes to improve function and activity generally, and also 
encourage weight loss to reduce impact forces on the legs.  
Depression levels were demonstrated to be higher in the patient groups than in controls 
and this difference continued throughout the study for the TKRs and was also evident as 
a persistent factor in the longstanding fracture group. Depression and anxiety, above the 
thresholds for clinical levels, was also highest in these two groups.  A significant 
association was demonstrated between depression and bone loss in the #<3wks group 
supporting findings from previous studies which show an association of depression with 
reduced BMD and increased fracture risk (101, 105, 279). In addition to the impact of 
depression on patients’ quality of life, the association with bone loss may have 
implications for the treatment of depression in patients following fracture or surgery. 
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Nevertheless, caution may need to be applied as the use of pharmaceutical 
antidepressants is also associated with reduced BMD which could exacerbate fracture 
risk in patients already at risk of bone loss as a consequence of their injury. For newly 
fractured patients, there is little that can be changed in the early stages to improve their 
functional recovery during the process of fracture healing and reduced weight-bearing, 
therefore the inevitable frustrations of limited function and activity are unavoidable. As 
pain does not appear to contribute significantly to depression in this group and most 
participants are well medicated following injury, there may be limited potential to 
improve the experience for these patients other than possibly offering some aids to 
sleep. Results from the multiple regression analysis indicated that depression in the 
TKR group was significantly associated with pain, poor perceptions of health, and 
anxiety. A formal assessment for these conditions is indicated whereby patients could 
benefit from advice or counseling to alleviate their symptoms and potentially improve 
functional recovery. As the potential for anti-depressant drugs to exacerbate bone loss is 
a subject of ongoing research, the use of these treatments in this group should be 
considered with caution.  
 
Previous studies have shown that rates of recovery of bone mass are slower than the 
original rate of bone loss, and return to customary levels of bone loading may not be 
sufficient to restore original bone density (9, 11). Heightened levels of exercise and 
activity, above habitual levels, may be required to stimulate recovery. It has been 
demonstrated in this study that the TKR group, whilst showing improved levels of 
function and activity over the study period, do not achieve the levels of the other groups 
one year post surgery.  It may therefore take a considerable period of time and physical 
effort to achieve full recovery in this group. Although there is pre- and post-surgical 
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service provision for TKR patients in the form of advice, physiotherapy and supervised 
exercise classes, the interventions offered to individuals (in the setting of this study) 
were very inconsistent. Group exercise classes could be a cost-effective option for 
healthcare services, benefiting both TKR and fracture patients by improving their 
function and activity levels whilst also encouraging weight loss. As some association 
has been shown between bone loss and depression, social networks forged through these 
groups could afford peer support to aid mental wellbeing and may help patients to have 
more realistic expectations for their progress in recovery. As use of antidepressant drugs 
is also thought to be associated with bone loss, opportunities for peer support or 
counseling, to avoid the need for pharmaceutical interventions, might also prove 
valuable in prevention of future hip fractures in these patients. 
 
Limitations 
The study had several limitations, most notably the difficulties involved with 
recruitment and the potential for recruitment bias. There may also have been some 
recruitment bias with the TKRs. The study had a largely rural catchment area and as 
many participants were required to travel large distances to attend the data collection 
sessions at a time when they were prohibited from driving, only those patients with 
appropriate support were able to take part. This suggests that many of them enjoyed a 
level of social support that may have influenced their general state of wellbeing such 
that the study results could have underestimated the levels of depression and anxiety in 
a wider population. The sample used in this study was 100% of white Caucasian 
ethnicity coming from a relatively affluent rural catchment area in the Southwest of 
England. The pedometer results suggest that the controls were a relatively active group 
for their age range and were frequently from backgrounds that afforded them the leisure 
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to take part in the study.  Although the socio-economic status of participants was not 
investigated, many, particularly amongst the control group, appeared to have 
backgrounds of relative affluence and good education that are generally associated with 
healthier lifestyles. To be equivalent to the population used for the NHANES database, 
on which DXA diagnostics are based, control participants would exhibit mean Z-scores 
of zero. However, the mean densitometry Z–scores at various sites were above average 
for all groups except the #>1yr group, indicating that participants from this region may 
not be fully representative of the national population which potentially limits the 
generalisability of the results.  It cannot be ruled out that that the control group, due to 
selection bias, are substantially above average fitness and that the #>1year group are 
possibly more representative of the general population. A further limitation was the size 
of the #< 3 wks group. Due to recruitment difficulties, this group was smaller than 
anticipated and the analyses of results may be underpowered. Caution should therefore 
be used when interpreting results and this may account, in part, for the unexpected 
differences between this and the #>1yr group.  In addition, because the #< 3 wks group 
was difficult to recruit, those subjects who did participate tended to have a keen interest 
in the research topic and it is feasible that they were susceptible to the Hawthorne effect, 
modifying their behaviour to optimize their recovery. It should also be acknowledged 
that a larger sample is more reliable for detecting significant associations in multiple 
regression, requiring increasing sample size for each additional predictor variable added 
to the model (271). It is therefore feasible that more of the independent variables would 
have been shown to have significant associations with the outcome variables had the 
sample size been larger. There were many potential and unavoidable confounders due to 
the nature of the pathologies under investigation, such as the presence of co-morbidities, 
previous knee replacements and treatments for low bone density that were prescribed 
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during the course of the study. Where appropriate and relevant to the outcome 
measures, these were added as explanatory variables in the analysis 
 
Conclusion 
Disuse bone loss in a post-menopausal population has not been previously reported, nor 
has it been investigated in a TKR population immediately following surgery. This study 
has demonstrated that bone loss at the hip, accompanied by muscle losses of varying 
degrees, is a consequence of immobilisation in both leg fracture and knee replacement 
patients. Bone loss, although a recognised consequence of immobilisation, is not 
currently investigated as a clinical outcome of leg fracture or surgery. For the majority 
of patients these changes will only result in a minimal increase in hip fracture risk, 
however epidemiological evidence has demonstrated an increase in hip fracture 
incidence post TKR surgery that suggests, for some patients with pre-existing low bone 
density, bone loss at the hip may make a contribution to this enhanced fracture 
incidence. As the number of patients undergoing TKR procedures increases globally, 
this may have a substantial impact on the incidence of hip fracture and the financial 
costs to health care providers. In addition to the physical effects of leg fracture or TKR, 
poor outcomes in function, activity and mental wellbeing contribute to a reduced quality 
of life that could potentially be improved for these patients. 
  
It is important to acknowledge the limitations of imaging technologies and of the 
fracture risk assessment tools currently available for clinical use. Clinicians should be 
aware of the potential over-reliance on BMD and the limited range of risk factors in 
fracture assessment tools to predict fracture in the individual. An awareness of the 
potential complication of bone loss following immobilisation is required with 
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consideration of screening and prophylactic treatments, post injury/surgery, to avoid or 
alleviate bone loss, particularly where other risk factors for low bone density are 
present. Development of alternative or complementary technologies (including 
molecular imaging) and software tools to assess bone architecture should be welcomed 
and advancements in this area may improve clinicians’ ability to predict fracture risk in 
the individual patient in the future.  
 
Future work  
As the recently fractured group used in this study was small and may have been 
influenced by selection bias, further work would be valuable to assess bone and muscle 
loss in a larger sample to confirm the validity of the results. It would be desirable to 
follow up the current cohort of participants at a later stage, of three to five years post 
baseline, to investigate longer-term changes in BMD and any hip fracture incidence.  A 
large multi-center study is needed to investigate baseline DXA measurements in a wider 
TKR population and the extent of bone loss at one year post surgery.  
 
This study has only provided a fairly superficial overview of the prevalence of 
depression and anxiety in these participant groups and a more ‘in depth’ assessment of 
the causes of these conditions would be valuable. It would be particularly interesting to 
establish the reasons for high levels of depression in the #>1yr group and whether these 
are attributable in any way to the outcomes of their leg fracture. 
 
Further work would be valuable to investigate the clinical- and cost-effectiveness of 
DXA assessment in the work-up pre-TKR to identify those patients at a higher fracture 
risk, and also whether implementation of improved pain relief and more consistently 
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applied post-surgical exercise regimes, including group classes, could prove beneficial 
and cost-effective in improving outcomes and recovery in the patient groups.   
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Recruitment poster – patient groups  
 
 
 
 
 
 
 
 
 
 
Appendix 2 
[276] 
 
Appendix 2 
 
Recruitment leaflet – Patient groups. 
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Appendix 3 
 
Disuse Osteopenia, short- and long-term effects 
 
INFORMATION SHEET 
 
 
Participant No: _________________________  Participant Initials:_________________________ 
 
 
Invitation: 
 
You are being invited to take part in this research study.  Before you decide it is very important for you to 
understand why the research is being undertaken and what it will involve.  Please take time to read the 
following information carefully and discuss it with friends, relatives and your GP if you wish.  Ask us if 
there is anything which is not clear or if you would like more information.  Take time to decide whether 
or not you wish to take part. 
 
What is the purpose of this study? 
 
Disuse osteopenia or osteoporosis, i.e. loss of bone density and strength, is a recognised complication of 
immobilization (restricted movement) and may occur as a result of inactivity following a leg or ankle 
fracture (break) or possibly after total knee replacement. The aim of this study is to investigate the 
severity and extent of any bone loss that results from immobilization following lower limb fracture or 
total knee replacement. The long-term goal is to identify risk factors, resulting from immobilisation, 
which may increase the likelihood of future fractures at the hip. This will help to identify when and to 
whom preventative treatments should be administered to reduce any bone density loss. 
 
Why have I been chosen? 
 
We are approaching women who have gone through the menopause (i.e. not had a period for over 12 
months) and undergone immobilization following leg or ankle fracture or total knee replacement. The 
study will include fracture patients who have had bone repairing surgery using plates and screws and also 
patients whose fractures have only been treated by plaster cast. It will not include patients whose fractures 
have been repaired by metal work fixed to the outside of their leg.  We also wish to recruit non-patients 
(controls) who have not undergone injury or surgery to their leg.  
 
You have been asked to participate as you fit into one of these groups.  Thank you for showing an interest 
in this project. This sheet is an invitation for you to take part in our project. It will tell you a bit more 
about the project and what we would like you to do. Please read this carefully before deciding whether or 
not to take part.  If you decide to participate we thank you. If you decide not to take part there will be no 
disadvantage to you of any kind and we thank you for considering our request. 
 
 
What is the project about? 
 
This study is looking at factors that may increase bone loss following leg or ankle injury/surgery and may 
therefore also increase the future risk of hip fracture. The end goal is to be able to identify those who may 
be at an increased risk of bone loss and potential increased risk of hip fracture and identifying potential 
preventative treatments.   
 
 
 
 
 
Who is taking part?  
 
We need 200 post-menopausal female volunteers, aged 45 years and older. 50 of these subjects will be 
non–patients (controls) who have not had lower limb fractures or total knee replacements.  The remainder 
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will be patients who have undergone immobilization following fracture of the leg/ankle or total knee 
replacement. 
 
 
What will I be asked to do? 
 
If you volunteer for this project we will ask you to visit us at the University of Exeter on up to four 
occasions at intervals of 6 weeks, 6 months and 1 year following an initial assessment. The initial 
assessment will take place before surgery for total knee replacement or 2 weeks after treatment for lower 
limb fractures. Control subjects will only be asked to visit 3 times for the initial assessment, and at 
intervals of 6 months and 1 year.  During your first visit we will help you to fill in some questionnaires 
about your health and any risk factors you may have for osteoporosis.  Each visit may last for 
approximately 1.5 hours or up to about 2.5 hours if you are also selected for an MRI scan. Each visit will 
involve; 
 
Height and weight measurements which will take about 5 minutes.  
 
A DXA scan of the bones of your spine, hip and whole body to measure the strength of your bones. For 
these scans you lay on your back on the scanner, which is of a very open design.  These scans use x-rays 
but of a very low dose. The same as if you were to sit outside in the Exeter sun for ½ a day, or less than 
taking a transatlantic flight. These scans will take about 30 minutes.   It is possible that you will be 
diagnosed as having low bone density or osteoporosis from these scans. If this is the case, your GP will 
be informed and you will be advised to make an appointment to see him or her.    
 
Some participants may also be asked to have a Magnetic Resonance Imaging (MRI) scan of the hips. This 
is entirely optional and you need not participate if you do not wish to.  It is also subject to scanner 
availability. The MRI scanner uses a strong magnetic field and does not use X-rays or ionising radiation, 
which means there is no radiation dose associated with these scans.  During these scans you will lay on 
your back inside the scanner. Most participants are able to enter the scanner feet first with their head 
remaining outside of the scanner ring. However it is sometimes necessary for taller people (above 6 foot) 
to enter head first. We will take a number of images, which will take approximately 45 minutes.  You will 
not feel any unusual sensations from the magnet.  There are loud (clunking) noises like the banging 
radiators make in houses that have steam/hot water heating systems.  You will be able to see and talk to 
the operators and you can also bring a CD of your favourite music to listen to during your scan.  You will 
be required to complete a safety questionnaire before this scan which will tell us if you are able to have 
the scan.  If you have ever had metal fragments in your eyes or have a pacemaker, you will not be able to 
have the MRI part of the study.   
 
For limited periods during the study, you will be asked to wear a small unobtrusive piece of equipment 
called an activity monitor/pedometer to measure your physical activity. You will also be asked to fill in a 
questionnaire about the types, duration and intensity of your physical activity during the same period as 
the accelerometer measurements.   
 
When you are allowed to weight-bear, we will assess your ability to do so by using a questionnaire and a 
testing device called force plates (similar to bathroom scales) during your visits. We will also ask you to 
fill in some questionnaires about your quality of life, wellbeing and functional improvement during your 
recovery.  
 
We fully appreciate that you may have difficulty walking initially following you treatment and, if 
required, we can arrange a reserved parking space for you and a wheel chair escort from your car to the 
scanner. 
 
 
 
Can I change my mind? 
 
You can stop being in the project at any time without giving a reason and without any disadvantage to 
yourself of any kind.  
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What will you do with the information? 
 
We will collect your name, address and contact details and information about any relevant clinical 
conditions, medication and personal data such as date of birth, weight, blood results etc and the data 
generated from the tests.  We will store them in the study files and on a computer.  The files will be 
protected in a locked room with only research team having access.  The computers are protected with 
passwords.  The building which houses all the research data is security protected.  When the data is in 
store the name and addresses will be removed from the data so that it can be identified only by an ID code 
and the data will be stored for 15 years.  When the results of the study are analysed individual participants 
will not be identifiable.  The data will be accessed and analysed only by the departments’ research staff, 
the supervisors of the research and research auditors.  You are welcome to request a copy of the results of 
the project.   
 
With your consent, results that may be of use to your doctor will be sent to your GP. If you are under the 
care of a consultant, they will also be advised. Confidentiality may not be breached without your consent 
unless for any reason there is a significant risk of harm to yourself.  
 
What if I have any questions? 
 
If you have any questions at any time, please feel free to ask Sue Hopkins on 01392 726131 or E-mail 
sjh217@exeter.ac.uk.  If you wish to talk to someone who is independent of the study team, please 
contact Rachel Palfrey on 01392 264086. 
 
 
What do I do if I have any worries of complaints? 
 
If you feel your treatment either prior to the study, during or after the study is of concern to you in any 
way, please contact Dr Karen Knapp  on  01392 264133 or  Dr, Joanne Welsman on 01392 262882. 
 
 
What do I do next? 
If you have read and understood everything that we want you to do and are happy to take part, please 
return the enclosed contact details form so that we can assess your suitability to participate. Please also 
sign the attached consent form and retain it for your own record. You will be asked to sign another copy 
for our use when you attend your first appointment. 
 
 
 
Sue Hopkins 
PhD Researcher 
 
 
 
This project has been reviewed and approved by the Local Research Ethics Committee. 
Appendix 3 
[280] 
 
Disuse Osteopenia, short- and long-term effects. 
 
CONSENT FORM FOR PARTICIPANTS 
 
I have read the information sheet concerning this project and understand what it is about. All my questions have been 
answered to my satisfaction. I understand that; (please initial each box) 
 
  My participation in the project is entirely voluntary.  
 
 
  I am free to withdraw from the project at any time without having to give a reason and without any 
disadvantage. 
 
 
 
  The results of the project may be published but my anonymity will be preserved.  
 
 
  I will be asked to complete questionnaires about my health and risk factors for osteoporosis. 
 
 
 
  I will be asked to complete questionnaires about my healing, wellbeing, physical activity, functional 
progress and quality of life. 
 
 
 
 
  I will have my ability to weight-bear assessed using a questionnaire and force plates.  
 
 
 
  My height and weight will be measured.  
 
 
  I will have scans of the hip, spine and whole body to look at bone strength. These scans involve a small 
dose of x-rays which is the same as spending ½ day outside in the Exeter sun. 
 
 
 
  If asked, I will have a MRI scan of my hips to look at bone structure at this site. 
 
 
 
  I will wear an activity monitor/pedometer to measure my physical activity for limited periods during the 
study. 
 
 
  I agree to take part in this project.  
 
 
  I understand that relevant sections of my medical notes and data collected during the study may be looked 
at by individuals from the research team, from regulatory authorities or from the NHS trust, where it is 
relevant to my taking part in this research. I give permission for these individuals to have access to my 
records.  
 
 
 
 
Signed        (Date) 
Participant………………………………………………………..  ………………….………………. 
 
Signed        (Date) 
Researcher………………………………………………………..  ……………………………......... 
 
This project has been reviewed and approved by the Local Research Ethics Committee. 
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Appendix 4 
 
Invitation to participate in study – patient groups 
 
                                                      
 
DATE 
 
Ms. XXXXXX 
 
Dear Ms XXXXX, 
 
Re: Disuse Osteopenia, short- and long-term effects. 
 
I am writing to you regarding the above study to invite you to participate either as a leg or ankle 
fracture (broken bone) or total knee replacement patient. This is an important study which aims 
to investigate the effects on bone structure and density at the hip resulting from immobilization 
(restricted movement) following treatment for fracture or total knee replacement. It includes 
groups of non-patient participants, leg and ankle fracture participants and participants 
undergoing total knee replacement.   
 
Please find enclosed a participant information sheet telling you more about the study.  You are 
under no obligation to participate in this study and your treatment at the hospital will not be 
affected by your decision. 
 
The study requires four visits to the University of Exeter, St Luke's campus, which may take up 
to 1.5 hours for each visit or 2.5 hours if you are also having an MRI scan.  You will be provided 
with a parking permit and reimbursement of your expenses. 
 
If you would like to take part, please return the ‘Contact details’ form enclosed. If you have any 
questions and wish to discuss the study further, do not hesitate to contact the research study 
co-ordinator, Sue Hopkins on 01392 726131 or e-mail sjh217@exeter.ac.uk.  Please note that this 
phone line is not manned full time and we would be grateful if you could leave a message with 
your name, telephone number and some convenient times to return your call.  
 
If you have sustained a fracture, it is important that we undertake the first scans around two 
weeks after your treatment and therefore we would be very grateful if you could reply as soon 
as possible. If you are going to have a total knee replacement, we will need to perform the first 
scans before your operation. 
 
Thank you for considering our request. 
Yours sincerely 
 
 
pp. Mr. Andrew Toms 
Consultant Orthopaedic Surgeon 
Royal Devon & Exeter NHS Foundation Trust 
 
Chairman:  Angela Ballatti    Chief Executive: Angela Pedder 
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Recruitment poster - Controls 
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Recruitment leaflet - Controls  
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 Recruitment poster – Fracture > 1 year group  
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Recruitment leaflet – Fracture > 1 year group  
 
Appendix 9 
[286] 
 
 
Appendix 9 
 
 
 MRI Participant Safety Checklist 
 
Name:       Date of Birth: 
Weight:      Name of Study/Volunteer 
Number: 
 
Please check the following list carefully, answering all appropriate questions. 
Please do not hesitate to ask staff, if you have any queries regarding these questions. 
 
1. Do you have a pacemaker, artificial heart valve or coronary stent?   Yes/No 
 
2. Have you ever had major surgery?   Yes/No 
If yes, please give brief details.    
 
 
3. Do you have any aneurysm clips (clips put around blood vessels during 
surgery)?   Yes/No 
 
4. Do you have any implants in your body 
 
Yes □ No □ Joint replacements, pins or wires 
Yes □ No □ Implanted cardioverter defibrillator (ICD) 
Yes □ No □ Electronic implant or device 
Yes □ No □ Magnetically-activated implant or device 
Yes □ No □ Neurostimulation system 
Yes □ No □ Spinal cord stimulator 
Yes □ No □ Insulin or infusion pump 
Yes □ No □ Implanted drug infusion pump 
Yes □ No □ Internal electrodes or wires 
Yes □ No □ Bone growth/bone fusion stimulator 
Yes □ No □ Any type of prosthesis 
Yes □ No □ Heart valve prosthesis 
Yes □ No □ Eyelid spring or wire 
Yes □ No □ Metallic stent, filter or coil 
Yes □ No □ Shunt (spinal or intraventricular) 
Yes □ No □ Vascular access port and/or catheter 
Yes □ No □ Wire mesh implant 
Yes □ No □ Bone/joint pin, screw, nail, wire, plate etc. 
Yes □ No □ Other Implant______________________ 
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5. Do you have an artificial limb, calliper or surgical corset?   Yes/No 
 
6. Do you have any shrapnel or metal fragments, for example from working in a 
machine tool shop?   Yes/No 
 
7. Do you have a cochlear implant?   Yes/No 
 
8. Do you wear dentures, plate or a hearing aid?   Yes/No 
 
9. Are you wearing a skin patch (e.g. anti-smoking medication), have any tattoos, 
body piercing, permanent makeup or coloured contact lenses?   Yes/No 
 
10. Are you aware of any metal objects present within or about your body, other 
than those described above?    Yes/No 
 
11. Are you susceptible to claustrophobia?   Yes/No 
 
12. Do you suffer from blackout, diabetes, epilepsy or fits?   Yes/No 
 
 
For women: 
13. Are you pregnant or experiencing a late menstrual period? Yes/No 
 
14. Do you have an intra-uterine contraceptive device fitted?    Yes/No 
 
15. Are you taking any type of fertility medication or having fertility treatment? 
Yes/No 
 
 
Important Instructions 
 
Remove all metallic objects before entering the scanner room including hearing 
aids, mobile phones, keys, glasses, hair pins, jewellery, watches, safety pins, 
paperclips, credit cards, magnetic strip cards, coins, pens, pocket knives, nail 
clippers, steel-toed boots/shoes and all tools. Loose metallic objects are especially 
prohibited within the MR environment. 
I have understood the above questions and have marked the answers correctly. 
 
 
Signature       Date 
(Participant/Parent/Guardian) 
 
MR Centre Staff Signature 
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Appendix 10 
 
Bone Questionnaire 
 
 
 
 
Please bring the completed 
questionnaire with you for your first 
appointment. 
 
 
 If you have any difficulties filling in the 
form, you can discuss these with the 
researcher at your  
appointment. 
 
 
 
 
Bone Questionnaire (Female) 
   
Please complete all the appropriate sections, using the tick boxes where provided. 
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Date questionnaire completed  
……………………………………………………………… 
 
Surname …………..……………….Forename(s)…………………………………Title..…… 
 
Address  ….……………………………………………………………………………………… 
 
………………………………………………………………………Postcode…...……………..
. 
Telephone Number (including area code)  ……….……………………………………… 
 
 
Date of Birth …………………… (day/month/year)      Age......................... 
 
 
Gender   Female   
 
 
Ethnic Background  White [  ]   Oriental  [  ] 
    Black   [  ] Mixed   [  ] 
    Asian   [  ]  Other   [  ] 
 
 
Height      …………………………..   Weight    
………….…………………………………...      
 
Height at age 21……………………  Weight at age 
21………………………………………. 
 
 
GP Name   ………………………………………………………….………. 
 
GP Address   …………………………………………………………….……. 
 
   …………………………………………………………….……. 
 
GP Telephone Number …………………………………………………………….……. 
 
 
 
 Have you had a DXA scan in the past 6 months?     Yes [  ]  No [  ] 
 
 
If yes, where was this done? ................................................................................. 
 
 
…………………………………………………………………………………………….. 
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Medical History 
 
 
1. Have you ever suffered from any of these conditions? 
 
No Yes 
Please state when diagnosed and 
duration of disease 
Rheumatoid arthritis    
Osteoarthritis    
Ankylosing spondylitis    
Diabetes    
Overactive thyroid    
Underactive thyroid    
Breast cancer    
Other cancer    
Pagets disease of bone    
Liver disease    
Kidney disease    
Gastric surgery    
Lactose intolerance (milk allergy)    
Crohn’s disease    
Coeliac disease    
Irritable bowel syndrome    
Malabsorption syndrome    
Osteomalacia (rickets)    
Bulimia    
Anorexia nervosa    
 
2. Do you suffer from any other on-going disease?  Yes [  ]     No [  ] 
 
If yes, please state disease and duration…………………………..………… 
 
…………………………………………………………………………………….. 
 
 
3. Have any of your family (parents / brothers / sisters / children / aunts / uncles / 
nieces / nephews / grandparents) suffered from the following conditions? 
Broken hip, spine &/or wrist?    Yes  [  ] No  [  ]     Which 
relative?……..............… 
Other broken bones?        Yes  [  ]  No  [  ]    Which 
relative?……………….…….. 
Osteoporosis?        Yes  [  ]  No  [  ]    Which 
relative?……………….…….. 
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4. Do any other diseases run in your family? Yes [  ]   No [  ] 
 
 If yes, please state the disease, and the relatives 
affected.………………………... 
 
………………………………………………………………………………………..........……
… 
 
5.       Have you been immobilised for more than 6 wks (complete bed rest/. 
hospitalisation)?     Yes [  ]      No  [  ] 
     If yes, was this before the age of 25  [  ], or after the age of 25  [  ] 
 
 
6. Have you ever taken any of the following drugs? 
Drug No Yes For how long did you take them? 
Corticosteroids 
(Please state dose) 
   
Anticonvulsants    
Diuretics    
Chemotherapy    
Immunosuppresive agents    
Heparin    
Thyroxine    
Didronel (Etidronate)    
Fosamax (Alendtronate)    
Calcitonin     
Actonel (Risidronate)    
Teriparatide (PTH)    
Protelos (Strontium Ranalate)    
Pamidronate (infusions)    
Zolendronate (injection)    
Ibandronate    
Fluoride    
 
 
7.  Have you taken any other drugs fro greater than 6 months?  Yes [  ] No [  ] 
What drug? For how Long? 
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8.  Do you take any of the following dietary supplements? 
Supplement No Yes For how long 
Multivitamins    
Calcium    
Vitamin D    
Other (please state)    
 
 
9. Have you ever fractured (broken) any bones?    Yes [  ]  No [  ] 
If yes, please state how old you were,  which bone(s) you broke, and 
how it happened, (please be as accurate and specific as possible): 
 
Age Bone What Happened? 
   
   
   
   
   
   
   
   
   
   
 
10. Do you, or have you in the past suffered from back pain? Yes [  ]      No [  ] 
 If yes, how many episodes and how severe was the pain?................................... 
…………………………………………………………………………………………………… 
 
11. Have you had any falls in the last year? Yes [  ]  No [  ] 
 If yes, now many and how did they happen? 
 
Fall No How did it happen Did you sustain any injuries? 
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Lifestyle 
 
12. Please tick which best applies to you Current smoker [  ] 
       Ex-smoker  [  ] 
       Never Smoked [  ] 
 
 If ex-smoker, what age were you when you stopped? .......................................... 
 How many cigarettes did you or do you smoke per 
day?............................……… 
 How may years did you or have you smoked for? 
…………………………..……… 
 
 
13.  How much alcohol do you drink per week? 
(1 unit = ½ pint beer, a measure of spirits or a glass of wine) 
Never             [  ]  11-15 units per week            [  ] 
Social occasions only[  ]  16-20 units per week            [  ] 
1-5 units per week     [  ]  More than 20 units per week [  ] 
6-10 units per week   [  ] 
 
 
14.  Are you vegetarian?     Yes  [  ] No  [  ]        If yes, for how 
long?......…years 
 
  Are you vegan?       Yes  [  ] No  [  ]        If yes, for how 
long?......…years 
 
 
15.  How many cups or cans of caffeine-containing beverages (coffee, tea and soft 
 drinks such as cola) do you drink per day? 
None      [  ]  11 – 15 cups/cans per day  [  ] 
1 – 5 cups/cans per day[  ]  More than 15 cups/cans per day [  ] 
6-10 cups/cans per day [  ] 
 
 
16. How much time do you typically spend taking exercise (for example walking or 
cycling out of doors) each day?  
 
None      [  ] 
Some, but less than half an hour  [  ] 
Half to one hour    [  ] 
More than one hour    [  ] 
 
17. Please outline any sporting or other activities you do partake in, and for how 
much time each week you spend doing these. 
 
………………………………………………………………………………………………… 
 
………………………………………………………………………………………………… 
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The rest of the questionnaire is for completion by women only 
 
18.  How old were you when your periods started?………………………….. 
  Has there been any time when your periods have stopped for a time of  
  more than 6 months except during pregnancy and menopause? Y[  ] N [  ] 
If Yes, for how long did they stop?……………………………… 
 
19.  Have you had a hysterectomy? Yes [  ] No [  ] 
 If yes, at what age  and for what reason?  Age ………………………….. 
 Reason………………………………………………………………………….. 
 
 Have you had your ovaries removed?Yes  [  ]     No  [  ]     Don’t know  [  ]   
 If yes, was 1 ovary removed  [  ] or both removed  [  ]  How old were you? 
 
        
20.  Are you still having natural periods? Yes [  ] No [  ] 
  If yes, are they regular?   Yes [  ] No [  ] 
  If no and your periods stopped naturally, at what age did they stop?…….. 
 
21.  Are you on, or have you ever taken HRT? Yes [  ] No [  ] 
  If yes, for how long have you taken it?……………………………………….. 
  Are you still taking HRT?    Yes [  ] No [  ] 
 If you have stopped taking HRT, why did you stop? ……………………….. 
…………………………………………………………………………………… 
 
22.  Are you on, or have you ever taken the oral contraceptive pill? Y [  ] N  [  ] 
 If yes, for how long have you taken it?………………………………………. 
  Are you still taking it? Yes  [  ]    No  [  ]  
 
23.  How many children have you had?……………………………………… 
  Did you breast feed your children?       Yes  [  ]    No   [  ] 
 If yes, for how many months did you breast feed each baby?  
  
Baby 1 2 3 4 5 
Months 
breast fed 
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Appendix 12 
 
Quality of Life Questionnaire EQ-5D 
 
©1990 EuroQol Group. EQ-5D ™ is a trade of the EuroQol Group 
 
Participant ID ......................................... Participant initials...................... 
 
Date........................................ 
 
Is this your: 
1
st
 Appointment 
6 week Appointment 
6 month Appointment 
12 month Appointment 
 
 
 
By placing a tick in one box in each group below, please indicate which statements 
best describe your own health state today. 
 
Mobility 
I have no problems in walking about  
I have some problems in walking about  
I am confined to bed � 
Self-Care 
I have no problems with self-care  
I have some problems washing or dressing myself  
I am unable to wash or dress myself  
Usual Activities (e.g. work, study, housework, family or 
leisure activities) 
I have no problems with performing my usual activities  
I have some problems with performing my usual activities  
I am unable to perform my usual activities  
Pain/Discomfort 
I have no pain or discomfort  
I have moderate pain or discomfort  
I have extreme pain or discomfort  
Anxiety/Depression 
I am not anxious or depressed  
I am moderately anxious or depressed  
I am extremely anxious or depressed  
 
 
To help people say how good or bad a health state is, we have drawn a scale (rather like 
a thermometer) on which the best state you can imagine is marked 100 and the worst 
state you can imagine is marked 0. 
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We would like you to indicate on this scale how good or bad your own health is today, 
in your opinion. Please do this by drawing a line from the box below to whichever point 
on the scale indicates how good or bad your health state is today. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Your own 
health state 
today 
100 
 90 
 10 
 20 
 30 
 40 
 50 
 60 
 70 
 80 
  0 
Best imaginable health 
state 
Worst imaginable health 
state 
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PHQ-9 
 
PATIENT HEALTH QUESTIONNAIRE - 9  
 
 
 
Over the last 2 weeks, how often have you been 
bothered by any of the following problems? 
 
 
 
Not at 
all 
 
 
 
Several 
days 
More 
than 
half the 
number 
of days 
 
 
Nearly 
every 
day 
1. Little interest or pleasure in doing things 0 1 2 3 
2. Feeling down, depressed or hopeless 0 1 2 3 
3. Trouble falling or staying asleep, or sleeping too 
much 
0 1 2 3 
4. Feeling tired or having little energy 0 1 2 3 
5. Poor appetite or overeating 0 1 2 3 
6. Feeling bad about yourself – or that you are a 
failure or have let yourself or your family down 
0 1 2 3 
7. Trouble concentrating on things, such as watching 
television or reading 
0 1 2 3 
8. Moving or speaking so slowly that other people 
could have noticed. Or the opposite – being so fidgety 
or restless that you have been moving around a lot 
more than usual 
0 1 2 3 
9. Thoughts that you would be better off dead or of 
hurting yourself in some way 
0 1 2 3 
 FOR OFFICE CODING 
___0__+_____+_____+_____ 
 
=Total Score:_______ 
 
If you ticked any problems, how difficult have these problems made it for you to do your 
work, take care of things at home, or get along with other people? 
 
              Not difficult               Somewhat                   Very                   Extremely  
                   at all                      difficult                     difficult                  difficult  
               □                     □                   □                     □ 
 
Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an 
educational grant from Pfizer Inc. 
Copyright © 2005 Pfizer, Inc. All rights reserved. Reproduced with permission. 
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Appendix 14 
 
Anxiety Questionnaire GAD-7 
 
Participant ID ......................................... Participant initials...................... 
 
Date........................................ 
 
Is this your: 
1
st
 Appointment 
6 week Appointment 
6 month Appointment 
12 month Appointment 
 
 
Over the last 2 weeks, how often have you been 
bothered by the following problems? 
 
Not  
at all 
 
Several 
days 
More than 
half the 
days 
 
Nearly 
every day 
        Feeling nervous, anxious or on edge  
0 
  
1 
 
2 
 
3 
        Not being able to stop or control worrying  
0 
  
1 
 
2 
 
3 
        Worrying too much about different things  
0 
  
1 
 
2 
 
3 
        Trouble relaxing  
0 
  
1 
 
2 
 
3 
         Being so restless that it is hard to sit still  
0 
  
1 
 
2 
 
3 
         Becoming easily annoyed or irritable  
0 
  
1 
 
2 
 
3 
         Feeling afraid as if something awful might happen  
0 
  
1 
 
2 
 
3 
 
                                                      Total     _____   =     Add        ____    +    ____    +    ____ 
        Score         Columns   
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If you checked off any problems, how difficult have these problems made it for you to do your 
work, take care of things at home, or get along with other people? 
Not difficult  
at all 
Somewhat 
 difficult 
Very 
difficult 
Extremely 
difficult  
    
 
The GAD-7 was developed by Drs. Robert L. Spitzer, Kurt Kroenke, Janet B.W. Williams, and Bernd 
Löwe.  For research information, contact Dr. Spitzer at rls8@columbia.edu.  Copyright© 2005 Pfizer Inc.  
All rights reserved.  Reproduced with permission 
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
Participant ID ......................................... Participant initials...................... 
 
Date........................................ 
 
Is this your: 
 
 
1
st
 Appointment 
 
6 week Appointment 
 
6 month Appointment 
 
12 month Appointment 
 
 
We are interested in finding out about the kinds of physical activities that people do as part of 
their everyday lives.  The questions will ask you about the time you spent being physically 
active in the last 7 days.  Please answer each question even if you do not consider yourself to 
be an active person.  Please think about the activities you do at work, as part of your house and 
yard work, to get from place to place, and in your spare time for recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous physical 
activities refer to activities that take hard physical effort and make you breathe much harder 
than normal.  Think only about those physical activities that you did for at least 10 minutes at a 
time. 
 
 
1. During the last 7 days, on how many days did you do vigorous physical activities like 
heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities on one of 
those days? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
Think about all the moderate activities that you did in the last 7 days.  Moderate activities refer 
to activities that take moderate physical effort and make you breathe somewhat harder than 
normal.  Think only about those physical activities that you did for at least 10 minutes at a time. 
 
 
3. During the last 7 days, on how many days did you do moderate physical activities like 
carrying light loads, bicycling at a regular pace, or doubles tennis?  Do not include 
walking. 
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_____ days per week 
 
   No moderate physical activities  Skip to question 5 
 
 
4. How much time did you usually spend doing moderate physical activities on one of 
those days? 
 
_____ hours per day 
_____ minutes per day 
 
  Don’t know/Not sure  
 
 
Think about the time you spent walking in the last 7 days.  This includes at work and at home, 
walking to travel from place to place, and any other walking that you might do solely for 
recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 minutes at a 
time?   
 
_____ days per week 
  
   No walking     Skip to question 7 
 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day  
 
  Don’t know/Not sure  
 
The last question is about the time you spent sitting on weekdays during the last 7 days.  
Include time spent at work, at home, while doing course work and during leisure time.  This may 
include time spent sitting at a desk, visiting friends, reading, or sitting or lying down to watch 
television. 
 
7. During the last 7 days, how much time did you spend sitting on a week day? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
 
This is the end of the questionnaire, thank you for participating. 
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Appendix 16 
 
 
Risk and Benefit Assessment 
 
 
OBJECTIVE: The current research available on disuse osteopenia, particularly long-term unilateral 
disuse osteopenia is limited.  Correct diagnosis means patients can be monitored and treated, reducing 
their future fracture risk.  Most research is focused on spinal cord injury, stroke patients, astronauts and 
bed-rest volunteers and may not be directly comparable to the effects of immobilisation of a single 
limb.  This research aims to investigate long-term disuse osteopenia in a wider population, including 
the fracture prevalence, and possible therapeutic interventions to provide a reduction in long-term low 
energy trauma fracture risk.  This is an important consideration for all healthcare teams caring for 
patients with long-term limb immobilization. 
 
OUTCOMES: Knowledge regarding the effects of immobilization on bone density and the resulting 
effect on future fracture risk. The effects of immobilization on functionality, quality of life and mental 
health (with regard to depression and anxiety) will also be investigated. 
 
EVIDENCE: Disuse osteopenia or osteoporosis is a well recognised complication of immobilisation
1-
4
.  In the majority of patients there is reversal of the disuse osteopenia upon remobilisation
5
.  However, 
stress fractures distal to the acute fractures have been reported in a small minority of patients post 
lower limb fracture upon mobilisation
6
.  Low energy trauma fractures have been reported in the lower-
limb long-bones of paraplegics
7,8
 and in non-ambulatory children with congenital conditions
9
, 
demonstrating that disuse osteopenia results in an increased fracture rate.   
 
There are few studies investigating disuse osteopenia in single limbs.  Tandon et al.
10
 reported reduced 
disuse osteopenia following external fixation of the tibia compared to those placed in plaster of Paris, 
even though those who underwent external fixation had more severe fractures.  Marchetti et al.
11
 
reported disuse osteopenia following shoulder surgery, which was partially reversed six weeks 
following remobilisation, whilst Rüegsegger et al 
12
 reported bone loss bilaterally post total hip 
replacement.  One of the most frequently studied groups suffering disuse osteoporosis are astronauts 
following time spent in microgravity during space missions.  Lang
13
 reported that up to 15% of bone 
strength can be lost at the proximal femur over a 6 month flight.  Rapid and severe bone loss has also 
been reported in patients suffering stroke
14
 and in volunteers on bed-rest studies
15
. 
 
Studies of bed-rest volunteers and spinal cord injury (SCI) patients have consistently reported an 
increase in markers of global bone resorption
15
.  However, in most studies the markers of bone 
formation have remained unchanged, suggesting that there is no decrease in bone formation as a result 
of disuse osteopenia
15,16
.  Maimoun et al. studied the effects of disuse osteopenia on osteoprotegerin 
(OPG) and reported that OPG was stimulated in SCI patients, whilst Receptor Activator for Nuclear 
Factor kB Ligand (RANKL) was inhibited.  These results led them to hypothesise that OPG may 
provide a protective mechanism in the body.  Whilst the OPG was deemed to have a protective role in 
this study, patients still lost bone and bone resorption markers were elevated, suggesting that the 
stimulation of OPG is insufficient to prevent osteoclastic proliferation and bone resorption
16
.  Studies 
of bed-rest volunteers have also reported increased urinary and faecal excretion of calcium coupled 
with increased serum calcium and decreased intestinal calcium absorption.  Increased serum calcium 
results in low parathyroid hormone and vitamin D, a regulatory response to the increased bone 
resorption, which results in a decreased intestinal calcium absorption through the vitamin D-mediated 
pathway
15,17-19
.   
 
Nutritional interventions have been reported to have a small influence of addressing the negative 
calcium balance in disuse osteopenia
20
. Early remobilisation is the most important factor for the 
prevention of disuse osteopenia
7
.  However, in patients where this is not possible, other therapeutic 
interventions may be required.  The bisphosphonate tiludronate has been demonstrated to be an 
effective treatment for disuse osteoporosis in paraplegic patients
21
, whilst alendronate has been 
demonstrated to be well tolerated and effective in non-ambulatory children
9
.  In an animal study Ma et 
al
22
 reported increases in trabecular bone in the tibiae of rats with continuously immobilised hind legs 
treated with 1,38 human parathyroid hormone (hPTH), suggesting this could be an effective treatment 
for disuse osteopenia.  It is possible that non-pharmacological therapeutic interventions might improve 
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disuse osteopenia such as weight-bearing exercise, or vibrating plates, both of which have been 
demonstrated to have positive effects on bone density
23,24
. 
 
In conclusion, the current research available on disuse osteopenia, particularly long-term unilateral 
disuse osteopenia is limited.  Correct diagnosis means that patients with this condition can be 
monitored and treated, reducing their future fracture risk.  Most research is focused on SCI, stroke 
patients, astronauts and bed-rest volunteers and may not be directly comparable to the effects of 
immobilisation of a single limb.  Further research is required to investigate long-term disuse osteopenia 
in a wide population, including the fracture prevalence, and possible therapeutic interventions to 
provide a reduction in their long-term low energy trauma fracture risk.  This is an important 
consideration for all healthcare teams caring for patients with long-term limb immobilisation and long-
term future fracture risk and appropriate therapeutic intervention requires consideration. 
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BENEFITS/HARMS: All scans will be conducted on a GE Lunar Prodigy machine, to ensure fast 
scan time with a low as possible radiation dose. The radiation doses each participant will be subjected 
to during a Lunar scan are detailed in Table 1, with comparative risks identified in Table 2.  
 
Table 1. Radiation doses from DEXA compared to other activities 
 Effective dose (Sv) 
AP spine* 0.7 
Hip* 0.68 
Total body* 0.5 
Lateral spine* 0.6 
Chest x-ray 20 
Lateral lumbar spine x-ray 700 
Daily background radiation 6 – 20 (depending on location) 
Return transatlantic flight 80 
*GE Lunar scan doses for a typical patient size using standard mode 
 
Table 2. Activities carrying a risk comparable to receiving an effective dose of 10 SV from a 
DEXA scan* 
Exposure to natural background radiation for 2 days 
Smoking a cigarette 
Travelling 30miles by car 
Travelling 150miles by aeroplane 
Working in a factory for a week 
*The Lunar Prodigy protocol of scanning bilateral hips, AP spine and whole body equates to = 2.56 
Sv. Indeed, the annual risk of death by natural causes (age 40) is 1 in 700, whilst the risk of death 
from an effective dose of 2Sv is 1 in 10 million. 
 
The University of Exeter Dose constraints (DXA laboratory IRMER procedures) are reproduced below 
as Table 4. (The dose constraints are derived from ICRP62 and the Medical and Dental Guidance 
Notes, and are identical to those employed within the Royal Devon and Exeter Foundation NHS Trust). 
As may be seen the level of risk for a 2 Sv effective dose is classified as trivial. 
 
Participants in the study will be post-menopausal females above 45 years old. Four repeat sets of scans 
are required at baseline, 6 week, 6 month and 12 month intervals giving a total effective dose of 10.4 
Sv. Only three sets of scans are required for control participants giving a total effective dose of 7.8 
Sv. 
 
The dose constraint for this trial has been set as 15 µSv, allowing for the possible repeat of individual 
exam(s) in the (unlikely) event of technical failure. 
 
In accordance with IRMER (2000), CHERC has a network of qualified experts in place to ensure any 
one person participating within a research project is not exposed to unnecessary risk. The network is 
detailed below; 
 
Position Name(s) Employer 
Employer Professor Steve Smith University of Exeter 
Referrer Dr Gill Vivian Derriford Hospital 
Practitioner Dr Gill Vivian Derriford Hospital 
Operators Dr Karen Knapp, Dr 
Joanne Welsman, Mr 
David Childs, Dr Ann 
Rowlands 
University of Exeter 
Medical Physics Expert Dr Bob Ward Royal Devon and Exeter Hospital 
Radiation Protection 
Adviser 
Ms Sonia Nuttall External Advisor 
Radiation Protection 
Supervisor 
Mr David Childs University of Exeter 
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The practitioner and operator are as defined in CHERC’s IRMER (2000) compliance document. As 
part of the Research Ethics Committee approval process for research projects, the Practitioner provides 
generic justification for exposures identified in that research proposal. All participants will then be 
assessed by the operators using osteoporotic risk factor and contra-indication questionnaires to assess 
the suitability for a scan. In cases where the person undergoing the procedure benefits from the 
exposure, the Practitioner is required to plan individual target levels of dose.  These are set at the time 
of justification and take into account the age of the individual and any other factors which affect the 
risk of that examination. In cases where there is no benefit to the individual, the setting of a dose 
constraint is required.  This is determined from the level of benefit to society and is detailed in Table 4. 
 
PROCEDURE FOR REFERRAL: If a participant is diagnosed with a BMD value (T or Z score
†
) 
that classifies them as Osteopenic or below according to the appropriate criteria (i.e., WHO criteria (see 
Table 3), NHANES criteria) they will be referred, by the operator, to the practitioner for further advice 
and possible intervention.  
 
Table 3. World Health Organisation Criteria for Interpretation of DEXA scans 
 
Diagnostic categories* Definitions 
Normal A value for BMD within 1SD of the young adult reference mean. 
Osteopenic  A value for BMD more than 1SD below the young adult mean but less 
than 2.5SD below this value. A T score between –1.0 and –2.5. 
Osteoporosis A value for BMD more than 2.5SD below the young adult mean. A T 
score below –2.5. 
Severe Osteoporosis A value for BMD more than 2.5SD below the young adult mean in the 
presence of one or more fragility fractures. 
*According to the T score 
 
CONCLUSIONS:  
 
The current research available on disuse osteopenia, particularly long-term unilateral disuse osteopenia 
is limited.  Correct diagnosis means patients can be monitored and treated, reducing their future 
fracture risk.  Most research is focused on spinal cord injury, stroke patients, astronauts and bed-rest 
volunteers and may not be directly comparable to the effects of immobilisation of a single limb.  This 
research aims to investigate long-term disuse osteopenia in a wider population, including the fracture 
prevalence, and possible therapeutic interventions to provide a reduction in long-term low energy 
trauma fracture risk.  This is an important consideration for all healthcare teams caring for patients with 
long-term limb immobilization. The research and risk and benefit assessment suggests
 
that the GE 
Lunar Prodigy could give the greatest benefit with least side effects in participants when assessing 
osteoporosis risk.  
                                                 
†
 T score: This represents the number of SD between the participants BMD and the mean reference 
value for the young sex-matched adults with peak BMD; Z score: This represents the number of SD 
between the BMD and the mean value of a sex and age matched population.  
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Table 4. Determination of benefit versus risk 
 
Required 
benefit to 
Society 
Dose Constraint 
1 † 
(Sv) 
Dose Constraint 
2† 
(Sv) 
Dose Constraint 
3† 
(Sv) 
Level of risk 
Minor 30 
100 500 
Trivial 
Intermediate 160 
500 2500 
Minor 
Moderate 1600 
5000 25,000 
Intermediate 
Substantial 3300 
10,000 50,000 
Moderate 
†These constraints apply to; 1 – children; 2 - adults under 50 years; 3 – adult over 50 years.  
 
 
Definitions of Benefit 
Minor: expected only to increase knowledge. 
Intermediate: related to increases in knowledge leading to health benefit. 
Moderate: aimed directly at the diagnosis, cure or prevention of disease. 
Substantial: directly related to the saving of a life or prevention/mitigation of serious disease.  
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Appendix 17 
 
 
ACTIVITY MONITOR INSTRUCTIONS 
 
 
Participant ID ......................................... Participant initials...................... 
Date........................................ 
Is this your: 
1
st
 Appointment 
6 week Appointment 
6 month Appointment 
12 month Appointment 
 
 
 
The activity monitor (pedometer) is a small, plastic box that records how much you are 
moving. We will use this information to assess how active you are when you are 
wearing it. 
PLEASE 
 WEAR IT FOR 3 DAYS and return it with this form in the envelope 
provided. 
 Wear the monitor all day (from getting up until bed time). 
 Wear it on your dominant side (i.e. right if you are right handed, left if left handed) OR 
on your uninjured side if you have had a fracture or surgery. 
 Do not wear whilst showering, bathing or swimming. 
 Press the RESET button at the start of each day (display will show 0). 
 Please record the reading (in the boxes below) at the end of each day. 
 
DAY 1  
DAY 2 
DAY 3 
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Appendix 18 
 
Immobilization record 
 
Participant ID ......................................... Participant initials...................... 
 
Date........................................ 
 
Is this your: 
1
st
 Appointment 
6 week Appointment 
6 month Appointment 
12 month Appointment 
 
 
Since your last appointment for this study:- 
 
Have you been fully mobile throughout the entire period? 
 
No 
Yes 
 
 If yes, please indicate approximately how much weight bearing activity you have done, 
on average, per day  
..................................................................................................................... 
 
Have you been partially immobilized for any period? 
 
No     
Several days                                               Please state how many.........................                                                        
1 week                                             
2 weeks 
More than 2 weeks                                   Please state how many......................... 
 
Please indicate approximately how much weight bearing activity you have done, on 
average, per day  
whilst partially immobilized 
..................................................................................................................... 
 
Have you been totally immobilized for any period? 
 
No     
Several days                                               Please state how many.........................                                           
1 week                                             
2 weeks 
More than 2 weeks                                    Please state how many......................... 
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Appendix 19 
 
Treatment and falls record 
 
Participant ID ......................................... Participant initials...................... 
 
Date........................................ 
 
Is this your: 
1
st
 Appointment 
6 week Appointment 
6 month Appointment 
12 month Appointment 
 
Since your last appointment for this study:- 
 
Have you had any falls during this period? 
No 
Yes 
If yes, please give details 
..........................................................................................................................................................................
..  
Have you sustained another fracture during this period? 
No 
Yes 
If yes, please give details 
..........................................................................................................................................................................
.. 
 
Have you been put onto any drug treatment for osteoporosis during this period? 
No 
Yes 
If yes,  
When did your treatment start?........................................................................................................... 
What drug(s) have you been prescribed?....................................................................................... ..... 
What is the dosage per day?................................................................................................................... 
 
Have you been put onto any other medication during this period? 
No 
Yes 
If yes,  
When did your treatment start?........................................................................................................... 
What drug(s) have you been prescribed?....................................................................................... ..... 
What is the dosage per day?................................................................................................................... 
 
Have you undergone any physical therapy for osteoporosis during this period? 
No 
Yes 
If yes,  
When did your treatment start?........................................................................................................... 
What therapy have you been having?............................................................................................ 
How often do you receive this therapy?................................................................................................... 
 
Have you undergone any other form of physical therapy during this period? 
No 
Yes 
If yes,  
When did your treatment start?............................................................................................................. 
What therapy have you been having?................................................................................................... 
How often do you receive this therapy?................................................................................................... 
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Have you been taking pain killers during this period? 
No 
Yes 
If yes,  
What medication have you used?........................................................................................................... 
Dose taken per day (on average)?............................................................................................................ 
How many weeks have you been using this medication?..................................................................... 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please indicate  by drawing a line 
on the scale below, what level of 
pain you experience on an average 
day. 100 represents intolerable pain. 
0 represents no pain at all. 
 
100 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
Intolerable pain 
No pain 
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Appendix 20 
 
 
MOOD DISORDERS CENTRE 
PROTOCOL FOR ASSESSING AND REPORTING RISK 
 
 The following principles and procedures govern risk assessment and reporting in the Mood 
Disorders Centre (MDC). The MDC does not manage risk. 
 
General principles 
 
MDC clinical academic faculty are responsible for risk assessment in their research programmes. This 
includes ensuring that staff, students and interns working with them receive adequate induction and 
training prior to participant contact in which risk could be disclosed and ongoing supervision during their 
research work. 
 
Many of the research projects in the MDC will include supplementary and more detailed protocols for 
risk assessment. 
 
The AccEPT Clinic Lead (for new assessments) and clinic therapists (for patients in therapy) are 
responsible for risk assessment in the AccEPT clinic.  
 
General procedures 
 
Background training materials are available on the shared directory.  
 
Whenever any significant risk is identified a risk assessment should be completed and (counter-) signed 
by the responsible member of staff. If at all possible this should be done at the time of the assessment, or 
as soon afterwards as possible.  
 
Any significant, but not imminent risk should be reported to the person’s GP and, if appropriate, other 
health care professionals, as soon as is reasonably possible. 
 
For research outside of the local area, PIs / supervisors should familiarise themselves with the local 
providers’ risk procedures, and researchers should hold the relevant contact details needed in the case of 
immediate risk. 
 
When clinical academic staff are away from the Centre they should ensure appropriate cover is arranged 
for any risk issues that might arise in their absence. 
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When conducting telephone interviews in which risk may be disclosed, the interviewer should establish 
the location of the participant at the start of the call, and clarify the boundaries of confidentiality (as per 
trial / clinic protocol). 
 
Applying MDC Risk Protocol to the AccEPT Clinical Service 
 
Typically risk may be detected at three stages during a client’s contact with the clinic: 
 
1. At telephone screening 
 
2. At face-to-face assessment  
 
3. During therapy, and before discharge from the Clinic. 
 
1. Telephone screening 
The MDC risk protocol should be enacted if any of the following boxes in section 2.1 are ticked: 
 
Hopeless/Suicide 
 Feeling hopeless or suicidal   Feeling persists 
 Considered self-harm    Did self-harm 
 
The outcome should be recorded in the telephone interview form. 
 
Staff / interns undertaking telephone screening under supervision should ensure they seek supervision for 
any risk assessments and have their reports and letters countersigned. 
 
2. At face-to-face assessment 
Client should be asked directly about whether suicidal ideation is present (usually as part of the current 
SCID, unless he / she is not currently experiencing depression). If there is any indication that this is the 
case from questioning / discussion, or from scores on self-report measures (score > 0 on CORE item 6 or 
PHQ-9 item 9 or BDI-II item 9), the risk protocol should be enacted. 
 
Particular attention should be paid to checking whether any client who reported significant levels of risk 
at the telephone assessment (action taken was B) have spoken with his / her GP (see protocol). 
 
The outcome of any risk assessment (including action taken) should be recorded in the client’s notes and 
communicated to the GP or others involved in the patient’s care as appropriate Staff / interns undertaking 
assessments under supervision should ensure they seek supervision for any risk assessments and have 
their reports and letters countersigned. 
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3. During therapy 
In individual therapy sessions risk should be assessed for clients reporting current suicidal ideation (either 
through questionnaire responses or during therapy discussion), following the MDC protocol.  
Group interventions should specify the trigger for further investigation of risk (for example, in the BA 
group risk is assessed if the client scores above 1 on BDI-II item 9, or changes from 0 to 1 on this item) 
and should assess risk using the MDC protocol. 
 
Clinicians are expected to exercise clinical judgment in determining suitable strategies for reporting and 
managing risk with regard to individual clients whose level of risk is assessed as being at ‘B’. For clients 
at immediate risk, the MDC risk protocol should be followed. 
 
Therapists are responsible for discharging patients back to the care of their GPs as soon after therapy is 
concluded as possible. This discharge summary should include reporting any risk issues, so that GPs can 
manage patient’s safety as part of their care plan. 
 
Exeter emergency contact numbers 
 
 Crisis Resolution Home Treatment Team (East and Mid Devon) 07968 845048 
Please note, this number is to make an urgent referral to the Crisis Team and should not be given out 
to participants / clients / members of the public under any circumstances. The participant’s / client’s 
GP can also make an urgent referral to the Crisis Team and should be the first port of call. 
 
 Exeter Accident and Emergency Department 
 This is located at the Royal Devon and Exeter Hospital (Wonford), Barrack  Road, Exeter, 
EX2 5DW 
 
 
 
Appendix 20 
[324] 
 
Exploring Risk in Research Interviews 
 
THOUGHTS 
 
“I see that you’ve said / you mentioned that……...  These are thoughts / feelings that people suffering 
from depression often have, but it’s important to make sure you are receiving the right kind of support.  
So if it’s OK, I would now like to ask you some more questions that will explore these feelings in a little 
more depth.” 
 
 PLANS 
1 Do you know how you would kill yourself?   Yes / No 
If yes – details 
 
 
 
 
2 Have you made any actual plans to end your life?  Yes / No 
If yes – details 
 
 
 
ACTIONS 
3 Have you made any actual preparations to kill yourself? Yes / No 
If yes – details 
 
 
 
4 Have you ever attempted suicide in the past?  Yes / No 
If yes – details 
 
 
 
PREVENTION 
5 Is there anything stopping you killing or harming yourself  
at the moment?       Yes / No 
If yes – details 
 
 
 
6 Do you feel that there is any immediate danger that you  
will harm or kill yourself?     Yes / No 
Details: 
 
 
 
 FOLLOW-UP FROM PREVIOUS CONTACT 
 
7 If Action B was enacted at previous assessment and level B risk is identified at current 
assessment: Last time we met I suggested that you spoke to your GP about these thoughts, and I also 
wrote to your GP about this. Have you been able to speak with your GP about these thoughts since 
we last met?   Yes / No 
See risk table overleaf for appropriate actions 
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Researcher Risk Protocol 
 
To be used following any indication of risk from questionnaire items, responses to interview questions or 
any other sources. Look at answers from the sheet to determine the level of risk, A B or C: 
 
Actions by Researcher Tell Participant 
All answers  ‘no’ apart from Q5 ‘yes’: 
 
 
A 
 
 
 
 
 
 
I can see that things have been very difficult for you, but 
it seems to me these thoughts about death are not ones 
you would act on – would this be how you see things?  
(if they say yes)  I would advise you to make an 
appointment to see your GP to talk about these feelings 
(as per trial protocol).  
  
‘Yes’ for any one of Qs 1-4;  plus ‘yes’ for 
Q5 and ‘no’ for Q6  
 
 
B1 
 
 
 
 
 
 
‘Yes’ for any one of Qs 1-4;  plus ‘yes’ for 
Q5 and ‘no’ for Q6 and ‘no’ to Q7 
 
 
 
 
Things seem to be very hard for you right now and I 
think it would help if you were to speak to your GP 
about these feelings.  I will be writing to your GP to tell 
them that you have been here today and have been 
having some troubling thoughts. I would also advise 
you to make an appointment to see your GP to talk 
about these feelings. (as per trial protocol). 
I think it’s important that your GP knows how difficult 
things are for you right now. I will be telephoning your 
GP to speak with him/her and suggest that you meet 
with one another. I also advise that you make an 
appointment to see your GP to talk about these feelings. 
(as per trial protocol).N.B: telephone call to GP to be 
followed up by letter. The letter should include the 
statement “the clinical management of this patient 
remains your responsibility, but it is part of our protocol 
to inform you of any risks disclosed to ourselves so that 
you can take account of them in your care plan.” 
Scoring ‘no’ to Q5 or ‘yes’ to Q6 
 
 
C Actively Suicidal 
 
 
 
 
 
I am very concerned about your safety at this moment, I 
am not a clinician but I would like you to talk to one 
right now. I am going to make some telephone calls now 
to arrange for your GP Care Co-ordinator / 
Crisis Management team/the emergency services to let 
them know how you are feeling and to arrange for you 
to receive immediate help. 
  
Action to take in the case of immediate risk: 
Participant needs immediate help – do not leave them alone, or if on telephone, do not hang up.  
Follow your trial’s chain of supervisory clinical contact in order to involve supervisory clinician right 
away. Then (with clinician if possible) follow the chain of contact below: 
1. GP / out of hours GP; if not  
2.Crisis team; if not  
3. Clinician accompanies to A&E; if not (or interview is over telephone)  
4. Call ambulance.                                                         
B2 
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Appendix 1                          Risk Report 
 
Patient name: _____________________  DOB: ________________ 
 
 
Suicide risk information: 
 
Include whether the participant has reported any of the following: 
 History of previous suicide attempts  
 Current suicidal ideation 
 Relevant inventory scores (e.g., BDI item 9) 
 Suicide plans / preparations 
 Protective factors 
 Regular contact with GP? 
 
 
 
 
 
 
 
 
 
 
 
 
 
Date reported: ___/___/___ 
 
Additional notes / actions taken: 
As part of the MDC risk protocol, suicide risk is managed by the patient’s GP. 
 
 
 
 
 
 
 
 
Date action taken: ___/___/___ 
 
 
 
Researcher / assessor: _________________ Signed: ______________ Date: ___/___/___ 
 
 
Supervisor: _________________________  Signed: ______________ Date: ___/___/___ 
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Appendix 21 
 
 
Example of the DXA output  
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Trabecular Bone Score (TBS) report example  
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